John E. Hall
Chair
Department:
SOM-Physiology & Biophysics
Email:
jehall@umc.edu
Work Phone:
(601) 984-1801
Education
Michigan State University, PhD, Physiology | 1974 |
U.S. Army, Military Service, Electronics/ Engineering | 1970 |
Kent State University, BS, Biology/Chemistry | 1968 |
Smithville High School, High School Diploma, General | 1964 |
Current Positions
Founding Director, Mississippi Center for Obesity Research, School of Medicine | 07/2013 - Present |
Arthur C. Guyton Professor and Chair, School of Medicine, Department of Physiology And Biophysics | 1989 - Present |
Professor, School of Medicine, Department of Physiology And Biophysics | 1982 - Present |
Member of Graduate Faculty, School of Medicine, Department of Physiology And Biophysics | 1977 - Present |
The University of Mississippi Medical Center Jackson, Mississippi 39216 |
Academic Appointments or Other Previous Appointments
Associate Vice Chancellor for Research, University of Mississippi Medical Center, School of Medicine | 2005 - 06/2013 |
Founding Director, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics | 1996 - 2009 |
Vice-Chairman, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics | 1988 - 1989 |
Director of Graduate Program, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics | 1980 - 1993 |
Associate Professor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics | 1979 - 1982 |
Assistant Professor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics | 1976 - 1979 |
Instructor, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics | 1975 - 1976 |
Postdoctoral Fellow, University of Mississippi Medical Center, School of Medicine, Department of Physiology And Biophysics | 1974 - 1976 |
Graduate Teaching Assistant, Michigan State University, School of Graduate, Department of Physiology And Biophysics | 1973 - 1974 |
Graduate Student, Michigan State University, School of Graduate, Department of Physiology And Biophysics | 1970 - 1973 |
Sponsored Program Funding
Extramural, Role of Renal Nerves in Obesity-Induced Hypertension, St. Jude Medical, Inc. | 07/2010 - 06/2012 |
Extramural, Non-Invasive Hemodynamic Monitoring, National Institutes of Health | 06/2010 - 07/2012 |
Extramural, Cardiovascular Dynamics and Their Control (minority supplement award), National Institutes of Health | 03/2009 - 11/2012 |
Extramural, Canadian Institutes of Health Research Fellowship Award for Dr. Shereen Hamza, Canadian Institutes of Health | 01/2009 - 12/2012 |
Extramural, Mechanisms in Obesity-Induced Renal Injury - postdoctoral fellowship award for Shankar Munusamy, American Heart Association | 01/2009 - 12/2011 |
Extramural, Cardiovascular Dynamics and their Control, National Institutes of Health | 12/2008 - 11/2013 |
Extramural, Blockade of Soluble Epoxide Hydrolase in Obesity Hypertension, ARETE Therapeutics | 08/2008 - 07/2009 |
Extramural, Chronic Metabolic Effects of Blocking Soluble Epoxide Hydrolase, ARETE Therapeutics | 06/2008 - 07/2009 |
Extramural, 11B-HSD1 inhibition in hypertension, Merck & Company, Inc. | 02/2008 - 01/2009 |
Extramural, Mechanisms of Obesity-Induced Renal Injury - postdoctoral fellowship award for Elizabeth Brandon, National Institutes of Health | 01/2007 - 12/2010 |
Extramural, Distinguished Lecture Series, Robert M. Hearin Support Foundation | 09/2006 - 08/2012 |
Extramural, Physician Scientist Training Program, Robert M. Hearin Support Foundation | 09/2006 - 08/2012 |
Extramural, Jackson Cardiovascular-Renal Meeting, Robert M. Hearin Support Foundation | 09/2006 - 08/2009 |
Extramural, Medical Research Scholars Program, Robert M. Hearin Support Foundation | 07/2006 - 06/2012 |
Extramural, Postdoctoral Fellowship Program, Robert M. Hearin Support Foundation | 07/2006 - 06/2009 |
Extramural, Cardiovascular-Renal Meeting, Robert M. Hearin Foundation | 01/2006 - 12/2010 |
Extramural, Postdoctoral Fellows Training Program, Robert M. Hearin Foundation | 01/2006 - 12/2010 |
Extramural, Blockade of Soluble Epoxide Hydrolase-a Novel Anti-hypertensive Therapy, ARETE Therapeutics | 01/2006 - 12/2007 |
Extramural, Novartis Institutes for Biomedical Research, Novartis | 07/2005 - 07/2008 |
Extramural, Jackson Heart Study, National Institutes of Health | 01/2005 - 12/2013 |
Extramural, Pfizer Global Research & Development, Pfizer | 01/2004 - 12/2006 |
Extramural, Role of the Melanocortin-4 Receptor in Obesity Hypertension - postdoctoral fellowship award for Lakshmi Tallam, American Heart Association | 01/2004 - 12/2006 |
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health | 01/2003 - 12/2008 |
Extramural, Role of Melanocortin & Sympathetic Nervous Systems in Mediating the Actions of Leptin in Type-1 Diabetes - postdoctoral fellowship award for Alexandre daSilva, American Heart Association | 01/2003 - 12/2005 |
Extramural, Endocannabinoids in Obesity, Merck & Co, Inc. | 01/2003 - 12/2004 |
Extramural, The Renin-Angiotensin-Aldosterone System and Obesity-induced Hypertension, Pharmacia Co. | 01/2002 - 12/2002 |
Extramural, Molecular Genetics Core Facility, Department of Health and Human Services | 01/2001 - 12/2002 |
Extramural, Jackson Heart Study, National Institutes of Health | 01/1999 - 12/2005 |
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health | 01/1998 - 12/2003 |
Extramural, Cardiorenal Adaptation in Obesity Hypertension - NRSA for Jeff Henegar, National Institutes of Health | 01/1998 - 12/2001 |
Extramural, Grant for Center for Excellence in Cardiovascular-Renal Research, Renal Care Foundation | 01/1998 - 12/2000 |
Extramural, Jackson Heart Study, Phase I Feasibility Study, National Institutes of Health | 01/1997 - 12/1999 |
Extramural, Grant for Center for Excellence in Cardiovascular-Renal Research, Renal Care Foundation | 01/1996 - 12/1997 |
Extramural, Role of Amylin in Mediating Cardiovascular Changes in Obesity, Amylin Pharmaceuticals | 01/1996 - 12/1996 |
Extramural, Neurohumoral Mechanisms of Obesity Hypertension - NRSA for Dion Zappe, National Institutes of Health | 01/1994 - 12/1996 |
Extramural, Obesity-Induced Hypertension: Role of the Sympathetic Nervous System & Renin-Angiotensin System - postdoctoral fellowship for Dion Zappe, American Heart Association, Mississippi Affiliate | 01/1994 - 12/1996 |
Extramural, The Renin-Angiotensin System and Obesity-Induced Hypertension, Bristol-Myers Squibb Co. | 01/1994 - 12/1996 |
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health | 01/1993 - 12/1999 |
Extramural, Physiology Graduate Fellowship Training Grant, GLAXO | 01/1993 - 12/1996 |
Extramural, Chronic Renal, Hormonal, and Blood Pressure Effects of a New Angiotensin Converting Enzyme Inhibitor During Chronic Congestive Heart Failure, Ciba-Geigy Corporation | 01/1990 - 12/1990 |
Extramural, Calcium Homeostasis in Hypertension, National Institutes of Health | 01/1989 - 12/1992 |
Extramural, Hormonal Control of Renal Function, National Institutes of Health | 01/1988 - 12/1994 |
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health | 01/1988 - 12/1993 |
Extramural, Chronic Renal Actions of Atrial Natriuretic Factor, National Institutes of Health | 01/1988 - 12/1991 |
Extramural, Role of Hyperinsulinemia in Obesity Hypertension, American Heart Association | 01/1988 - 12/1990 |
Extramural, Young Scholar Award, Marion Laboratories | 01/1988 - 12/1988 |
Extramural, Blood Pressure and Renal Function in Hyperinsulinemia, National Institutes of Health | 01/1987 - 12/1993 |
Extramural, Role of Hyperinsulinemia in Hypertension Associated with Obesity, National Institutes of Health | 01/1987 - 12/1987 |
Extramural, Comparison of the Chronic Renal and Blood Pressure Effects of a New Renin Inhibitor (CP-71362) With a Converting Enzyme Inhibitor in Conscious Dogs, Pfizer Central Research | 01/1986 - 12/1986 |
Extramural, Renal and Hormonal Mechanisms of Blood Pressure Control, National Institutes of Health | 01/1984 - 12/1987 |
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health | 01/1983 - 12/1988 |
Extramural, Neural Control of the Kidney, National Institutes of Health | 01/1983 - 12/1985 |
Extramural, Hormonal Control of Renal Function, National Institutes of Health | 01/1982 - 12/1987 |
Extramural, Angiotensin and Neural Control of Kidney, Mississippi Heart Association | 01/1982 - 12/1984 |
Extramural, Intrarenal Role of Renin Angiotensin System, Mississippi Heart Association | 01/1980 - 12/1982 |
Extramural, Hormonal Control of Renal Function, National Institutes of Health | 01/1978 - 12/1984 |
Extramural, Hormonal Control of Renal Function, National Institutes of Health | 01/1978 - 12/1982 |
Extramural, Intrarenal Role of the Renin-Angiotensin System, Mississippi Heart Association | 01/1978 - 12/1980 |
Extramural, Role of Adrenal Cortical Hormones in Regulating Renal Function, Kidney Foundation of Mississippi | 01/1978 - 12/1978 |
Extramural, Cardiovascular Dynamics and Their Control, National Institutes of Health | 01/1977 - 12/1982 |
Extramural, Role of the Renal Medulla in the Control of Blood Pressure, Mississippi Heart Association | 01/1976 - 12/1977 |
Extramural, Peripheral Vascular Control During Hemorrhage, National Institutes of Health | 01/1975 - 12/1978 |
Publications
Biography | |
Hall JE Remembering Arthur C. Guyton, MD J Miss State Med Assoc, 150th Commemorative Edition 2018; 59: 526-531. | 2018 |
Hall JE, The renin-angiotensin-aldosterone system: a personal perspective and Festschrift for John H. Laragh, MD. American journal of hypertension, 2014 Aug;27(8):1005-7 | 2014 |
Hall JE, Cowley AW Jr, Bishop VS, Granger DN, Navar LG, Taylor AE, In memoriam. Arthur C. Guyton (1919-2003). The Physiologist, 2003 Jun;46(3):126-8 | 2003 |
Guideline | |
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ, Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research, Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension (Dallas, Tex. : 1979), 2005 Jan;45(1):142-61 | 2005 |
Consensus Development Conference | |
Whelton PK, Appel LJ, Sacco RL, Anderson CA, Antman EM, Campbell N, Dunbar SB, Frohlich ED, Hall JE, Jessup M, Labarthe DR, MacGregor GA, Sacks FM, Stamler J, Vafiadis DK, Van Horn LV, Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation, 2012 Dec 11;126(24):2880-9 | 2012 |
Journal Article | |
Jones DW, Hall JE. Racial and ethnic differences in blood pressure: biology and sociology Circulation. 2006; 114:2757-2759 | 2006 |
Liu J, daSilva AA, Tallam L, Hall JE. Chronic central nervous system hyperinsulinemia and regulation of arterial presure and food intake J Hypertension. 2006; 24:1391-1395 | 2006 |
daSilva AA, Tallam LS, Liu J, Hall JE. Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity Am J Physiol Regul Integr Comp Physiol. 2006; 291:1275-1282 | 2006 |
Tallam LS, da Silva AA, Hall JE. The melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin Hypertension. 2006; 48:58-64 | 2006 |
Hall JE. Obesity, adipokines and hypertension J. Hypertension. 2006; 24 (Suppl. 6): 12-13 | 2006 |
daSilva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Does dietary-induced obesity induce “resistance” to the long-term cardiovascular and metabolic actions of hypothalamic melanocortin 3/4 receptor activation? Hypertension. 2006; 47:259-264 | 2005 |
Tallam LS, Stec DE, Willis MA, daSilva AA, Hall JE. Melanocortin-4 receptor deficient mice are not hypertensive or salt-sensitive despite obesity, insulin resistance and hypertleptinemia Hypertension. 2005; 46:326-332 | 2005 |
Vachharajani VT, Russsell JM, Scott KL, Conrad S, Stokes KY, Tallam L, Hall JE, Granger DN. Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain Microcirculation. 2005; 12:183-194 | 2005 |
Gu JW, Fortepiani L, Reckelhoff JF, Adair TH, Wang J, Hall JE. Increased vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats Microcirculation. 2004; 11:689-697 | 2004 |
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz TW, Sheps SG, Roccella EJ. Recommendations for measuring blood pressure in humans and animals. Part 1. Blood pressure measurement in humans Hypertension. 2005; 45:142-161 | 2004 |
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for measuring blood pressure in humans and animals. Part 2. Blood pressure measurement in animals Hypertension. 2005; 45:299-310 | 2004 |
Tallam LS, Kuo JJ, daSilva AA, Hall JE. Cardiovascular, renal and metabolic responses to chronic central administration of agouti related peptide Hypertension. 2004; 44:853-858 | 2004 |
Wofford MR, Hall JE. Pathophysiology and treatment of obesity hypertension Curr Pharm Des. 2004; 10:3621-3637 | 2004 |
Gu JW, Wang J, Stockton A, Lokitz B, Henegar L, Hall JE. Cytokine gene expression profiles in kidney medulla and cortex of obese hypertensive dogs Kidney Int. 2004; 66:713-721 | 2004 |
Philip-Couderc P, Smih F, Hall JE, Patul A, Roncalli J, Massabuau P, Galinier M, Senard JM, Rouet P Kinetic analysis of cardiac transcriptome regulation during chronic high fat diet in dogs Physiol Genomics. 2004; 19:32-40 | 2004 |
Davy KP, Hall JE. Obesity and hypertension: two epidemics or one? Am J Physiol. 2004; 286:R803-R813 | 2004 |
da Silva AA, Kuo JJ, Hall JE. Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal and metabolic actions of leptin Hypertension. 2004; 43:1312-1317 | 2004 |
Salahudeen AK, Fleischmann EH, Bower JD, Hall JE. Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population Nephrol Dial Transplant. 2004; 19:427-432 | 2004 |
Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, Tallam L. Is obesity a major cause of chronic renal disease? Adv Ren Replacement Ther. 2004; 11:41-54 | 2004 |
Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation Hypertension. 2004; 43:370-375 | 2004 |
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension Hypertension. 2004; 43:383-387 | 2004 |
DePaula RB, daSilva AA, Hall JE. Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration Hypertension. 2004; 43:41-47 | 2003 |
Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam L, Liu J. Impact of the obesity epidemic on hypertension and kidney disease Curr Hypertens Rep. 2003; 5:386-392 | 2003 |
Hall JE. Historical perspective of the renin-angiotensin system Mol Biotechnol. 2003; 24:27-39 | 2003 |
Kuo JJ, Jones OB, Hall JE. Chronic cardiovascular and renal actions of leptin during hyperinsulinemia Am J Physiol. 2003; 284:R1037-R1042 | 2003 |
Hall JE, Kuo JJ, da Silva A, DePaula R, Liu J, Tallam L. Obesity-associated hypertension and kidney disease Curr Opin Nephrol Hypertens. 2003; 12:195-200 | 2003 |
Hall JE. The kidney, obesity, and hypertension Hypertension. 2003; 41:625-633 | 2003 |
Kuo JJ, Silva AA, Hall JE. Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function Hypertension. 2003; 41:768-774 | 2002 |
Hall JE, Crook ED, Dubbert PM, Jones DW, Wofford MR. Mechanisms of obesity-associated cardiovascular and renal disease Am J Med Sci. 2002; 324:127-137 | 2002 |
Dubbert PM, Carithers T, Sumner AE, Barbour K, Clark B, Hall JE, Crook ED. Obesity, physical inactivity, and risk for cardiovascular disease Am J Med Sci. 2002; 324:116-126 | 2002 |
Crook ED, Flack JM, Salem M, Salahudeen AK, Hall JE. Primary renal disease as a cardiovascular risk factor Am J Med Sci. 2002; 324:138-145 | 2002 |
Hall JE, Jones DW What can we do about the "epidemic" of obesity? Am J Hypertens. 2002; 15:657-659 | 2002 |
Carlyle ME, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity Hypertension. 2002; 39:496-501 | 2002 |
Fitzgerald SM, Hall JE, Brands MW. Rapid hypotensive response to fasting in spontaneously hypertensive rats Am J Hypertension. 2001; 14:1123-1127 | 2001 |
Hall JE. The promise of translational physiology Am J Physiol. 2001; 281:C1411-C1412 | 2001 |
Fitzgerald SM, Henegar JR, Brands MW, Henegar LK, Hall JE. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats Am J Physiol. 2001; 281:R547-R552 | 2001 |
Wofford, MR, Anderson DC, Brown CA, Jones DW, Miller ME, Hall JE. Antihypertensive effect of α and β blockade in obese and lean hypertensive subjects Am J Hypertens. 2001; 14:694-698 | 2001 |
Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity J Am Soc Nephrol. 2001; 12:1211-1217 | 2001 |
Hall JE, Hildebrandt DA, Kuo J. Obesity hypertension – role of leptin and sympathetic nervous system Am J Hypertens. 2001; 14:103s-115s | 2001 |
Kuo J, Jones OB, Hall JE. Inhibition of NO enhances the cardiovascular and renal actions of leptin Hypertension. 2001; 37:670-676 | 2001 |
Dwyer TM, Banks SA, Alonso-Galicia M, Cockrell K, Carroll JF, Bigler SA, Hall JE. Distribution of renal medullary hyaluronan in lean and obese rabbits Kidney Int. 2000; 58:721-729 | 2000 |
Dwyer TM, Bigler SA, Moore NA, Carroll JF, Hall JE. The altered structure of renal papillary outflow tracts in obesity Ultrastruct Pathol. 2000; 24:251-257 | 2000 |
Hall JE, Brands MW, Hildebrandt DA, Kuo J, Fitzgerald S. Role of the sympathetic nervous system and neuropeptides in obesity hypertension Braz J Med Biol Res. 2000; 33:605-618 | 2000 |
Hall JE. Pathophysiology of obesity hypertension Curr Hypertens Rep. 2000; 2:139-147 | 2000 |
Hall JE. Integration and regulation of cardiovascular function Am J Physiol. 1999; 22:s174-s186 | 1999 |
Hall JE, Brands MW, Henegar JR. Mechanisms of hypertension and kidney disease in obesity Ann N Y Acad Sci. 1999; 892:91-107 | 1999 |
Khalil RA, Crews JK, Carroll JF, Hall JE. Enhanced vascular reactivity and Ca2+ entry with low salt diet. Effect of obesity Hypertension. 1999; 34:882-888 | 1999 |
Hall JE, Shek EW, Brands MW. Does leptin contribute to obesity hypertension? Curr Opin Endocrinol Diab. 1999; 6:225-229 | 1999 |
Hall JE. Angiotensin II and long-term arterial pressure regualation: the overriding dominance of the kidney J Am Soc Nephrol. 1999; 10 (Suppl 12):s258-s265 | 1999 |
Hildebrandt DA, Smith MJ Jr., Hall JE. Cardiovascular regulation during insulin infusion into the carotid or vertebral artery in dogs J Hypertens. 1999; 17:251-260 | 1999 |
Hall JE. Renal mechanisms of obesity hypertension and relevance to essential hypertension Therapeutic Research. 1999; 20:78-91 | 1999 |
Brands MW, Hall JE. Renal perfusion pressure is an important determinant of sodium and calcium excretion in DOC-salt hypertension Am J Hypertens. 1998; 11:1199-1207 | 1998 |
Keen HL, Brands MW, Smith Jr. MJ, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats Hypertension. 1998; 31:637-642 | 1998 |
Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure Hypertension. 1998; 31:409-414 | 1998 |
Hall JE. Sodium and hypertension: Physiology Proc Nat Kid Found., Clin Nephrol. 1998; 105-106 | 1998 |
Hall JE, Brands MW, Henegar JR, Skek EW-M Abnormal kidney function as a cause and a consequence of obesity hypertension Clin Exp Pharmacol Physiol. 1998; 25:65-69 | 1998 |
Brands MW, Hall JE, Keen HL Is insulin resistance linked to hypertension? Clin Exp Pharmacol Physiol. 1998; 25:70-76 | 1998 |
Keen HL, Brands MW, Smith MJ Jr., Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats Am J Hypertens. 1997; 10:1125-1131 | 1997 |
Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension Am J Hypertens. 1997; 10:49s-55s | 1997 |
Rust OA, Bofill JA, Magann EF, Zappe DH, Hall JE, Burnett JC, Martin JA. The origin of endothelin in patients with severe peeeclampsia Obstet Gynecol. 1997; 89:754-757 | 1997 |
Summers RL, Montani JP, Woodward LH, Coleman TG, Hall JE. Theoretical analysis of the mechanisms of hyperinsulinemia Comput Biol Med. 1997; 27:249-256 | 1997 |
Hall WD, Ferrario CM, Moore MA, Hall JE, Flack JM, Cooper W, Simmons JD, Egan BM, Lackland DT, Perry M Jr, Roccella EJ. Hypertension related morbidity and mortality in the Southeastern United States Am J Med Sci. 1997; 313:195-209 | 1997 |
Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system Hypertension. 1997; 29:1014-1019 | 1997 |
Keen HL, Brands MW, Smith MJ Jr, Shek EW, Hall JE. Thromboxane is required for full expression of angiotensin hypertension in rats Hypertension. 1997; 29:310-314 | 1997 |
Keen H L, Brands MW, Alonso-Galacia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats Am J Hypertens. 1996; 9:1192-1199 | 1996 |
Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats: Role of angiotensin II and adrenergic activity Hypertension. 1996; 28:1047-1054 | 1996 |
Hall JE, Zappe DH, Alonso-Galicia M, Granger JP, Brands MW, Kassab SE. Mechanisms of obesity-induced hypertension News Physiol Sci. 1996; 11:255-261 | 1996 |
Hall JE, Brands MW, Shek E. Central role of the kidneys and abnormal fluid volume control in hypertension J Hum Hypertens. 1996; 10:633-639 | 1996 |
Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats Am J Physiol. 1996; 271:R276-R281 | 1996 |
Summers RL, Woodward LH, Sanders DY, Hall JE. Graphical analysis for the study of metabolic states Advan Physiol Educ. 1996; 270:s81-s87 | 1996 |
Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Cardiovascular actions of insulin: Are they important in long-term blood pressure regulation? Clin Exp Pharmacol. 1995; 22:689-700 | 1995 |
Van Vliet BN, Hall JE, Mizelle LH, Montani JP, Smith Jr. MJ. Reduced parasympathetic control of heart rate in obese dogs Am J Physiol. 1995; 269:H629-H637 | 1995 |
Hall JE, Brands MW, Zappe DH, Granger JP, Kassab S, Alonso-Galicia M , Keen H. Pathophysiology of obesity associated hypertension J Hypertension. 1995; 2 (Suppl 2): s3-s13 | 1995 |
Brands MW, Hall JE, Van Vliet BN, Alonso-Galicia M., Herrera GA, Zappe DH. Obesity and hypertension: Roles of hyperinsulinemia, sympathetic nervous system, and intrarenal mechanisms J Nutr. 1995; 125:1725s-1731s | 1995 |
Hall JE, Brands MW, Zappe DH, Dixon WN, Mizelle HL, Reinhart, Hildebrandt DA. Hemodynamic and renal responses to chronic hyperinsulinemia in obese, insulin resistant dogs Hypertension. 1995; 25:994-1002 | 1995 |
Alonso-Galicia M, Dwyer TM, Herrera GA, Hall JE. Increased hyaluronic acid in the inner medulla of obese dogs Hypertension. 1995; 25:888-892 | 1995 |
Hall JE, Brands MW, Zappe DH, Alonso-Galicia M. Insulin resistance, hyperinsulinemia and hypertension: Causes, consequences, or merely correlations? Proc Soc Exp Biol Med. 1995; 208:317-329 | 1995 |
Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity Hypertension. 1995; 25:893-897 | 1995 |
Hall JE, Summers RL, Keen H, Brands MW, Alonso-Galicia M. Insulin resistance and its role in hypertension Am J Hypertens. 1994; 7:772-788 | 1994 |
Hall JE. Louis K. Dahl memorial lecture. Renal and cardiovascular mechanisms of hypertension in obesity Hypertension. 1994; 23:381-394 | 1994 |
Hall JE, Brands MW, Zappe DH, Keen H, Alonso-Galicia M. The insulin hypothesis of hypertension-experimental evidence J Hypertens. 1994; Ed. Esp 1 (Suppl. 1): S3-S13 | 1994 |
Brands MW, Garrity CA, Holman MG, Hall JE. Exaggerated pressor and chronotropic responses to chronic hyperinsulinemia in SH and WKY rats Am J Hypertens. 1994; 7:75-81 | 1994 |
Brands MW, Garrity CA, Holman MG, Hall JE. High fructose diet does not raise 24 hour mean arterial pressure in rats Am J Hypertens. 1994; 7:104-109 | 1994 |
Hall JE, Brands MW, Dixon WN, Smith Jr. MJ. Obesity-induced hypertension: Renal function and systemic hemodynamics Hypertension. 1993; 22:292-299 | 1993 |
Mizelle HL, Montani JP, Hester RL, Didlake RH, Hall JE. Role of pressure natriuresis in long-term control of renal electrolyte excretion Hypertension. 1993; 22:102-110 | 1993 |
Hall JE. Hyperinsulinemia: A link between obesity and hypertension? Kidney Int. 1993; 43:1402-1417 | 1993 |
Brands MW, Alonso- Galicia M, Mizelle HL, Hildebrandt DA, Hall JE. Chronic angiotensin converting enzyme inhibition improves cardiac output and fluid balance during heart failure Am J Physiol. 1993; 264:R414-R422 | 1993 |
Brands MW, Hall JE. Insulin resistance, hyperinsulinemia, and obesity- associated hypertension J Am Soc Nephrol. 1992; 3:1064-1077 | 1992 |
Hildebrandt DA, Mizelle HL, Brands MW, and Hall JE. Comparison of renal actions of urodilation and atrial natriuretic peptide Am J Physiol. 1992; 262:R395-R399 | 1992 |
Hall JE. Kidney function and hypertension Japan J Appl Physiol. 1992; 22(Suppl.):59-60 | 1992 |
Hall JE, Brands MW. Obesity-associated hypertension: Role of insulin and renal mechanisms Spectrum der Nephrologie. 1992;8: 3-12 | 1992 |
Brands, MW, Hildebrandt DA, Mizelle HL, Hall JE. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive Hypertension. 1992; 19 (Suppl. I): I83-I89 | 1992 |
Mizelle HL, Gaillard CA, Manning RD, Hall JE. Mechanism of decreased cardiac output during ANP infusion in conscious anephric dogs Am J Physiol. 1992; 262:R120-R125 | 1992 |
Hall JE, Brands MW, Hildebrandt DA, Mizelle HL. Obesity-associated hypertension: Hyperinsulinemia and renal mechanisms Hypertension. 1992; 19 (Suppl I):I45-I55 | 1992 |
Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Pressure natriuresis and angiotensin II in reduced kidney mass- salt induced hypertension Am J Physiol. 1992; 262:R61-R71 | 1992 |
Hall JE. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension Am J Hypertens. 1991; 4 (10 Pt 2):523s-533s | 1991 |
Hall JE. Control of blood pressure by the renin-angiotensin-aldosterone system Clin Cardiol. 1991; 14 (Suppl. 4): 6-21 | 1991 |
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia does not cause hypertension Am J Physiol. 1991; 260:F663-F669 | 1991 |
Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats Am J Physiol. 1991; 260:R764-R768 | 1991 |
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia in conscious dogs Am J Hyper. 1991; 4:164-168 | 1991 |
Gaillard CA, Mizelle HL, Montani JP, Brands MW, Hildebrandt DA, Hall JE. Atrial natriuretic factor and blood pressure control: Role of sodium and aldosterone Am J Physiol. 1990; 259:R973-R980 | 1990 |
Hildebrandt DA, Mizelle HL, Brands MW, Gaillard CA, Smith Jr. MJ, Hall JE. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically Am J Physiol. 1990; 259:R585-R592 | 1990 |
Hildebrandt DA, Mizelle HL, Brands MW, Gaillard CA, Smith MJ Jr, Hall JE. Intrarenal atrial natriuretic peptide infusion lowers arterial pressure chronically Am J Physiol. 1990; 259:R585-R592 | 1990 |
Hall JE, Mizelle HL, Hildebrandt DA, Brands MW. Abnormal pressure natriuresis: A cause or a consequence of hypertension? Hypertension. 1990; 15:547-559 | 1990 |
Mizelle HL, Hildebrandt DA, Gaillard CA, Brands MW, Montani JP, Smith Jr. MJ, Hall JE. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs Am J Physiol. 1990; 258:R1445-R1452 | 1990 |
Hall JE, Brands MW, Mizelle HL, Kivlighn SD, Hildebrandt DA, Gaillard CA. Chronic hyperinsulinemia and blood pressure: Interactions with catecholamines? Hypertension. 1990; 15:519-527 | 1990 |
Hall JE, Mizelle HL. Control of arterial pressure and renal function during chronic renin inhibition J Hypertens. 1990; 8:352-360 | 1990 |
Hall JE, Coleman TG, Mizelle HL, Smith Jr. MJ. Chronic hyperinsulinemia and blood pressure regulation Am J Physiol. 1990; 258:F722-F731 | 1990 |
Hall JE, Guyton AC, Mizelle HL. Role of the renin-angiotensin system in control of sodium excretion and arterial pressure Acta Physiologica-Scandinavia. 1990; 139 (Suppl. 591): 48-62 | 1990 |
Mizelle HL, Hall JE, Hildebrandt DA. Atrial natriuretic peptide and pressure natriuresis: Interactions with angiotensin Am J Physiol. 1989; 257:R1169-R1174 | 1989 |
Hall JE. Intrarenal actions of converting enzyme inhibitors Am J Hypertens. 1989; 2:875-884 | 1989 |
Hall JE, Coleman TG, Guyton AC. The renin-angiotensin system: Normal physiology and changes in older hypertensives J Am Geriatr Soc. 1989; 37: 801-813 | 1989 |
Mizelle HL, Hall JE, Montani JP. Role of renal nerves in control of sodium excretion during chronic congestive heart failure Am J Physiol. 1989; 256:F1084-F1093 | 1989 |
Hall JE, Coleman TG, Mizelle HL. Does Chronic Hyperinsulinemia Cause Hypertension? Am J Hyper. 1989; 2:171-173 | 1989 |
Woods LL, Mizelle HL, Hall JE. Control of sodium excretion in NE-ACTH hypertension: Role of pressure natriuresis Am J Physiol. 1988; 255:R894-R900 | 1988 |
Mizelle HL, Hall JE, Woods LL. Interactions between angiotensin II and the renal nerves during chronic sodium deprivation Am J Physiol. 1988; 255:F823-F827 | 1988 |
Hall JE, Mizelle HL, Montani JP, Woods LL. Pressure natriuresis and control of arterial pressure during chronic norepinephrine infusion J Hypertens. 1988; 6:723-732 | 1988 |
Guyton AC, Montani JP, Hall JE, Manning Jr. RD. Computer models for designing hypertension experiments and studying concepts Am J Med Sci. 1988; 295:320-326 | 1988 |
Guyton AC, Hall JE, Montani JP. Kidney function and hypertension Acta Physiologica Scandinavica. 1988; 133 (Suppl. 571): 163-173 | 1988 |
Woods LL, Mizelle HL, Hall JE. Role of the liver in renal hemodynamic response to amino acid infusion Am J Physiol. 1987; 252:F981-F985 | 1987 |
Olsen ME, Hall JE, Montani JP, Cornell JE. Interaction with renal prostaglandins and angiotensin II in controlling glomerular filtration in the dog Clin Sci. 1987; 72:429-436 | 1987 |
Mizelle HL, Hall JE, Woods LL, Montani JP. Role of renal nerves in compensatory adaptation to chronic reductions in sodium intake Am J Physiol. 1987; 252:F291-F298 | 1987 |
Woods LL, Mizelle HL, Hall, JE. Autoregulation of renal blood flow and glomerular filtration rate in the pregnant rabbit Am J Physiol. 1987; 252:F69-F72 | 1987 |
Woods LL, Mizelle Hl, Hall JE. Control of renal hemodynamics in hyperglycemia: Possible role of tubuloglomerular feedback Am J Physiol. 1987; 252:F65-F73 | 1987 |
Hall JE, Guyton AC, Coleman TG, Mizelle HL, Woods LL. Regulation of arterial pressure: Role of pressure natriuresis and diuresis Fed Proc. 1986; 45: 2897-2903 | 1986 |
Guyton AC, Manning Jr. RD, Norman Jr. RA, Montani JP, Lohmeier TE, Hall JE. Current concepts and perspectives of renal volume regulation in relationship to hypertension J Hypertens. 1986; 4(Suppl. 4):S49-S56 | 1986 |
Hall JE, Granger JP, Hester RL, Montani JP. Mechanisms of sodium balance in hypertension: Role of pressure natriuresis J Hypertens. 1986; 4(Suppl. 4):S57-S65 | 1986 |
Woods LL, Mizelle HL, Montani JP, Hall JE. Mechanisms controlling renal hemodynamics and electrolyte excretion during amino acids Am J Physiol. 1986; 251:F303-F312 | 1986 |
Hall JE, Mizelle HL, Woods LL. The renin-angiotensin system and long-term regulation of arterial pressure J Hypertens. 1986; 4:387-397 | 1986 |
Hall JE. Control of sodium excretion by angiotensin: Intrarenal mechanisms and blood pressure regulation Am J Physiol. 1986; 250:R960-R972 | 1986 |
Hall JE, Granger, JP. Adenosine alters glomerular filtration control by angiotensin II Am J Physiol. 1986; 250:F917-F923 | 1986 |
Hall JE, Montani JP, Woods LL, Mizelle HL. Renal escape from vasopressin: Role of pressure diuresis Am J Physiol. 1986; 250: F907-F916 | 1986 |
Hall JE. Regulation of glomerular filtration and sodium excretion by angiotensin II Fed Proc. 1986; 45:1431-1437 | 1986 |
Hall JE, Granger JP. Renal hemodynamics and arterial pressure during chronic intrarenal adenosine infusion in conscious dogs Am J Physiol. 1986; 250:F32-F39 | 1986 |
Olsen ME, Hall JE, Montani JP, Cornell JE. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins J Hypertens. 1985; 3(Suppl 3):S255-S258 | 1985 |
Olsen ME, Hall JE, Montani JP, Guyton AC, Langford HG, Cornell JE. Mechanisms of angiotensin II natriuresis and antinatriuresis Am J Physiol. 1985; 249:F299-F307 | 1985 |
Premen AJ, Hall JE, Smith Jr. MJ. Postprandial regulation of renal hemodynamics: Role of pancreatic glucagon Am J Physiol. 1985; 248:F656-F662 | 1985 |
Hall JE, Granger JP, Hester RL. Interactions between adenosine and angiotensin II in controlling glomerular filtration Am J Physiol. 1985; 248:F340-F347 | 1985 |
Premen AJ, Hall JE, Mizelle LH, Cornell JE. Maintenance of renal autoregulation during infusion of aminophylline or adenosine Am J Physiol. 1985; 248:F366-F373 | 1985 |
Granger JP, Hall JE. Control of renal hemodynamics, electrolyte excretion, and arterial pressure during acute and chronic intrarenal infusion of bradykinin Am J Physiol. 1985; 248:F87-R92 | 1985 |
Guyton AC, Coleman TG, Manning Jr RD, Hall JE. Some problems and solutions for modeling overall cardiovascular regulation Math Biosci. 1984; 72:141-155 | 1984 |
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and antinatriuresis: Role of renal artery pressure in anesthetized dogs J Hypertens. 1984; (Suppl 3):347-350 | 1984 |
Kastner PK, Hall JE, Guyton AC. Control of glomerular filtration rate: Role of intrarenally formed Angiotensin II Am J Physiol. 1984; 246: F897-F906 | 1984 |
Hall JE, Granger JP, Hester RL, Coleman TG, Smith Jr MJ, Cross RB. Mechanisms of escape from sodium retention during angiotensin II hypertension Am J Physiol. 1984; 246:F627-F634 | 1984 |
Hall JE, Granger JP, Smith Jr MJ, Premen AJ. Role of renal hemodynamics and arterial pressure in aldosterone "escape" Hypertension. 1984; 6(Suppl. 1) I183-I192 | 1984 |
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and antinatriuresis-Role of renal artery pressure, renal hemodynamics, and tubular reabsorption Acta Medica Scandinavica. 1984; S693:81-88 | 1984 |
Guyton AC, Manning Jr RD, Hall JE, Young DB. Renal abnormalities that cause hypertension versus those that cause uremia Neth J Med. 1984; 27:117-123 | 1984 |
Guyton AC, Manning Jr RD, Hall JE, Norman Jr RA, Young DB, Pan YJ. The pathogenic role of the kidney J Cardiovasc Pharmacol. 1984; 6 (Suppl. 1): S151-S161 | 1984 |
Hall JE, Granger JP. Renal hemodynamic actions of angiotensin II: Interactions with tubuloglomerular feedback Am J Physiol. 1983; 245:R166-R173 | 1983 |
Hester RL, Granger JP, Williams J, Hall JE. Acute and chronic servo-control of renal perfusion pressure Am J Physiol. 1983; 244:F455-F460 | 1983 |
Navar LG, Marsh DJ, Blantz RC, Hall JE, Ploth DW, Nasjletti A. Intrinsic control of renal hemodynamics Fed Proc. 1982; 41:3022-3030 | 1982 |
Kastner PK, Hall JE, Guyton AC. Renal hemodynamic responses to increased renal venous pressure: Role of angiotensin II Am J Physiol. 1982; 243:F260-F264 | 1982 |
Hall JE, Granger JP. Mechanisms of the blood pressure and renal hemodynamic effects of captopril Am J Cardiol. 1982; 49:1527-1529 | 1982 |
Hall JE, Coleman TG, Guyton AC, Kastner PR, Granger JP. Control of glomerular filtration by circulating angiotensin II Am J Physiol. 1981; 241:R190-R197 | 1981 |
Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Kastner PR. Blood pressure regulation: Basic concepts Fed Proc. 1981; 40: 2252-2256 | 1981 |
Guyton AC, Hall JE, Lohmeier TE, Jackson TE, Manning Jr RD. The Ninth J. A. F. Stevenson Memorial Lecture: The many roles of the kidney in arterial pressure control and hypertension Can J Physiol Pharmacol. 1981; 59: 513-519 | 1981 |
Hall JE, Guyton AC, Jackson TE, Kastner PR, Granger JP. Autoregulation of glomerular filtration role of angiotensin Proceedings from the Eighth International Congress of Nephrology. Symposium on Renal Hemodynamics. 1981; pp 162-169 | 1981 |
Hall JE, Guyton AC, Smith Jr. MJ, Coleman TG. Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin Am J Physiol. 1980; 239:F271-F280 | 1980 |
Hall JE, Morse CL, Smith Jr. MJ, Young DB, Guyton AC. Control of arterial pressure and renal function during glucocorticoid excess in dogs Hypertension. 1980; 2:39-148 | 1980 |
Guyton AC, Hall JE, Young DB, Lohmeier TE, Jackson TE, Kastner PR. A computer and experimental analysis of arterial pressure regulation and hypertension Cardiovasc Physiol. 1980; 8:13-27 | 1980 |
Salgado HC, Hall JE, Guyton AC. Effects of acute rehydration on renin release in conscious dogs Acta Physiologica Latino Americana. 1980; 30:73-74 | 1980 |
Hall JE, Guyton AC, Smith JR MJ, Coleman TG. Long-term regulation of arterial pressure, glomerular filtration, and renal sodium reabsorption by angiotensin II Clin Sci. 1980; 59(Suppl. 6): 87s-90s | 1980 |
Young DB, Lohmeier TE, Hall JE, DeClue JE, Bengis RG, Coleman TG, Guyton AC. The role of the renal effects of angiotensin II in hypertension Cor Vasa. 1980; 22:49-58 | 1980 |
Hall JE, Guyton AC, Smith JR MJ, Coleman TG. Chronic blockade of angiotensin II formation during sodium deprivation Am J Physiol. 1979; 237:F424-432 | 1979 |
Hall JE, Coleman TG, Guyton AC, Balfe JW, Salgado HC. Intrarenal role of angiotensin II and [Des-Asp1] angiotensin II Am J Physiol. 1979; 236:F252-259 | 1979 |
Guyton AC, Hall JE. The juxtaglomerular complex: Its possible control of multiple nephron functions Nature. 1979; 277:601-602 | 1979 |
Hall JE, Guyton AC, Salgado HC, McCaa RE, Balfe JW. Renal hemodynamics in acute and chronic angiotensin II hypertension Am J Physiol. 1978; 235:F174-F179 | 1978 |
Guyton AC, Cowley Jr AW, Coleman TG, McCaa RE, Young DB, Hall JE. Physiological basis of blood pressure control Tribuna Medica. 1978; 38:3-11 | 1978 |
Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by renin-angiotensin system Am J Physiol. 1977; 233:F366-F372 | 1977 |
Lohmeier TE, Cowley Jr AW, Trippodo NC, Hall JE, Guyton AC. Effects of endogenous angiotensin II on renal sodium excretion and renal hemodynamics Am J Physiol. 1977; 233:F388-399 | 1977 |
Jackson TE, Guyton AC, Hall JE. Transient responses of glomerular filtration rate and renal blood flow to step changes in arterial pressure Am J Physiol. 1977; 233:F396-F402 | 1977 |
Hall JE, Guyton AC, Trippodo NC, Lohmeier TE, McCaa RE, Cowley Jr AW. Intrarenal control of electrolyte excretion by angiotensin II Am J Physiol. 1977; 233:F538-F544 | 1977 |
Trippodo NC, Hall JE, Lohmeier TE, Guyton AC. Intrarenal role of angiotensin II in controlling sodium excretion in dehydrated dogs Clin Sci Mol Med. 1977; 52:545-548 | 1977 |
Hall JE, Guyton AC, Cowley Jr. AW. Dissociation of renal blood flow and filtration rate autoregulation by renin depletion Am J Physiol. 1977; 232:F215-F221 | 1977 |
Guyton AC, Hall JE, Young DB, DeClue JW, Lohmeier TE, McCaa RE. Role of the kidney in the control of blood pressure Medicina. 1977; 37(SI):30-39 | 1977 |
Guyton AC, Cowley Jr. AW, Young DB, Hall JE, Lohmeier TE. The hemodynamics of hypertension Excerpta Medica. 1977; 5-21 | 1977 |
Hall JE, Guyton AC, Farr BM. A single injection method for measuring glomerular filtration rate Am J Physiol. 1977; 232:F72-F76 | 1977 |
Hall JE, Guyton AC. Changes in renal hemodynamics and renin release caused by increased plasma oncotic pressure Am J Physiol. 1976; 231:1550-1556 | 1976 |
Guyton AC, Coleman TG, Norman Jr. RA, Hall JE, Young DB. Overall circulatory control in hypertension Aust N Z J Med (Supplement 2). 1976;6:72-80 | 1976 |
Hall JE, Schwinghamer JM, Lalone B. Mechanisms of blood vessel constriction during hemorrhage Am J Physiol. 1976; 230:569-578 | 1976 |
Guyton AC, Young DB, DeClue JW, Trippodo N, Hall JE. Fluid balance, renal function, and blood pressure Clin Nephrol. 1975; 4:122-126 | 1975 |
Hall JE. Hypertension Update 2011 Hypertension. 2011; 58:975-977 | 2011 |
Hall JE. Hypertension Update 2008 Hypertension. 2008; 52:425-428 | 2008 |
Brandon EL. Cantwell L. Gu JW, Hall JE. Obesity enhances melanoma tumor growth independently of leptin FASEB J. 2007; 21:A927 | 2007 |
Jones DW, Hall JE. World Hypertension Day 2007 Hypertension. 2007; 49:939-940 | 2007 |
Hall JE. Hypertension Update 2006 Hypertension. 2006; 48:343-346 | 2006 |
Hall JE. Hypertension update -2005 Hypertension. 2005; 45:316-318 | 2005 |
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE. Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee Arterioscler Thromb Vasc Biol. 2005; 25:478-479 | 2005 |
Hall JE. The pioneering use of systems analysis to study cardiac output regulation Am J Physiol. 2004; 287:R1009-R1011 | 2004 |
Benos DJ, Kirk KL, Hall JE. How to review a paper Adv Physiol Educ. 2003; 27:47-52 | 2003 |
Hall JE, Cowley AW Jr, Bishop VS, Granger DN, Navar LG, Taylor AE. In memoriam. Arthur C. Guyton (1919-2003) The Physiologist. 2003; 46:126-128 | 2003 |
Loscalzo J, Balaban R , Becker LB, Ginsburg GS, Hachinski VC, Hall JE, Heisted DD, Leinwald LA, Lenfant CJ, Marban E, Olson EN, Schwartz SM Task force on strategic research direction-basic science subgroup key topics report Circulation. 2002; 106:e149-e161 | 2002 |
Jones DW, Hall JE. The National High Blood Pressure Education Program: Thirty years and counting Hypertension. 2002; 39:941-942 | 2002 |
Hall JE. Hypertension – an update Hypertension. 2002; 40:115-116 | 2002 |
Hall JE. Hypertension – opportunities and challenges Hypertension. 2002; 39:1-2 | 2002 |
Hall JE. The postgenomic era – a golden age for physiologists? The Physiologist. 2001; 44:65, 74-79 | 2001 |
Hall JE. Pathophysiology of cardiorenal systems in obesity: a symposium in memory of A. Clifford Barger Clin Exper Pharm Physiol. 1998; 25:57 | 1998 |
Juraschek SP, Miller ER 3rd, Chang AR, Anderson CAM, Hall JE, Appel LJ, Effects of Sodium Reduction on Energy, Metabolism, Weight, Thirst, and Urine Volume: Results From the DASH (Dietary Approaches to Stop Hypertension)-Sodium Trial. Hypertension (Dallas, Tex. : 1979), 2020 Mar;75(3):723-729 | 2020 |
Yalamanchili C, Chittiboyina AG, Haider S, Vasquez Y, Khan S, do Carmo JM, da Silva AA, Pinkerton M, Hall JE, Walker LA, Khan IA, In search for potential antidiabetic compounds from natural sources: docking, synthesis and biological screening of small molecules from Lycium spp. (Goji). Heliyon, 2020 Jan;6(1):e02782 | 2020 |
do Carmo JM, da Silva AA, Gava FN, Moak SP, Dai X, Hall JE, Impact of leptin deficiency compared with neuronal-specific leptin receptor deletion on cardiometabolic regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2019 Oct 1;317(4):R552-R562 | 2019 |
Gordon DM, Adeosun SO, Ngwudike SI, Anderson CD, Hall JE, Hinds TD Jr, Stec DE, CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation. Archives of biochemistry and biophysics, 2019 Sep 15;672:108072 | 2019 |
da Silva AA, do Carmo JM, Wang Z, Hall JE, Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension. Current hypertension reports, 2019 Apr 26;21(6):46 | 2019 |
Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME, Obesity, kidney dysfunction and hypertension: mechanistic links. Nature reviews. Nephrology, 2019 Jun;15(6):367-385 | 2019 |
Lohmeier TE, Hall JE, Device-Based Neuromodulation for Resistant Hypertension Therapy. Circulation research, 2019 Mar 29;124(7):1071-1093 | 2019 |
Wang Z, do Carmo JM, da Silva AA, Bailey KC, Aberdein N, Moak SP, Hall JE, Role of SOCS3 in POMC neurons in metabolic and cardiovascular regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2019 Apr 1;316(4):R338-R351 | 2019 |
do Carmo JM, da Silva AA, Moak SP, da Silva FS, Spradley FT, Hall JE, Role of melanocortin 4 receptor in hypertension induced by chronic intermittent hypoxia. Acta physiologica (Oxford, England), 2019 Apr;225(4):e13222 | 2019 |
Edwards KS, Ashraf S, Lomax TM, Wiseman JM, Hall ME, Gava FN, Hall JE, Hosler JP, Harmancey R, Uncoupling protein 3 deficiency impairs myocardial fatty acid oxidation and contractile recovery following ischemia/reperfusion. Basic research in cardiology, 2018 Oct 29;113(6):47 | 2018 |
do Carmo JM, da Silva AA, Moak SP, Browning JR, Dai X, Hall JE, Increased sleep time and reduced energy expenditure contribute to obesity after ovariectomy and a high fat diet. Life sciences, 2018 Nov 1;212:119-128 | 2018 |
Jones DW, Luft FC, Whelton PK, Alderman MH, Hall JE, Peterson ED, Califf RM, McCarron DA, Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment? Hypertension (Dallas, Tex. : 1979), 2018 Jul;72(1):10-11 | 2018 |
Adeosun SO, Gordon DM, Weeks MF, Moore KH, Hall JE, Hinds TD Jr, Stec DE, Loss of biliverdin reductase-A promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells. American journal of physiology. Renal physiology, 2018 Aug 1;315(2):F323-F331 | 2018 |
do Carmo JM, da Silva AA, Freeman JN, Wang Z, Moak SP, Hankins MW, Drummond HA, Hall JE, Neuronal Suppressor of Cytokine Signaling 3: Role in Modulating Chronic Metabolic and Cardiovascular Effects of Leptin. Hypertension (Dallas, Tex. : 1979), 2018 Jun;71(6):1248-1257 | 2018 |
Kamimura D, Suzuki T, Wang W, deShazo M, Hall JE, Winniford MD, Kullo IJ, Mosley TH, Butler KR, Hall ME, Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Hypertension research : official journal of the Japanese Society of Hypertension, 2018 Aug;41(8):629-638 | 2018 |
Hamza SM, Hall JE, Novel Approach for Simultaneous Recording of Renal Sympathetic Nerve Activity and Blood Pressure with Intravenous Infusion in Conscious, Unrestrained Mice. Journal of visualized experiments : JoVE, 2018 Feb 14;(132) | 2018 |
da Silva AA, Freeman JN, Hall JE, do Carmo JM, Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice. American journal of physiology. Regulatory, integrative and comparative physiology, 2018 Apr 1;314(4):R533-R539 | 2018 |
Aberdein N, Dambrino RJ, do Carmo JM, Wang Z, Mitchell LE, Drummond HA, Hall JE, Role of PTP1B in POMC neurons during chronic high-fat diet: sex differences in regulation of liver lipids and glucose tolerance. American journal of physiology. Regulatory, integrative and comparative physiology, 2018 Mar 1;314(3):R478-R488 | 2018 |
Hart EC, Head GA, Carter JR, Wallin BG, May CN, Hamza SM, Hall JE, Charkoudian N, Osborn JW, Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization. American journal of physiology. Heart and circulatory physiology, 2017 May 1;312(5):H1031-H1051 | 2017 |
do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, Perez de Lara CE, Hall JE, Role of the brain melanocortins in blood pressure regulation. Biochimica et biophysica acta. Molecular basis of disease, 2017 Oct;1863(10 Pt A):2508-2514 | 2017 |
do Carmo JM, da Silva AA, Romero DG, Hall JE, Changes in ambient temperature elicit divergent control of metabolic and cardiovascular actions by leptin. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017 Jun;31(6):2418-2428 | 2017 |
Muntner P, Abdalla M, Correa A, Griswold M, Hall JE, Jones DW, Mensah GA, Sims M, Shimbo D, Spruill TM, Tucker KL, Appel LJ, Hypertension in Blacks: Unanswered Questions and Future Directions for the JHS (Jackson Heart Study). Hypertension (Dallas, Tex. : 1979), 2017 May;69(5):761-769 | 2017 |
Wang Z, do Carmo JM, Aberdein N, Zhou X, Williams JM, da Silva AA, Hall JE, Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress. Hypertension (Dallas, Tex. : 1979), 2017 May;69(5):879-891 | 2017 |
Hall ME, Halinski JA, Skelton TN, Campbell WF, McMullan MR, Long RC, Alexander MN, Pollard JD, Hall JE, Fox ER, Winniford MD, Kamimura D, Left Ventricular False Tendons are Associated With Left Ventricular Dilation and Impaired Systolic and Diastolic Function. The American journal of the medical sciences, 2017 Sep;354(3):278-284 | 2017 |
Townsend EA, Naylor JE, Negus SS, Edwards SR, Qureshi HN, McLendon HW, McCurdy CR, Kapanda CN, do Carmo JM, da Silva FS, Hall JE, Sufka KJ, Freeman KB, Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats. Psychopharmacology, 2017 Sep;234(17):2597-2605 | 2017 |
Clemmer JS, Pruett WA, Coleman TG, Hall JE, Hester RL, Mechanisms of blood pressure salt sensitivity: new insights from mathematical modeling. American journal of physiology. Regulatory, integrative and comparative physiology, 2017 Apr 1;312(4):R451-R466 | 2017 |
da Silva AA, Hall JE, Moak SP, Browning J, Houghton HJ, Micheloni GC, do Carmo JM, Role of autonomic nervous system in chronic CNS-mediated antidiabetic action of leptin. American journal of physiology. Endocrinology and metabolism, 2017 May 1;312(5):E420-E428 | 2017 |
Bourgeois B, Watts K, Thomas DM, Carmichael O, Hu FB, Heo M, Hall JE, Heymsfield SB, Associations between height and blood pressure in the United States population. Medicine, 2017 Dec;96(50):e9233 | 2017 |
Yano Y, Butler KR, Hall ME, Schwartz GL, Knopman DS, Lirette ST, Jones DW, Wilson JG, Hall JE, Correa A, Turner ST, Mosley TH, Associations of Nocturnal Blood Pressure With Cognition by Self-Identified Race in Middle-Aged and Older Adults: The GENOA (Genetic Epidemiology Network of Arteriopathy) Study. Journal of the American Heart Association, 2017 Oct 27;6(11) | 2017 |
Hall ME, Wang W, Okhomina V, Agarwal M, Hall JE, Dreisbach AW, Juncos LA, Winniford MD, Payne TJ, Robertson RM, Bhatnagar A, Young BA, Cigarette Smoking and Chronic Kidney Disease in African Americans in the Jackson Heart Study. Journal of the American Heart Association, 2016 May 25;5(6) | 2016 |
Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, Hall JE, Hundley WG, Beta-Blocker Use Is Associated with Higher Renal Tissue Oxygenation in Hypertensive Patients Suspected of Renal Artery Stenosis. Cardiorenal medicine, 2016 Aug;6(4):261-8 | 2016 |
do Carmo JM, da Silva AA, Wang Z, Fang T, Aberdein N, de Lara Rodriguez CE, Hall JE, Obesity-Induced Hypertension: Brain Signaling Pathways. Current hypertension reports, 2016 Jul;18(7):58 | 2016 |
Hall JE, Renal Dysfunction, Rather Than Nonrenal Vascular Dysfunction, Mediates Salt-Induced Hypertension. Circulation, 2016 Mar 1;133(9):894-906 | 2016 |
do Carmo JM, da Silva AA, Wang Z, Freeman NJ, Alsheik AJ, Adi A, Hall JE, Regulation of Blood Pressure, Appetite, and Glucose by Leptin After Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons. Hypertension (Dallas, Tex. : 1979), 2016 Feb;67(2):378-86 | 2016 |
do Carmo JM, da Silva AA, Moak SP, Houghton HJ, Smith A, Hall JE, Regulation of Blood Pressure, Appetite, and Glucose by CNS Melanocortin System in Hyperandrogenemic Female SHR. American journal of hypertension, 2016 Jul;29(7):832-40 | 2016 |
Jones DW, Weatherly L, Hall JE, SPRINT: What Remains Unanswered and Where Do We Go From Here? Hypertension (Dallas, Tex. : 1979), 2016 Feb;67(2):261-2 | 2016 |
Bassi M, Nakamura NB, Furuya WI, Colombari DS, Menani JV, do Carmo JM, da Silva AA, Hall JE, Colombari E, Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function. Acta physiologica (Oxford, England), 2015 Apr;213(4):893-901 | 2015 |
da Silva AA, do Carmo JM, Dubinion JH, Bassi M, Mokhtarpouriani K, Hamza SM, Hall JE, Chronic central nervous system MC3/4R blockade attenuates hypertension induced by nitric oxide synthase inhibition but not by angiotensin II infusion. Hypertension (Dallas, Tex. : 1979), 2015 Jan;65(1):171-7 | 2015 |
Chen M, Ma L, Hall JE, Liu X, Ying Z, Dual regulation of tumor necrosis factor-α on myosin light chain phosphorylation in vascular smooth muscle. American journal of physiology. Heart and circulatory physiology, 2015 Mar 1;308(5):H398-406 | 2015 |
Henegar JR, Zhang Y, Hata C, Narciso I, Hall ME, Hall JE, Catheter-Based Radiofrequency Renal Denervation: Location Effects on Renal Norepinephrine. American journal of hypertension, 2015 Jul;28(7):909-14 | 2015 |
Bassi M, Furuya WI, Zoccal DB, Menani JV, Colombari E, Hall JE, da Silva AA, do Carmo JM, Colombari DS, Control of respiratory and cardiovascular functions by leptin. Life sciences, 2015 Mar 15;125:25-31 | 2015 |
do Carmo JM, da Silva AA, Hall JE, Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats. Journal of hypertension, 2015 Jun;33(6):1201-6 | 2015 |
Maranon R, Lima R, Spradley FT, do Carmo JM, Zhang H, Smith AD, Bui E, Thomas RL, Moulana M, Hall JE, Granger JP, Reckelhoff JF, Roles for the sympathetic nervous system, renal nerves, and CNS melanocortin-4 receptor in the elevated blood pressure in hyperandrogenemic female rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2015 Apr 15;308(8):R708-13 | 2015 |
da Silva AA, Spradley FT, Granger JP, Hall JE, do Carmo JM, Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling. Journal of neurophysiology, 2015 Apr 1;113(7):2786-91 | 2015 |
Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME, Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circulation research, 2015 Mar 13;116(6):991-1006 | 2015 |
Munusamy S, do Carmo JM, Hosler JP, Hall JE, Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin. American journal of physiology. Renal physiology, 2015 Oct 15;309(8):F731-43 | 2015 |
do Carmo JM, da Silva AA, Sessums PO, Ebaady SH, Pace BR, Rushing JS, Davis MT, Hall JE, Role of Shp2 in forebrain neurons in regulating metabolic and cardiovascular functions and responses to leptin. International journal of obesity (2005), 2014 Jun;38(6):775-83 | 2014 |
Maranon RO, Lima R, Mathbout M, do Carmo JM, Hall JE, Roman RJ, Reckelhoff JF, Postmenopausal hypertension: role of the sympathetic nervous system in an animal model. American journal of physiology. Regulatory, integrative and comparative physiology, 2014 Feb 15;306(4):R248-56 | 2014 |
Bassi M, Furuya WI, Menani JV, Colombari DS, do Carmo JM, da Silva AA, Hall JE, Moreira TS, Wenker IC, Mulkey DK, Colombari E, Leptin into the ventrolateral medulla facilitates chemorespiratory response in leptin-deficient (ob/ob) mice. Acta physiologica (Oxford, England), 2014 May;211(1):240-8 | 2014 |
Henegar JR, Zhang Y, De Rama R, Hata C, Hall ME, Hall JE, Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs. American journal of hypertension, 2014 Oct;27(10):1285-92 | 2014 |
da Silva AA, do Carmo JM, Wang Z, Hall JE, The brain melanocortin system, sympathetic control, and obesity hypertension. Physiology (Bethesda, Md.), 2014 May;29(3):196-202 | 2014 |
Hall ME, Maready MW, Hall JE, Stec DE, Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation. American journal of physiology. Endocrinology and metabolism, 2014 Aug 1;307(3):E316-25 | 2014 |
do Carmo JM, da Silva AA, Ebaady SE, Sessums PO, Abraham RS, Elmquist JK, Lowell BB, Hall JE, Shp2 signaling in POMC neurons is important for leptin's actions on blood pressure, energy balance, and glucose regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2014 Dec 15;307(12):R1438-47 | 2014 |
da Silva AA, do Carmo JM, Hall JE, Role of leptin and central nervous system melanocortins in obesity hypertension. Current opinion in nephrology and hypertension, 2013 Mar;22(2):135-40 | 2013 |
Zouein FA, Zgheib C, Hamza S, Fuseler JW, Hall JE, Soljancic A, Lopez-Ruiz A, Kurdi M, Booz GW, Role of STAT3 in angiotensin II-induced hypertension and cardiac remodeling revealed by mice lacking STAT3 serine 727 phosphorylation. Hypertension research : official journal of the Japanese Society of Hypertension, 2013 Jun;36(6):496-503 | 2013 |
Dubinion JH, do Carmo JM, Adi A, Hamza S, da Silva AA, Hall JE, Role of proopiomelanocortin neuron Stat3 in regulating arterial pressure and mediating the chronic effects of leptin. Hypertension (Dallas, Tex. : 1979), 2013 May;61(5):1066-74 | 2013 |
Ying Z, do Carmo JM, Xiang L, da Silva AA, Chen M, Ryan MJ, Ostrowski M, Rajagopalan S, Hall JE, Inhibitor κB kinase 2 is a myosin light chain kinase in vascular smooth muscle. Circulation research, 2013 Aug 16;113(5):562-70 | 2013 |
do Carmo JM, da Silva AA, Rushing JS, Pace B, Hall JE, Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons. American journal of physiology. Regulatory, integrative and comparative physiology, 2013 Aug 15;305(4):R359-68 | 2013 |
do Carmo JM, da Silva AA, Dubinion J, Sessums PO, Ebaady SH, Wang Z, Hall JE, Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway. IUBMB life, 2013 Aug;65(8):692-8 | 2013 |
do Carmo JM, da Silva AA, Morgan J, Jim Wang YX, Munusamy S, Hall JE, Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in obese mice. Nutrition, metabolism, and cardiovascular diseases : NMCD, 2012 Jul;22(7):598-604 | 2012 |
do Carmo JM, da Silva AA, Rushing JS, Hall JE, Activation of the central melanocortin system contributes to the increased arterial pressure in obese Zucker rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2012 Mar 1;302(5):R561-7 | 2012 |
Fu Y, Hall JE, Lu D, Lin L, Manning RD Jr, Cheng L, Gomez-Sanchez CE, Juncos LA, Liu R, Aldosterone blunts tubuloglomerular feedback by activating macula densa mineralocorticoid receptors. Hypertension (Dallas, Tex. : 1979), 2012 Mar;59(3):599-606 | 2012 |
Bassi M, Giusti H, Leite CM, Anselmo-Franci JA, do Carmo JM, da Silva AA, Hall JE, Colombari E, Glass ML, Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight. Pflugers Archiv : European journal of physiology, 2012 Aug;464(2):145-53 | 2012 |
Bassi M, do Carmo JM, Hall JE, da Silva AA, Chronic effects of centrally administered adiponectin on appetite, metabolism and blood pressure regulation in normotensive and hypertensive rats. Peptides, 2012 Sep;37(1):1-5 | 2012 |
Hamza SM, Hall JE, Direct recording of renal sympathetic nerve activity in unrestrained, conscious mice. Hypertension (Dallas, Tex. : 1979), 2012 Sep;60(3):856-64 | 2012 |
Hall ME, Smith G, Hall JE, Stec DE, Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity. American journal of physiology. Regulatory, integrative and comparative physiology, 2012 Dec 15;303(12):R1241-50 | 2012 |
Hall JE, Granger JP, do Carmo JM, da Silva AA, Dubinion J, George E, Hamza S, Speed J, Hall ME, Hypertension: physiology and pathophysiology. Comprehensive Physiology, 2012 Oct;2(4):2393-442 | 2012 |
Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, Sacks FM, Smith SC Jr, Vafiadis DK, Van Horn LV, The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation, 2011 Mar 15;123(10):1138-43 | 2011 |
do Carmo JM, Bassi M, da Silva AA, Hall JE, Systemic but not central nervous system nitric oxide synthase inhibition exacerbates the hypertensive effects of chronic melanocortin-3/4 receptor activation. Hypertension (Dallas, Tex. : 1979), 2011 Mar;57(3):428-34 | 2011 |
Dubinion JH, da Silva AA, Hall JE, Chronic blood pressure and appetite responses to central leptin infusion in rats fed a high fat diet. Journal of hypertension, 2011 Apr;29(4):758-62 | 2011 |
do Carmo JM, da Silva AA, Cai Z, Lin S, Dubinion JH, Hall JE, Control of blood pressure, appetite, and glucose by leptin in mice lacking leptin receptors in proopiomelanocortin neurons. Hypertension (Dallas, Tex. : 1979), 2011 May;57(5):918-26 | 2011 |
Kelsen S, Hall JE, Chade AR, Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease. American journal of physiology. Renal physiology, 2011 Jul;301(1):F218-25 | 2011 |
Hall ME, Smith G, Hall JE, Stec DE, Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. American journal of physiology. Heart and circulatory physiology, 2011 Jul;301(1):H253-60 | 2011 |
Fagard RH, Grassi G, Hall J, Harrap S, Lindholm LH, Schiffrin EL, Heagerty AM, International Society of Hypertension Low and Middle Income Countries Committee: Review of the goals of the Committee and of 5 years of ISH activities in low and middle income countries. Journal of hypertension, 2010 Mar;28(3):635-6 | 2010 |
Hall JE, da Silva AA, do Carmo JM, Dubinion J, Hamza S, Munusamy S, Smith G, Stec DE, Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. The Journal of biological chemistry, 2010 Jun 4;285(23):17271-6 | 2010 |
Dubinion JH, da Silva AA, Hall JE, Enhanced blood pressure and appetite responses to chronic central melanocortin-3/4 receptor blockade in dietary-induced obesity. Journal of hypertension, 2010 Jul;28(7):1466-70 | 2010 |
da Silva AA, do Carmo J, Dubinion J, Hall JE, The role of the sympathetic nervous system in obesity-related hypertension. Current hypertension reports, 2009 Jun;11(3):206-11 | 2009 |
da Silva AA, do Carmo JM, Freeman JN, Tallam LS, Hall JE, A functional melanocortin system may be required for chronic CNS-mediated antidiabetic and cardiovascular actions of leptin. Diabetes, 2009 Aug;58(8):1749-56 | 2009 |
do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, Hall JE, Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice. American journal of physiology. Regulatory, integrative and comparative physiology, 2009 Sep;297(3):R803-12 | 2009 |
Brandon EL, Gu JW, Cantwell L, He Z, Wallace G, Hall JE, Obesity promotes melanoma tumor growth: role of leptin. Cancer biology & therapy, 2009 Oct;8(19):1871-9 | 2009 |
da Silva AA, do Carmo JM, Kanyicska B, Dubinion J, Brandon E, Hall JE, Endogenous melanocortin system activity contributes to the elevated arterial pressure in spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2008 Apr;51(4):884-90 | 2008 |
do Carmo JM, Hall JE, da Silva AA, Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats. American journal of physiology. Heart and circulatory physiology, 2008 Nov;295(5):H1974-81 | 2008 |
Silva AA, Kuo JJ, Tallam LS, Liu J, Hall JE, Does obesity induce resistance to the long-term cardiovascular and metabolic actions of melanocortin 3/4 receptor activation? Hypertension (Dallas, Tex. : 1979), 2006 Feb;47(2):259-64 | 2006 |
Tallam LS, da Silva AA, Hall JE, Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin. Hypertension (Dallas, Tex. : 1979), 2006 Jul;48(1):58-64 | 2006 |
da Silva AA, Tallam LS, Liu J, Hall JE, Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity. American journal of physiology. Regulatory, integrative and comparative physiology, 2006 Nov;291(5):R1275-82 | 2006 |
Liu J, da Silva AA, Tallam LS, Hall JE, Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake. Journal of hypertension, 2006 Jul;24(7):1391-5 | 2006 |
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE, Subcommittee of Professional and Public Education of the American Heart Association, Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. Hypertension (Dallas, Tex. : 1979), 2005 Feb;45(2):299-310 | 2005 |
Vachharajani V, Russell JM, Scott KL, Conrad S, Stokes KY, Tallam L, Hall J, Granger DN, Obesity exacerbates sepsis-induced inflammation and microvascular dysfunction in mouse brain. Microcirculation (New York, N.Y. : 1994), 2005 Mar;12(2):183-94 | 2005 |
Tallam LS, Stec DE, Willis MA, da Silva AA, Hall JE, Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia. Hypertension (Dallas, Tex. : 1979), 2005 Aug;46(2):326-32 | 2005 |
de Paula RB, da Silva AA, Hall JE, Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension (Dallas, Tex. : 1979), 2004 Jan;43(1):41-7 | 2004 |
Kuo JJ, da Silva AA, Tallam LS, Hall JE, Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation. Hypertension (Dallas, Tex. : 1979), 2004 Feb;43(2):370-5 | 2004 |
da Silva AA, Kuo JJ, Tallam LS, Hall JE, Role of endothelin-1 in blood pressure regulation in a rat model of visceral obesity and hypertension. Hypertension (Dallas, Tex. : 1979), 2004 Feb;43(2):383-7 | 2004 |
Hall JE, Henegar JR, Dwyer TM, Liu J, Da Silva AA, Kuo JJ, Tallam L, Is obesity a major cause of chronic kidney disease? Advances in renal replacement therapy, 2004 Jan;11(1):41-54 | 2004 |
Salahudeen AK, Fleischmann EH, Bower JD, Hall JE, Underweight rather than overweight is associated with higher prevalence of hypertension: BP vs BMI in haemodialysis population. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004 Feb;19(2):427-32 | 2004 |
Davy KP, Hall JE, Obesity and hypertension: two epidemics or one? American journal of physiology. Regulatory, integrative and comparative physiology, 2004 May;286(5):R803-13 | 2004 |
da Silva AA, Kuo JJ, Hall JE, Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin. Hypertension (Dallas, Tex. : 1979), 2004 Jun;43(6):1312-7 | 2004 |
Philip-Couderc P, Smih F, Hall JE, Pathak A, Roncalli J, Harmancey R, Massabuau P, Galinier M, Verwaerde P, Senard JM, Rouet P, Kinetic analysis of cardiac transcriptome regulation during chronic high-fat diet in dogs. Physiological genomics, 2004 Sep 16;19(1):32-40 | 2004 |
Gu JW, Wang J, Stockton A, Lokitz B, Henegar L, Hall JE, Cytokine gene expression profiles in kidney medulla and cortex of obese hypertensive dogs. Kidney international, 2004 Aug;66(2):713-21 | 2004 |
Tallam LS, Kuo JJ, da Silva AA, Hall JE, Cardiovascular, renal, and metabolic responses to chronic central administration of agouti-related peptide. Hypertension (Dallas, Tex. : 1979), 2004 Dec;44(6):853-8 | 2004 |
Gu JW, Fortepiani LA, Reckelhoff JF, Adair TH, Wang J, Hall JE, Increased expression of vascular endothelial growth factor and capillary density in hearts of spontaneously hypertensive rats. Microcirculation (New York, N.Y. : 1994), 2004 Dec;11(8):689-97 | 2004 |
Kuo JJ, Jones OB, Hall JE, Chronic cardiovascular and renal actions of leptin during hyperinsulinemia. American journal of physiology. Regulatory, integrative and comparative physiology, 2003 Apr;284(4):R1037-42 | 2003 |
Kuo JJ, Silva AA, Hall JE, Hypothalamic melanocortin receptors and chronic regulation of arterial pressure and renal function. Hypertension (Dallas, Tex. : 1979), 2003 Mar;41(3 Pt 2):768-74 | 2003 |
Benos DJ, Kirk KL, Hall JE, How to review a paper. Advances in physiology education, 2003 Dec;27(1-4):47-52 | 2003 |
Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J, Impact of the obesity epidemic on hypertension and renal disease. Current hypertension reports, 2003 Oct;5(5):386-92 | 2003 |
Carlyle M, Jones OB, Kuo JJ, Hall JE, Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension (Dallas, Tex. : 1979), 2002 Feb;39(2 Pt 2):496-501 | 2002 |
Dubbert PM, Carithers T, Sumner AE, Barbour KA, Clark BL, Hall JE, Crook ED, Obesity, physical inactivity, and risk for cardiovascular disease. The American journal of the medical sciences, 2002 Sep;324(3):116-26 | 2002 |
Hall JE, Crook ED, Jones DW, Wofford MR, Dubbert PM, Mechanisms of obesity-associated cardiovascular and renal disease. The American journal of the medical sciences, 2002 Sep;324(3):127-37 | 2002 |
Crook ED, Flack JM, Salem M, Salahudeen AK, Hall J, Primary renal disease as a cardiovascular risk factor. The American journal of the medical sciences, 2002 Sep;324(3):138-45 | 2002 |
Loscalzo J, Balaban R, Becker LB, Ginsburg GS, Hachinski VC, Hall JE, Heistad DD, Leinwand LA, Lenfant CJ, Marban E, Olson EN, Schwartz SM, American Heart Association. Task Force on Strategic Research Direction. Basic Science Subgroup, Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. Circulation, 2002 Nov 12;106(20):e149-61 | 2002 |
McLaughlin PG, Drug therapy in asthma. Australian family physician, 1984 Mar;13(3):199-203 | 1984 |
Chawla LS, Sehgal AK, Verma RS, Balakrishanan V, Chhuttani PN, Lundh test in the diagnosis of exocrine pancreatic insufficiency. The Indian journal of medical research, 1973 May;61(5):700-3 | 1973 |
Wofford MR, Hall JE, Pathophysiology and treatment of obesity hypertension. Current pharmaceutical design, 2004;10(29):3621-37 | |
Maric C, Hall JE, Obesity, metabolic syndrome and diabetic nephropathy. Contributions to nephrology, 2011;170:28-35 | |
Alpert JS, Chipkin SR, Aronin N, Diabetes mellitus and silent myocardial ischemia. Advances in cardiology, 1990;37:297-303 | |
Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE, Obesity, hypertension, and chronic kidney disease. International journal of nephrology and renovascular disease, 2014;7:75-88 | |
Chade AR, Hall JE, Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity. American journal of nephrology, 2016;44(5):354-367 | |
Hall ME, Jordan JH, Juncos LA, Hundley WG, Hall JE, BOLD magnetic resonance imaging in nephrology. International journal of nephrology and renovascular disease, 2018;11:103-112 | |
da Silva AA, Hall JE, do Carmo JM, Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions. PloS one, 2017;12(11):e0184805 | |
Review Article | |
Hart EC, Head GA, Carter JR, Wallin BG, May CN, Hamza SM, Hall JE, Charkoudian N, Osborn JW Recording sympathetic nerve activity in conscious humans and other mammals: guidelines and the road to standardization Am J Physiol: Heart and Circulatory Physiology. 2017; 312:H1031-H1051 | 2017 |
Hall JE, Guyton AC, Brands MW. Pressure-volume regulation in hypertension Kidney Int. 1996; 49: S35-S41 | 1996 |
Hall JE. The renin-angiotensin system: Renal actions and blood pressure regulation Compr Ther. 1991; 17:8-17 | 1991 |
Abstracts | |
do Carmo JM, da Silva AA, Hall JE. AT1 receptor antagonism blockade but not mineralocorticoid receptor blockade lowers blood pressure in obese Zucker rats FASEB J. 2012; 26:1093.6 | 2012 |
Bassi M, Furuya WI, Nakamura NB, Columbari DS, Menani JV, Glass ML, Hall JE, Columbari E. Central mechanisms activated by leptin to modify hypercapnia-induced ventilatory responses FASEB J. 2012; 26:702.16 | 2012 |
Hamza SM, Hall JE. Direct recording of renal sympathetic nerve activity in unrestrained conscious mice FASEB J. 2012; 26:1091.46 | 2012 |
Zouein FA, Zgheib C, Hamza SM, Hall JE, Ruiz A, Juncos LA, Booz GA. Dual role of STAT3 in hypertension-induced cardiac remodeling FASEB J. 2012; 26:1060.19 | 2012 |
da Silva AA, do Carmo JM, Dubinion JH, Hall JE. Ganglionic blockade does not impair the chronic CNS-mediated antidiabetic action of leptin in streptozotocin-induced diabetic rats FASEB J. 2012; 26:1128.3 | 2012 |
Hamza SM, Dubinion JH, Adi A, Hall JE. Melanocortin 4 receptors in the paraventricular nucleus of the hypothalamus do not mediate the chronic metabolic or cardiovascular effects of leptin after established obesity in mice FASEB J. 2012; 26:876.13 | 2012 |
do Carmo JM, da Silva AA, Hall JE. Metabolic and appetite responses to fasting and refeeding in mice with Shp2 deletion in forebrain neurons FASEB J. 2012; 26:877.2 | 2012 |
Bassi M, do Carmo JM, Colombari R, Hall JE. Leptin treatment within RVLM/RTN regions enhances ventilatory response to CO2 in ob/ob mice Neuroscience. 2011; 62.A820.11 | 2011 |
do Carmo JM, da Silva AA, Hall JE. Differential control of appetite and cardiovascular function after selective rescue of melanocortin-4 receptor in proopiomelanocortin neurons Hypertension. 2011; 58:e9 | 2011 |
Bassi M, Nakamura N, Colombari D, Menani JV, Glass ML, Hall J, Colombari E. Effects of central injections of leptin or melanocortin antagonist on arterial pressure and ventilatory responses to hypercapnia Hypertension. 2011; 58:e136 | 2011 |
Dubinion J, do Carmo J, Munusamy S, Hamza S, da Silva A, Hall JE. STAT3 inactivation in POMC neurons attenuates leptin-induced elevations in arterial pressure Hypertension. 2011; 58:e36 | 2011 |
Hamza SM, Hildebrandt DA, Hall JE. Acute mineralocorticoid receptor blockade produces rapid renal vasodilation with no impairment of autoregulation in vivo FASEB J. 2011; 25:lb646 | 2011 |
do Carmo JM, da Silva AA, Rushing JS, Hall JE Cardiovascular and metabolic responses to chronic central MC3/4R antagonism in obese Zucker rats FASEB J. 2011; 25:823.6 | 2011 |
do Carmo JM, Bassi M, Hamza SM, da Sila AA, Hall JE. Cardiovascular and metabolic responses to thermoneutrality and cold ambient temperature in lean and obese leptin deficient mice FASEB J. 2011; 25:1028.4 | 2011 |
Dwyer TM, Stec DE, Hall JE, Csongradi E. Hyaluronan is required for the renal medulla to maximally concentrate urine FASEB J. 2011; 25:1079.5 | 2011 |
Fu Y, Hall JE, Lin L, Gomez-Sanchez C, Liu R. Aldosterone blunts tubuloglomerular feedback by activating mineralocorticoid receptors on the macula densa Hypertension. 2010; 56:e158 | 2010 |
da Silva AA, Dubinion JH, do Carmo JM, Hall JE. Chronic central nervous system MC3/4R blockade attenuates the hypertension induced by peripheral nitric oxide synthase blockade but not by angiotensin II infusion Hypertension. 2010; 56:e103 | 2010 |
do Carmo JM, Silva AA, Hall JE. Divergeny chronic metabolic and cardiovascular responses to leptin: effects of ambient temperature Hypertension. 2010; 56:e105 | 2010 |
Munusamy S, do Carmo JM, Hosler JP, Hall JE. Role of mitochondrial dysfunction and ER stress in the development of obesity-induced renal injury Hypertension. 2010; 56:e62 | 2010 |
Smith GH, Hall ME, Stec DE, Hall JE. Cardiac-specific Cre-recombinase causes a dose-dependent transient reduction in systolic function FASEB J. 2010; 24:596.3 | 2010 |
Freeman JN, do Carmo JM, Hall JE, da Silva AA. Central NPY deficiency does not enhance the chronic actions of melanocortin 3 and 4 receptors (MC3/4R) activation on glucose homeostasis, appetite and cardiovascular function in diabetic mice FASEB J. 2010; 24:597.6 | 2010 |
do Carmo JM, Bassi M, da Silva AA, Hall JE. Chronic central nervous system MC3/4R activation exacerbates the cardiovascular responses to peripheral nitric oxide synthase inhibition FASEB J. 2010; 24:1051.1 | 2010 |
Bassi M, do Carmo JM, Silva AA, Hall JE. Chronic CNS actions of adiponectin on appetite, metabolism and blood pressure FASEB J. 2010; 24: 780.1 | 2010 |
do Carmo JM, Silva AA, Morgan J, Hall JE. Inhibition of soluble epoxide hydrolase reduces food intake and increases metabolic rate in mice fed high fat-high fructose diet FASEB J. 2010; 24: 996.2 | 2010 |
Bassi M, do Carmo JM, Hamza S, Hall JE. Leptin deficiency impairs hypercapnic ventilatory responses independently of changes in body weight FASEB J. 2010; 24: 1026.4 | 2010 |
Freeman JN, doCarmo JM, Hall JE, daSilva AA. Central neuropeptide Y (NPY) deficiency does not enhance the dietary or cardiovascular responses to chronic activation of melanocortin 3 and 4 receptors (MC3/4R) Hypertension. 2009; 54:e103 | 2009 |
doCarmo JM, Bassi M, daSilva AA, Hall JE. Control of cardiovascular, metabolic and respiratory functions during prolonged obesity in leptin-deficient and diet-induced obese mice Hypertension. 2009; 54:e104 | 2009 |
doCarmo JM, daSilva AA, Hall JE. Divergent control of appetite, cardiovascular and metabolic functions by leptin in mice with leptin receptor deletion in POMC neurons Hypertension 2009; 54:e102 | 2009 |
do Carmo JM, da Silva AA, Hall JE. Cardiovascular and metabolic regulation in mice with Shp2 deletion in forebrain neurons FASEB J. 2009; 23:785.5 | 2009 |
Dubinion JH, da Silva AA, do Carmo JM, Hall JE. Cardiovascular and metabolic responses to chronic central infusion of leptin in rats fed a high fat diet FASEB J. 2009; 23:1015.5 | 2009 |
Dubinion JH, da Silva AA, do Carmo JM, Hall JE. Cardiovascular and metabolic responses to chronic cPYY infusion FASEB J. 2009; 23:983.4 | 2009 |
do Carmo JM, Hall JE, da Silva AA. Chronic central leptin infusion restores sympatho-vagal balance, cardiovascular variability, and baroreflex sensitivity in diabetic rats Am J Physiol: Heart Circ Physiol. 2008; 295:H1974-H1981 | 2008 |
do Carmo JM, da Silva AA, Hall JE. Impaired baroreflex sensitivity and absence of hypertension in old leptin deficient obese mice Hypertension. 2008; 52:e104.P244 | 2008 |
Hall JE. Obesity, hypertension and renal hemodynamics Proceedings of the International Society of Hypertension Nexus Symposium, Dublin, Ireland, 2008 | 2008 |
Dubinion J, Silva A, Dreher A, Hall JE. Cardiovascular and metabolic responses to chronic central MC3/4R antagonism in rats fed a high fat diet FASEB J. 2008; 22:947.4 | 2008 |
do Carmo JM, da Silva AA, Brandon E, Hall JE. Cardiovascular function and metabolism in old melanocortin-4 receptor deficient obese mouse FASEB J. 2008; 22:947.2 | 2008 |
da Silva AA, do Carmo JM, Freeman JN, Hall JE. Chronic MC3/4R activation does not mimic the actions of leptin on baroreceptor sensitivity and heart rate regulation in diabetic rats FASEB J. 2008; 22:947.5 | 2008 |
Hall ME, Hall JE, Smith G, Stec D. Rapid cardiac dysfunction caused by inducible cardiac specific leptin receptor deletion FASEB J. 2008; 22:743.3 | 2008 |
Brandon E, do Carmo JM, da Silva AA, Hosler JP, Hall JE. Renal lipid accumulation and mitochondrial function in leptin deficient and melanocortin-4 deficient obese mice FASEB J. 2008; 22:947.3 | 2008 |
Lee JH, Liu J, Taylor HA, Hall JE, Dubbert P, Crook E, Garrison R. Insulin Resistance and Obesity in Relation to Cardiovascular Disease Risk Factors in Non-Diabetic Overweight/Obese Participants of Jackson Heart Study Circulation 2008 | 2008 |
do Carmo JM, da Silva AA, Hall JE. Protection against obesity and hypertension induced renal injury in melanocortin 4-deficient mice treated with L-NAME Proceedings of Jackson Cardiovascular-Renal Meeting, Jackson, MS, USA, 2008 | 2008 |
Hall JE. Renal-pressure natriuresis - An infinite gain feedback mechanism for long-term blood pressure regulation? Proceedings of International Society of Nephrology Nexus Symposium, Vienna, Austria, 2007 | 2007 |
da Silva AA, Brandon E, do Carmo JM, Hall JE. Endogenous activity of the CNS melanocortin system contributes to the elevated arterial pressure in spontaneously hypertensive rats Proceedings of the Inter-American Society of Hypertension, Miami, FL, May 2007 | 2007 |
Ying Z, Ryan MJ, Webb RC, Hall JE. Inhibitor kappaB kinase 2 (IKK2) is necessary for vasoconstriction FASEB J. 2007; 21:lb539 | 2007 |
Brandon EL, Cantwell L, Gu JW, Hall JE. Obesity enhances melanoma tumor growth independently of circulating leptin FASEB J. 2007; 21:763.3 | 2007 |
daSilva AA, Tallam LS, Liu J, Brandon E, Hall JE. A functional melanocortin system is required for the CNS actions of leptin on peripheral glucose regulation and cardiovascular function FASEB J. 2006; 20:A1168 | 2006 |
Tallam LS, Roberts JV, daSilva AA, Hall JE. Impact of obesity on renal structure and function in the absence of hypertension: Eidence from the melanocortin-4 receptor (MC4R) deficient mice FASEB J. 2006; 20:A1168 | 2006 |
daSilva AA, Tallam LS, Liu J, Hall JE. CNS actions of leptin play a major role in peripheral glucose regulation independent of adrenergic activation Hypertension. 2005; 46:823 | 2005 |
daSilva AA, Kuo JJ, Tallam LS, Liu J, Hall JE. Role of the central melanocortin system in regulating arterial pressure in SHR Hypertension. 2005; 46:867 | 2005 |
Tallam LS, daSilva AA, Hall JE. Role of the melanocortin-4 receptor in mediating the chronic cardiovascular and metabolic actions of leptin Hypertension. 2005; 46:822 | 2005 |
daSilva AA, Kuo JJ, Tallam LS, Brown P, Liu J, Hall JE. Chronic cardiovascular, metabolic and renal actions of central hyperleptinemia in type-1 diabetic rats FASEB J. 2005; 19:A631 | 2005 |
Tallam LS, Stec DE, daSilva AA, Hall JE. Renal changes in melanocortin-4 receptor (MC4R(-/-)) deficient mice that are severly obese but not hypertensive FASEB J. 2005; 19:A1581 | 2005 |
Liu J, da Silva AA, Meng S, Hall JE. Chronic central hyperinsulinemia transiently decreases food intake without changing arterial pressure or heart rate in rats Hypertension. 2004; 44:560 | 2004 |
Gu JW, Gadonski G, Granger JP, Kodali M, Fortepiani L, Hall JE. Exercise training reduces blood pressure in LDLR gene knockout (-/-) mice Hypertension. 2004; 44:507 | 2004 |
Tallam LS, Stec DE, da Silva AA, Kuo JJ, Hall JE. Melanocortin-4 receptor deficient mice are neither hypertensive nor salt-sensitive despite obesity, insulin resistance and hyperleptinemia Hypertension. 2004; 44:503 | 2004 |
Meng S, da Silva AA, Liu J, Tallam LS, Hall JE. Role of oxidative stress in mediating chronic cardiovascular actions of leptin Hypertension. 2004; 44:504 | 2004 |
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Chronic cardiovascular and dietary responses to activation of melanocortin 3/4 receptors in a model of diet-induced obesity J Hypertens. 2004; 22 (suppl I):s202 | 2004 |
da Silva AA, Kuo JJ, Tallam LS, Hall JE. Blood pressure regulation in rats whose mothers were fed a low protein diet during gestation; role of endothelin-1 FASEB J. 2004; 18:A738 | 2004 |
Kuo JJ, Silva AA, Tallam LS, Hall JE. Chronic cardiovascular and renal actions of melanin concentrating hormone FASEB J. 2004; 18:A297 | 2004 |
Liu J, Hall JE. Mechanical stretch and oleic acid interact to syimulate TGF-1 and collagen I formation in glomerular mesangial cells and this response is blocked by PPAR activation FASEB J. 2004; 18:A303 | 2004 |
Tallam LS, Kuo JJ, Silva AA, Hall JE. Role of agouti related peptide in chronic regulation of cardiovascular and renal function FASEB J. 2004; 18:A294 | 2004 |
Kuo JJ, da Silva AA, Tallam LS, Hall JE. Role of adrenergic activity in cardiovascular and renal responses to chronic hypothalamic melanocortin receptor activation Hypertension. 2003; 42:422 | 2003 |
da Silva AA, Kuo JJ, Tallam LS, Hall JE. The role of endothelin-1 in blood pressure regulation in a rat model of diet-induced visceral obesity and hypertension Hypertension. 2003; 42:394 | 2003 |
Hildebrandt D, Henegar J, Hall JE. Chronic increases in intrarenal angiotensin II do not cause renal injury independent of hypertension Proc Inter-American Soc Hyper. 2003, p.73 | 2003 |
Silva AA, Kuo JJ, Hall JE. Hypothalamic melanocortin-3/4 receptor inhibition abolishes the dietary and cardiovascular responses to chronic leptin infusion Proc Inter-American Soc Hyper. 2003, p.89 | 2003 |
De Paula RB, da Silva AA, Hall JE. Role of aldosterone in obesity-induced hypertension Proc Inter-American Soc Hyper. 2003; 50 | 2003 |
Gu, JW, Fortepiani L, Reckelhoff JF, Adair TA, Wang J, Hall JE. Increased expression of vascular endothelial growth factor (VEGF) and capillary density in heart of spontaneously hypertensive rats FASEB J. 2003; 17:A845 | 2003 |
Liu J, Kuo J, Dai Y, Klett C, Hall JE. Mechanical stretch enhances angiotensin II stimulated TGF-b1, collagen IV production, and upregulation of AT1 receptor in mesangial cells FASEB J. 2003; 17:A488 | 2003 |
Hall JE, Kuo J, da Silva A, Tallam L, Liu J, Dai Y. Obesity hypertension, sympathetic activation and neuroendocrine pathways Clin Auton Res. 2003; 13:112 | 2003 |
Kuo JJ, Silva AA, Hall JE. Chronic cardiovascular and renal responses to melanocortin-4 receptor activation or inhibition Hypertension. 2002; 40:386 | 2002 |
Kuo JJ, Silva A, Hall JE. Cardiovascular and renal responses to chronic hypothalamic melanocortin-4 blockade FASEB J. 2002; 16:A793 | 2002 |
Gu JW, Wang J, Stockton A, Adair TH, Henegar L, Hall JE. Comparison of gene expression profiles in kidney cortex and medulla of obese and lean dogs FASEB J. 2002; 16:A820 | 2002 |
Liu J Kuo J, Tang J, Henegar L, Hall JE. Increases expression of heat shock protein 47, mitogen-sctivated kinase-1, and collagen IV in mesangial cells after sustained mechanical stretch FASEB J. 2002; 16:A92 | 2002 |
Liu J Kuo J, Tang J, Henegar L, Hall JE. Sustained mechanical stretch upregulates expression of TGF-β and TGF-β type I receptors in glomerular mesangial cells FASEB J. 2002; 16:A93 | 2002 |
Klett CP, Kelley KL, Sirous ZN, Henegar L, Hall JE. Gene expression profiling in renal cortex and inner medulla of lean and obese dogs Hypertension. 2001; 38:478 | 2001 |
Carlyle ME, Jones OB, Kuo JJ, Hall JE. Role of adrenergic activity in mediating chronic cardiovascular actions of leptin Hypertension. 2001; 38:506 | 2001 |
Fitzgerald SF, Henegar JR, Brands MW, Henegar LK, Hall JE. Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats J Hypertens. 2001; 19:s95 | 2001 |
Kuo JJ, Jones OB, Hall JE. Chronic cardiovascular and renal actions of leptin during hyperinsulinemia FASEB J. 2001; 15:A466 | 2001 |
Gu JW, Wang J, Lokitz B, Al-Turk A, Adair TH, Henegar L, Hall JE. Expression profile arrays of 375 genes in kidney medulla of obese and lean dogs FASEB. J. 2001; 15:A787 | 2001 |
Hussain T, Lokhandwala MF, Henegar J, Henegar L, Hall JE. Increased expression of Na, H-exchanger and Na,K-ATPase in renal cortex of obese dogs fed a high fat diet FASEB. J. 2001; 15:A134 | 2001 |
Henegar JR, Hall JE. Ultrastructural changes in the glomerulus in the early stages of obesity FASEB J. 2001; 15:A834 | 2001 |
Hall JE. Renal mechanisms of obesity hypertension Kidney Blood Press Res. 2000; 23:51 | 1999 |
Khalil RA, Crews JK, Carroll JF, Hall JE. Enhancement of Ca++ entry mechanisms of arterial vasoconstriction with low salt diet. Effect of obesity Hypertension. 1999; 33:1081 | 1999 |
Young A, Kolterman O, Hall JE. Amylin- innocent in essential hypertension? Diabetologia. 1999; 42:1029 | 1999 |
Hall JE. Basic science review of salt intake and cardiovascular disease Am J Hypertension. 1999; 12:231A | 1999 |
Hall JE. Obesity, hypertension and end-stage renal disease Proc XIII Scientific Meeting Inter-American Soc. Hypertension. 1999; 96A | 1999 |
Shek EW, Kim PK, Hall JE. Adrenergic blockade prevents leptin-induced hypertension Fed Proc. 1999; 13:A456 | 1999 |
Fitzgerald SM, Hall JE, Brands MW. Rapid hypotensive response to fasting in spontaneously hypertensive rats (SHR) Fed Proc 1999; 13:A457 | 1999 |
Hildebrandt DA, Kirk D, Hall JE. Renal and cardiovascular responses to chronic increases in cerebrovascular free fatty acids Fed Proc. 1999; 13:A780 | 1999 |
Henegar JR, Hall JE. Role of endothelin in blood pressure control in lean and obese dogs Fed Proc. 1999; 13:A781 | 1999 |
Hall JE, Jones DW, Fletcher BW, Cameron J, Mehrotra BD, Mehrotra B, Kirchner KA. Jackson Heart Study symposium on cardiovascular disease in African-Americans Am J Med Sci. 1999; 317:141 | 1999 |
Shek EW, Keen HL, Brands MW, Hall JE. Blockade of nitric oxide synthesis amplifies insulin-induced hypertension in rats Hypertension. 1998; 32:592 | 1998 |
Tyagi SC, Mujumdar VS, Shek EW, Brands MW, Hayden MR, Hall JE. Hyperhomocyst(e)inemia induces cardiovascular hypertrophy, fibrosis and hypertension Hypertension. 1998; 32:629 | 1998 |
Wofford MR, Adair C, Anderson DC, Hall JE, Miller MM, Jones DW. α and β adrenergic blockade in obese and lean hypertensive subjects Hypertension. 1998; 32:595 | 1998 |
Brands MW, Keen HL, Hailman AE, Hall JE. Chronic intravenous glucose infusion raises blood pressure in rats FASEB J. 1998; 12:A94 | 1998 |
Shek EW, Hall JE, Mujumdar VS, Tyagi SC. Hyperhomocysteinemia alters renal hemodynamics and cardiovascular function FASEB J. 1998; 12:A42 | 1998 |
Tyagi SC, Mujumdar VS, Smiley LM, Coleman TG, Hall JE. Hyperhomocysteinemia causes endothelial injury and vascular dysfunction FASEB J. 1998; 12:A328 | 1998 |
Hall JE, Henegar JR, Shek EW, Brands MW. Role of renin-angiotensin system in obesity hypertension Circulation. 1997; 96:I-33 | 1997 |
Shek EW, Brands MW, Hall JE. Cardiovascular and renal actions of chronic central nervous system leptin infusion Hypertension. 1997; 30:472 | 1997 |
Henegar JR, Shek EW, Henegar L, Hall JE. Renal functional and structural changes in the early stages of obesity Hypertension. 1997; 30:474 | 1997 |
Hall JE. Cardiovascular and renal pathophysiology of obesity Am J Hypertens. 1997; 10:234A | 1997 |
Shek EW, Keen HL, Henegar JR, Brands MW, Hall JE. Does increased leptin contribute to obesity hypertension? FASEB J. 1997; 11:A258 | 1997 |
Keen HL, Brands MW, Shek EW, Hall JE. Maintenance of baseline angiotensin II potentiates insulin-hypertension FASEB J. 1997; 11:A258 | 1997 |
Hall JE. Renal mechanisms of obesity hypertension and relevance to essential hypertension Proc. XXXIII Internat. Cong. Physiol. Sci., L058.02, 1997 | 1997 |
Hall JE, Van Vliet BN, Garrity CA, Brands MW. Obesity hypertension- Role of adrenergic mechanisms Hypertension. 1996; 21:528 | 1996 |
Keen Hl, Brands MW, Shek EW, Hall JE. Thromboxane synthesis is required for full expression of angiotensin-hypertensin Hypertension. 1996; 28:537 | 1996 |
Zappe DH, Capel WT, Keen HL, Shek EW, Brands MW, Hall JE. Role of renal afferent nerves in obesity-induced hypertension Am J Hypertens. 1996; 9:20A | 1996 |
Coleman F, Alonso-Galicia M, Summers RL, Coleman TG, Hall JE. A computer simulation of the role of renal medullary compression in obesity hypertension FASEB J. 1996; 10:A397 | 1996 |
Shek EW, Keen HL, Brands MW, Hall JE. Inhibition of nitric oxide synthesis enhances insulin-hypertension in conscious rats FASEB J. 1996; 10:A556 | 1996 |
Keen HL, Brands MW, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin-hypertension in rats FASEB J. 1996; 10:A556 | 1996 |
Summers RL, Woodward LH, Sanders DY, Hall JE. Using graphical analysis for the study of metabolic states FASEB J. 1996; 10:A264 | 1996 |
Keen HL, Brands MW, Alonso-Galicia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension Hypertension. 1995; 26:552 | 1995 |
Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats is dependent on angiotensin II Hypertension. 1995; 26:554 | 1995 |
Brands MW, Gardner AL, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Chronic ACE inhibition prevents insulin-hypertension in Sprague-Dawley rats Am J Hypertens. 1995; 8:55A | 1995 |
McKay MK, Hall JE, Hester RL. Alterations in arteriolar diameter by insulin in the cremaster muscle FASEB J. 1995; 9:A20 | 1995 |
Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin-hypertension in Sprague-Dawley rats FASEB J. 1995; 9:A297 | 1995 |
Zappe DH, Kassab SE, Brands MW, Hall JE. Chronic adrenergic blockade attenuates the development of hypertension due to weight gain in dogs FASEB J. 1995; 9:A296 | 1995 |
Alonso-Galicia M, Brands MW, Smith MJ, Zappe DH, Hall JE. Chronic AT1 receptor blockade in obese Zucker rats FASEB J. 1995; 9:A296 | 1995 |
Hall JE. Insulin resistance and hypertension in the elderly Proceedings from the Internatonal Congress of Hypertension in the Elderly. 1995. p 53 | 1995 |
Hall JE. Mechanisms of obesity-associated hypertension and relevance to essential hypertension Proceedings from the XIII International Congress of Nephrology. 1995. p 32 | 1995 |
Kassab SE, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Bilateral renal denervation prevents the development of obesity-induced hypertension in dogs Hypertension. 1994; 3:375 | 1994 |
Alonso-Galicia M, Dwyer TM, Hererra GA, Hall JE. Increased hyaluronic acid in the inner medulla of obese dogs Hypertension. 1994; 3:402 | 1994 |
Hall JE, Garrity CA, Zappe DH, Brands MW. Long-term systemic hemodynamic actions of insulin: Role of nitric oxide and B-adrenergic mechanisms Hypertension. 1994; 3:375 | 1994 |
Hall JE. Neurohumoral and renal mechanisms of obesity hypertension Am J Hypertens. 1994; 7:26A | 1994 |
Kassab S, Wilkins C, Kato T, Mizelle L, Hall J, Granger J. Renal nerves play an important role in mediating the sodium retention in response to a high fad diet in conscious dogs Am J Hypertens. 1994; 7:26A | 1994 |
Alonso-Galicia M, Dwyer TM, Herrera G, Hall JE. Altered renal medullary glycosaminoglycan (GAG) content in obese dogs FASEB J. 1994; 8:A580 | 1994 |
Zappe DH, Garrity CA, Brands MW, Hall JE. Role of B-adrenergic systems in mediating chronic systemic hemodynamic effects of insulin FASEB J. 1994; 8:A527 | 1994 |
Kassab S, Wilkins C, Kato T, Mizelle L, Hall J, Granger JP. Role of renal nerves in mediating the sodium retention in obese dogs FASEB J. 1994; 8:A527 | 1994 |
Brands MW, Harrison DA, Hall JE. Sustained intrarenal calcium infusion does not lower arterial pressure in normal dogs FASEB J. 1994; 8:A527 | 1994 |
Hildebrandt DA, Heath BJ, Hall JE. Systemic arterial pressure and heart rate responses to acute and chronic carotid or vertebral artery insulin infusion FASEB J. 1994; 8:A528 | 1994 |
Mitchell CL, Garrity CA, Zappe D, Brands MW, Hall JE. Adrenergic mechanisms contribute to obesity-induced hypertension MS Acad Sci. 1994; 39:55 | 1994 |
Torrey C, Van Vliet BN, Garrity CA, Hall JE. Cholinergic control of heart rate in obesity MS Acad Sci. 1994; 39:54 | 1994 |
Garrity CA, Brands MW, Hall JE. Chronic blockade of endothelial-derived nitric oxide (EDNO) in obese and normal dogs MS Acad Sci. 1994; 39:55 | 1994 |
Holman MG, Brands MW, Garrity CA, Hall JE. Chronic hyperinsulinemia has an exaggerated pressor and chronotropic effect in SHR compared to WKY rats MS Acad Sci. 1994; 39:54 | 1994 |
Alonso-Galicia M, Dwyer TM, Hall JE. Estimation of renal medullary glycosaminoglycan (GAG) content in obese dogs MS Acad Sci. 1994; 39:53 | 1994 |
Arnold MD, Brissie R, Soonz JS, Dwyer T, Hall J, Herrera GA. Obesity associated renal medullary changes Lab Investigations. 1994; 70:156A | 1994 |
Hall JE, Garrity CA, Brands MW. Renal and systemic hemodynamics during chronic endothelial derived nitric oxide (EDNO) blockade in obesity hypertension Proceedings from the 15th Meeting of the International Society of Hypertension. 1994 | 1994 |
Hall JE. Resistance to metabolic actions of insulin: A cause or a consequence of hypertension Proceedings from the 76th Meeting of the Endocrine Society. 1994; 190 | 1994 |
Keen HL, Brands MW, Harrison DL, Hall JE. Sympathetic blockade prevents the chronotropic but not the pressor response to chronic insulin infusion in rats MS Acad Sci. 1994; 39:54 | 1994 |
Brands MW, Garrity CA, Hall JE. High-fructose diet does not cause hypertension in rats Am J Hypertens. 1993; 6:59A | 1993 |
Hall JE, Van Vliet BN, Garrity CA, Brands MW. Adrenergic mechanisms and obesity-induced hypertension FASEB J. 1993; 7:A188 | 1993 |
Van Vliet BN, Torrey C, Hall JE. Autonomic determinants of resting heart rate in obese dogs FASEB J. 1993; 7:A624 | 1993 |
Brands MW, Garrity C, Holman MG, Hall JE. Exaggerated pressor response to chronic hyperinsulinemia in SHR versus WKY rats FASEB J. 1993; 7:A6 | 1993 |
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Systemic hemodynamic actions of long-term intravertebral angiotensin II infusion FASEB J. 1993; 7:A405 | 1993 |
Hall JE, Connell RD, Garrity CA, Brands MW. Endothelial-derived relaxing factor (EDRF) in long-term circulatory control in normal and obese dogs Circulation. 1992; 86:I489 | 1992 |
Hall JE, Van Vliet BN, Garrity CA, Connell RD, Brands MW. Role of increased adrenegic activity in obesity-induced hypertension Circulation. 1992; 86:I541 | 1992 |
Hall JE. The kidney, obesity, and essential hypertension Hypertension. 1992; 19 (Suppl. 1): I-1 | 1992 |
Gahnem FJ, Hall JE, Sealey JE. High fat diet increases plasma prorenin in normal dogs Am J Hypertens. 1992; 5:54A | 1992 |
Hildebrandt DA, Van Vliet BN, Brands MW, Mizelle HL, Hall JE. Chronic intravertebral (IVT) angiotensin II infusion increases arterial pressure FASEB J. 1992; 6:A1469 | 1992 |
Dzielak DJ, Doherty MC, Callahan J, Hall JE. Partial renal infarct hypertension does not develop in animals treated with DUP-753 FASEB J. 1992; 6:A945 | 1992 |
Brands MW, Alonso-Galicia M, Mizelle HL, Hildebrandt DA, Hall JE. Renal perfusion pressure and sodium balance in DOCA-salt sensitive hypertension FASEB J. 1992; 6:A1469 | 1992 |
Summers RL, Montani JP, Hall JE. Theoretical analysis of the mechanisms of steady-state insulin resistance FASEB J. 1992; 6:A1492 | 1992 |
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Blood pressure regulation during chronic hyperinsulinemia in obese, insulin resistant dogs Proceedings from the XIV Meeting of the International Society of Hypertension. 1992, p 224 | 1992 |
Hall JE, Herrera GA, Granger JP. Renal pathophysiology in obesity-induced hypertension Hypertension. 1991; 18:395 | 1991 |
Brands MW, Hall JE, Hildebrandt DA, Mizelle HL. Hypertension during chronic hyperinsulinemia in rats is not salt-sensitive Am J Hypertens. 1991; 4:13A | 1991 |
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Renal function in obesity-associated hypertension in conscious dogs Am J Hypertens. 1991; 4:118A | 1991 |
Brands MW, Hall JE, Mizelle HL, Hildebrandt DA. Chronic angiotensin converting enzyme inhibition (ACEI) improves cardiac output and fluid balance during heart failure FASEB J. 1991; 5:A738 | 1991 |
Hall JE, Brands MW, Dixon WN, Mizelle HL, Hildebrandt DA. Hyperinsulinemia does not elevate blood pressure in obese hypertensive dogs FASEB J. 1991; 5:A737 | 1991 |
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Low salt diet abolishes the renal response to urodilation FASEB J. 1991; 5:A1019 | 1991 |
Mizelle HL, Montani JP, Hester RL, Hall JE. Renal hemodynamics and sodium excretion during chronic reductions in renal perfusion pressure FASEB J. 1991; 5:A737 | 1991 |
Miller BA, Dixon WN, Brands MW, Mizelle HL, Hildebrandt DA, Hall JE. Control of arterial pressure and renal function during hyperinsulinemia in obese dogs MS Acad Sci. 1991; 36:46 | 1991 |
Dixon WN, Brands MW, Miller BA, Mizelle HL, Hildebrandt DA, Hall JE. Renal and systemic hemodynamics in obesity-associated hypertension MS Acad Sci. 1991; 36:46 | 1991 |
Mizelle HL, Montani JP, Hester RL, Hall JE. Role of renal perfusion pressure in long-term control of sodium excretion Hypertension. 1990; 16:327 | 1990 |
Mizelle HL, Gaillard CA, Manning RD, Hall JE. ANP decreases cardiac output independent of blood volume changes in conscious nephrectomized dogs Am J Hypertens. 1990; 3:82A | 1990 |
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Chronic intrarenal hyperinsulinemia and blood pressure regulation Am J Hypertens. 1990; 3:26A | 1990 |
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. The hemodynamic response to chronic hyperinsulinemia Am J Hypertens. 1990; 3:19A | 1990 |
Mizelle HL, Brands MW, Gaillard CA, Manning RD, Dixon WN, Hildebrandt DA, Hall JE. Chronic hemodynamic actions of the atrial natriuretic peptide (ANP) FASEB J. 1990; 4:A694 | 1990 |
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Comparison of the renal action of urodilation (URD) and atrial natriuretic peptide (ANP) FASEB J. 1990; 4:A695 | 1990 |
Brands MW, Hall JE, Hildebrandt DA, Mizelle HL. Hypertension during chronic hyperinsulinemia in conscious rats FASEB J. 1990; 4:A817 | 1990 |
Hall JE, Mizelle HL, Brands MW, Hildebrandt DA. Salt-induced hypertension: Role of pressure natriuresis FASEB J. 1990; 4:A817 | 1990 |
Hall JE, Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA. Control of arterial pressure during chronic intrarenal or systemic hyperinsulinemia J Hypertens. 1990; 8 (Suppl. 3): 59 | 1990 |
Brands MW, Mizelle HL, Gaillard CA, Hildebrandt DA, Hall JE. Hemodynamic responses to chronic hyperinsulinemia Proceedings from the XI International Society of Hypertension. 1990; p 160 | 1990 |
Hall JE, Dixon WN, Brands MW, Mizelle HL, Hildebrandt DA. Obesity, hyperinsulinemia, and hypertension: Control of renal function and systemic hemodynamics J Am Soc Nephrol. 1990; 1:490 | 1990 |
Hildebrandt DA, Mizelle HL, Brands MW, Hall JE. Renal pressure natriuresis and urodilation: A new natriuretic hormone J Am Soc Nephrol. 1990; 1:417 | 1990 |
Hall JE. Renal vasodilation: Pathophysiological and therapeutic implications Eur J Pharmacol. 1990; 183:45 | 1990 |
Mizelle HL, Brands MW, Hildebrandt DA, Hall JE. Role of renal perfusion pressure in chronic hypercalcuria J Am Soc Nephrol. 1990; 1:496 | 1990 |
Gaillard CA, Hall JE, Mizelle HL, Hildebrandt DA, Montani JP. Atrial natriuretic factor and long-term blood pressure control: Interaction with renin-angiotensin-aldosterone system Kidney Int. 1990; 37:339 | 1990 |
Hall JE. What is the role of the intrarenal renin-angiotensin system in blood pressure control? Pediatr Nephrol. 1990; 4:87 | 1990 |
Gaillard CA, Hall JE, Mizelle HL, Hildebrandt DA, Montani JP. Chronic low dose ANF infusion causes hypotension in sodium depleted dogs Am J Hypertens. 1989; 2:33A | 1989 |
Hall JE, Brands MW, Kivlighn SD, Hildebrandt DA, Mizelle HL, Gaillard CA. Hyperinsulinemia, catecholamines, and long-term blood pressure regulation Am J Hypertens. 1989; 2:32A | 1989 |
Mizelle HL, Hall JE, Hildebrandt DA, Montani JP. Renal hemodynamics and electrolyte excretion during chronic intrarenal infusion of atrial natriuretic peptide (ANP) FASEB J. 1989; 3:A697 | 1989 |
Hall JE. Angiotensin II and renal pressure natriuresis mechanism in long-term control of arterial pressure Proceedings of the XXXI International Congress of Physiological Sciences. 1989; p 26 | 1989 |
Smith CD, Mizelle HL, Hildebrandt DA, Hall JE. Angiotensin-adenosine interactions in the renal vasculature: Mechanisms of calcium activation Kidney Int. 1989; 35:474 | 1989 |
Hall JE, Coleman TG, Mizelle HL. Arterial pressure and renal function during chronic hyperinsulinemia Kidney Int. 1989; 35:326 | 1989 |
Mizelle HL, Hall JE, Hildebrandt DA, Hall JE. Does atrial natriuretic peptide (ANP) cause chronic natriuresis? Kidney Int. 1989; 35:295 | 1989 |
Hall JE, Mizelle HL. Arterial pressure and renal function during chronic renin inhibition in conscious dogs Hypertension. 1988; 12:340 | 1988 |
Hall JE, Coleman TG, Mizelle HL. Does chronic hyperinsulinemia cause hypertension? Am J Hypertens. 1988; 1:46A | 1988 |
Mizelle HL, Hall JE, Hildebrandt DA, Smith CD. Interactions between atrial natriuretic factor, pressure natriuresis, and the renin-angiotensin system Am J Hypertens. 1988; 1:102A | 1988 |
Hall JE, Coleman TG, Brown CA, Mizelle HL. Arterial pressure regulation during chronic hyperinsulinemia FASEB J. 1988; 2:A1279 | 1988 |
Mizelle, HL, Hall JE, Montani JP. Renal function and the renin-angiotensin system in a model of chronic compensated congestive heart failure FASEB J. 1988; 2:A1320 | 1988 |
Guyton AC, Hall JE, Coleman TG, Norman Jr. RA, Montani JP. Long-term arterial pressure regulation and hypertension - A computer and experimental study Proceedings from Symposium on Frontiers in Cardiopulmonary Mechanics. 1988; p 15 | 1988 |
Hall JE, Mizelle HL, Woods LL, Montani JP. Regulation of Na balance in norepinephrine hypertension: Role of pressure natriuresis Kidney Inter. 1988; 33:296 | 1988 |
Woods LL, Mizelle HL, Hall JE. Role of increased renal artery pressure in control of sodium excretion during ACTH hypertension Kidney Int. 1988; 33:430 | 1988 |
Woods LL, Mizelle HL, Hall JE. Role of the liver in controlling renal hemodynamics during amino acid infusion Fed Proc. 1987; 46:637 | 1987 |
Mizelle HL, Hall JE, Montani JP, Woods LL. Role of the renal nerves in the sodium retention of congestive heart failure Fed Proc. 1987; 46:1235 | 1987 |
Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics during amino acid infusion: Role of the liver Kidney Int. 1987; 31:427 | 1987 |
Hall JE. Arterial pressure and body fluid homeostasis Fed Proc. 1986; 45:2862-2863 | 1986 |
Mizelle, HL, Woods LL, Montani JP, Hall JE. Interactions between angiotensin and the renal nerves during chronic sodium restriction Fed Proc. 1986; 45:539 | 1986 |
Woods LL, Mizelle HL, Hall JE. Tubuloglomerular feedback control of renal hemodynamics during hyperglycemia Fed Proc. 1986; 45:515 | 1986 |
Woods LL, Mizelle HL, Hall JE. Mechanisms controlling renal hemodynamic responses to amino acids and glucose: Role of tubuloglomerular feedback Proceedings from the International Union of Physiological Scientists. 1986; 16:29 | 1986 |
Montani JP, Hall JE, Guyton AC. NA/K ATPase inhibition and long-term blood pressure control Proceedings from the International Union of Physiological Scientists. 1986; 16:602 | 1986 |
Hall JE, Mizelle HL, Woods LL. Renal actions of angiotensin and aldosterone Proceedings from the International Union of Physiological Scientists. 1986; 16:375 | 1986 |
Woods LL, Mizelle HL, Hall JE. Control of renal hemodynamics during hyperglycemia: Role of macula densa feedback Kidney Int. 1986; 29:389 | 1986 |
Montani JP, Hall JE, Guyton AC. Na/K pump inhibition with reduced renal mass does not produce chronic hypertension Kidney Int. 1986; 29:253 | 1986 |
Mizelle HL, Woods LL, Montani JP, Dzielak DJ, Hall JE. Role of the renal nerves in adaption to chronic sodium restriction Kidney Int. 1986; 29:253 | 1986 |
Hall JE, Montani J-P, Woods LL, Mizelle HL. Control of fluid balance in vasopressin hypertension: Role of renal perfusion pressure Fed Proc. 1985; 44:1011 | 1985 |
Woods LL, Mizelle HL, Montani JP, Richards RM, Cornell JE, Hall JE. Control of renal hemodynamics and electrolyte excretion during amino acid infusion Fed Proc. 1985; 44:1739 | 1985 |
Montani JP, Hall JE, Guyton AC. Na/K pump inhibition increases vascular reactivity but does not produce chronic hypertension Fed Proc. 1985; 44:1555 | 1985 |
Mizelle HL, Woods LL, Montani JP, Hall JE. Role of renal nerves in adaptation to chronic sodium deprivation Fed Proc. 1985; 44:1011 | 1985 |
Hall JE, Montani JP. Role of increased renal arterial pressure in escape from antidiuretic effects of vasopressin Kidney Int. 1985; 27:192 | 1985 |
Hall JE, Granger JP, Montani JP, Premen AJ. Renal hemodynamic actions of adenosine: Interactions with angiotensin and tubuloglomerular feedback Fed Proc. 1984; 43:409 | 1984 |
Premen AJ, Hall JE. Role of adenosine in autoregulation of glomerular filtration rate and renal blood flow Kidney Int. 1984; 25:291 | 1984 |
Dzielak DJ, Norman Jr RA, Hall JE. Servo-occluder technique for characterization of arterial pressure changes caused by CNS ischemia Fed Proc. 1984; 43:694 | 1984 |
Hall JE, Montani JP. Adaptation of renal excretion to chronic servo-controlled reduction in perfusion pressure: Role of GFR autoregulation and decreased tubular reabsorption Proceedings of the X International Society of Hypertension. 1984; 423 | 1984 |
Olsen ME, Hall JE, Montani JP, Guyton AC. Angiotensin II natriuresis and diuresis, role of renal artery pressure in anesthetized dogs Proceedings from the 10th International Society of Hypertension. 1984; 111 | 1984 |
Hall JE, Montani JP. GFR autoregulation during long-term reductions in renal perfusion pressure The Physiologist. 1984; 27:208 | 1984 |
Hall JE, Montani JP. Long-term renal autoregulation and adaptation to decreased renal perfusion pressure Proceedings from the IX International Congress of Nephrology. 1984; 394 | 1984 |
Guyton AC, Hall JE, Jackson TE. Renal afferent and efferent arteriolar control of arterial pressure Proceedings from the 10th International Society of Hypertension. 1984; 421 | 1984 |
Premen AJ, Hall JE, Smith MJ, Rushing P. Role of glucagon during protein-induced elevations in renal blood flow and glomerular filtration rate The Physiologist. 1984; 27:208 | 1984 |
Montani JP, Nuwayhid BS, Summers RL, Markov AK, Hall JE, Guyton AC. Role of Na/K ATPase activity in long-term blood pressure control Proceedings from IX International Congress of Nephrologists.1984; 394 | 1984 |
Olsen ME, Hall JE, Montani JP, Cornell J. Role of renal prostaglandins in selective protection of preglomerular vessels from angiotensin II vasoconstriction Proceedings from IX International Congress of Nephrology. 1984; 458 | 1984 |
Hall JE, Granger JP, Premen AJ. Mechanisms of aldosterone escape: Role of glomerular filtration and arterial pressure Kidney Int. 1984; 25:200 | 1984 |
Coleman TG, Davis JR MH, Hall JE. Rapid plasma renin activity changes during hemorrhage in the rat Fed Proc. 1983; 42:318 | 1983 |
Hall JE, Granger JP. Role of peripheral sympathetic nervous system in mediating the chronic blood pressure and renal hemodynamic effects of angiotensin II Fed Proc. 1983; 42:589 | 1983 |
Granger JP, Hall JE. Role of renin-angiotensin system and tubuloglomerular feedback in altering the renal responses to glandular kallikein Fed Proc. 1983; 42:590 | 1983 |
Hall JE, Granger JP, Premen AJ. Angiotensin II constricts preglomerular vessels in the presence of adenosine The Physiologist. 1983; 26:A127 | 1983 |
Premen AJ, Hall JE, Granger JP. Control of arterial pressure and renal hemodynamics during chronic intrarenal adenosine infusion The Physiologist. 1983; 26:A127 | 1983 |
Hall JE, Granger JP. Mechanisms of escape from chronic sodium retaining effects of angiotensin II Proceedings from the 29th Congress of the International Union of Physiogical Sciences. 1983; 318 | 1983 |
Olsen ME, Hall JE, Montani JP, Guyton AC. Natriuretic and antinatriuretic actions of angiotensin II: Role of renal artery pressure and proximal tubular reabsorption The Physiologist. 1983; 26:A127 | 1983 |
Granger JP, Hall JE. Control of renal hemodynamics, electrolyte excretion, and arterial pressure during acute and chronic intrarenal infusion of glandular kallikrein Kidney Int. 1983; 23:279 | 1983 |
Hall JE, Granger JP. Escape from the chronic sodium retaining actions of angiotensin IIL role of increased renal arterial pressure Kidney Int. 1983; 23:170 | 1983 |
Hall JE, Granger JP, Twu B. Interactions between angiotensin II and intrinsic autoregulatory mechanisms in control of renal segmental resistances Fed Proc. 1982; 41:1257 | 1982 |
Granger JP, Hall JE, Twu B. Long-term control of renal hemodynamics, electrolyte excretion and arterial pressure by circulating bradykinin in conscious dogs Fed Proc. 1982; 41:1247 | 1982 |
Granger JP, Twu B, Hall JE. Control of renal segmental resistances by angiotensin II in the absence of tubuloglomerular feedback J MS Acad Sci. 1982; 27: 31 | 1982 |
Twu B, Granger JP, Hall JE. Renin secretion into the renal circulation and lymph during increased ureteral pressure J MS Acad Sci. 1982; 27:31 | 1982 |
Hall JE, Granger JP. Role of angiotensin II in mediating renal hemodynamic effects of adenosine The Physiologist. 1982; 25:317 | 1982 |
Granger JP, Hall JE, Twu B. The role of circulating and endogenous kinins in long-term regulation of hemodynamics, electrolyte excretion, and arterial pressure in conscious dogs J MS Acad Sci. 1982; 27:32 | 1982 |
Kastner PK, Hall JE, Guyton AC. Autoregulation of glomerular filtration rate: Role of intrarenally formed angiotensin II Fed Proc. 1981; 40:516 | 1981 |
Granger JP, Hall JE. Does azotemia potentiate the chronic blood pressure and renal vasoconstrictor effects of aniotensin II? Fed Proc. 1981; 40:435 | 1981 |
Hall JE, Granger JP. Mechanisms of captopril's chronic blood pressure and renal hemodynamic effects Fed Proc. 1981; 40:435 | 1981 |
Granger JP, Hall JE. Effects of azotemia on control of arterial pressure, renal hemodynamics, and electrolyte excretion by angiotensin II J MS Acad Sci. 1981; 26:58 | 1981 |
Hall JE, Granger JP. Mechanisms of the chronic blood pressure and renal hemodynamic effects of captopril (SQ-14225) Proceedings from the Eighth International Society of Hypertension. 1981; 170 | 1981 |
Hall JE, Morse CL, Smith Jr. MJ, Young DB, Guyton AC. Regulation of renal hemodynamics, electrolyte excretion, and arterial pressure during chronic glucocorticoid excess Fed Proc. 1980; 39:963 | 1980 |
Kastner PR, Hall JE, Guyton AC. Renin secretion and renal hemodynamics responses following step increases in renal venous pressure before and after angiotensin converting enzyme inhibition Fed Proc. 1980; 39:949 | 1980 |
Hall JE, Guyton AC, Smith Jr. MJ, Coleman TG. Long-term relationships between arterial pressure, renal hemodynamics and sodium excretion: Role of renin-angiotensin system Proceedings from the Seventh International Society of Hypertension. 1980; 49 | 1980 |
Hall JE, Coleman TG, Guyton AC, Kastner PR, Salgado HC. Control of glomerular filtration rate by renin-angiotensin system: Role of circulating angiotensin II The Physiologist. 1979; 22:51 | 1979 |
Guyton AC, Lohmeier TE, Hall JE, Kastner PR, Hockel GM. Overall control of the circulation Proceedings from Australian Physiology and Pharmacology Society. 1979 | 1979 |
Coleman TG, Hall JE. Tubuloglomerular feedback does not explain autoregulation of renal blood flow and glomerular filtration rate The Physiologist. 1979; 22:21 | 1979 |
Hall JE, Guyton AC, Coleman TG, Smith MJ. Role of angiotensin and aldosterone in control of arterial pressure and renal hemodynamics during chronic converting enzyme inhibition Kidney Int. 1979; 16:793 | 1979 |
Hall JE, Guyton AC, Coleman TG, McCaa RE. Long-term control of renal hemodynamics and electrolyte excretion during converting enzyme inhibition The Physiologist. 1978; 21:49 | 1978 |
Hall JE, Guyton AC, Salgado HC, Balfe JW, McCaa RE. Role of [Des-Asp1] angiotensin III (AIII) and Angtiotensin II (AII) in controlling renal hemodynamics and electrolyte excretion Fed Proc. 1978; 37:307 | 1978 |
Guyton AC, Hall JE, Balfe JW, Lohmeier TE, Jackson TE, Norman Jr RA. Pathophysiological renal mechanisms that cause hypertension, hypotension, and uremia Proceedings from the VII International Congress of Nephrology. 1978 37:307 | 1978 |
Coleman TG, Hall JE. Perfused tissues: constant flow vs. constant pressure systems Proceedings from Annual Conference of Engineering in Medicine and Biology. 1978; 20:219 | 1978 |
Hall JE, Guyton AC, Coleman TG, McCaa RE. Long-term relationship between arterial pressure, urinary output, and renal hemodynamics after converting enzyme inhibition Kidney Int. 1978; 14:696 | 1978 |
Trippodo NC, Hall JE, Lohmeier TE, Guyton AC. Effect of intrarenal blockade of angiotensin II on sodium excretion in dehydrated dogs Fed Proc. 1977; 36:574 | 1977 |
Hall JE, Guyton AC, McCaa RE, Salgado HC. Control of renal hemodynamics and electrolyte excretion after converting enzyme inhibition The Physiologist. 1977; 20:40 | 1977 |
Hall JE, Guyton AC, McCaa RE, Salgado HC. Intrarenal role of the renin-angiotensin system Circulation. 1977; 56:246 | 1977 |
Guyton AC, Hall JE, Lohmeier TE, Fagard RH, Cowley Jr. AW. Salt retention and gfr autoregulation mediated by efferent arteriolar effects of intrarenal renin-angiotensin Proceedings from International Union of Physiological Sciences. 1977; 13:295 | 1977 |
Hall JE, Guyton AC, Salgado HC, McCaa RE. Changes in renal hemodynamics and body fluids during acute and chronic angiotensin II (AII) hypertension Kidney Int. 1977; 12:500 | 1977 |
Hall JE, Guyton AC. Single injection clearances of 125I-Iothalamate Fed Proc. 1976; 35:542 | 1976 |
Hall JE, Guyton AC. Uncoupling of renal blood flow (RBF) and glomerular filtration rate (GFR) autoregulation after renin depletion The Physiologist. 1976; 19:217 | 1976 |
Hall JE, Guyton AC, Cowley Jr. AW, McCaa RE, McCaa CS. Intrarenal role of angiotensin II (AII) Kid Int. 1976; 10:530 | 1976 |
Hall JE, Guyton AC, Jackson TE. Effects of increased plasma colloid osmotic pressure on renal hemodynamics and renin secretion The Physiologist. 1975; 18:238 | 1975 |
Lalone B, Schwinghamer J, Hall J. Autoregulation of skeletal muscle blood flow during hemorrhage The Physiologist. 1974; 17:270 | 1974 |
Hall J, Lalone B, Schwinghamer J, Adams T. Neurally and humorally mediated vascular responses to hemorrhage The Physiologist. 1973; 16:333 | 1973 |
Musson, JB, Lalone B, Hall J, Schwinghamer J. Skin and muscle vascular responses to hypothermia The Physiologist. 1973; 16:404 | 1973 |
Lalone B, Hall J, Musson J, Schwinghamer J. Vascular responses to adrenochrome in the dog forelimb Clin Res. 1973; 21:431 | 1973 |
Hall J, Lalone B, Buck M, Schwinghamer J Mechanisms of large vessel constriction and fluid mobilization during hemorrhage The Physiologist. 1972; 15:158 | 1972 |
Hall J, Lalone B, Buck M, Schwinghamer J Role of circulating constrictor agents in vascular response to hemorrhage Clin Res. 1972; 20:719 | 1972 |
Book Chapter | |
Hall ME, Wang Z, do Carmo J, Kamimura D and Hall JE Obesity and metabolic syndrome hypertension In: Disorders of Blood Pressure Regulation: Phenotypes, Mechanisms, Therapeutic Options. Eds. AE Berbari, G Mancia. Springer Publishing. 2018; 705-722. | 2018 |
Hall JE, Granger JP, Jones DW, Hall ME Pathophysiology of hypertension. In: Hurst’s The Heart 14th ed., Eds. V. Fuster, R.Harrington, J Narula, Z. Eapen. McGraw-Hill Medical, New York. 2017; pp. 720-750 | 2017 |
Hall ME and Hall JE Pathogenesis of Hypertension In: Hypertension: A Companion to Braunwald’s Heart Disease, 3rd edition, Eds. GL Bakris, M Sorrentino. Elsevier, Inc, Philadelphia. 2017; pp. 33-51 | 2017 |
Maric C, Hall JE. Obesity, metabolic syndrome and diabetic nephropathy. In: Diabetes and the kidney, contibutions to nephrology Eds. KN Lai, SCW Tang. Karger, Basel, 2011. pp. 28-35 | 2011 |
Hall JE, Granger JP, Jones DW, Hall ME. Pathophysiology of hypertension. In: Hurst’s the heart, 13th ed Eds. V Fuster, RA O’Rourke, RA Walsh, PA Poole-Wilson. McGraw-Hill Medical, New York, 2011. pp 1549-1584 | 2011 |
Hall ME, Hall JE, Granger JP, Jones DW. Systemic hypertension: pathogenesis and etiology In: Hurst’s The Heart Manual of Cardiology, 12th ed. Eds. R.A. O’Rourke, R.A. Walsh, V. Fuster. McGraw-Hill Medical, New York, pp 339-350, 2009 | 2009 |
Hester RL, Hall JE. Local autoregulation of blood flow In: Hypertension Primer, 4th edition, American Heart Assoc. Eds. J. L. Izzo Jr. and H. C. Black. pp. 129-132, 2008 | 2008 |
Hall JE, Granger JP, Hall ME, Jones DW. Pathophysiology of hypertension In: Hurst’s The Heart, 12th ed. Eds. V. Fuster, R.A. O’Rourke, R.A. Walsh, P.A. Poole-Wilson. McGraw-Hill Medical, New York, pp. 1570-1608, 2008 | 2008 |
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Hypertension Primer, 4th edition, American Heart Assoc . Eds. J. L. Izzo Jr. and H. C. Black. pp. 132-135, 2008 | 2008 |
Hall JE, daSilva AA, Brandon E, Stec DE, Ying Z, Jones DW. Pathophysiology of obesity hypertension and target organ injury In: Comprehensive Hypertension. Eds. Lip, G.Y.P. and J.E. Hall. Elsevier, New York, pp. 447-468, 2007 | 2007 |
Granger JP, Hall JE. Role of the kidney sodium and fluid excretion in hypertension In: Comprehensive Hypertension. Eds. Lip, G.Y.P. and J.E. Hall. Elsevier, New York, pp. 241-263, 2007 | 2007 |
Hall JE, Jones DW, Kuo JJ, da Silva AA, Liu J, Tallam L. Obesity and hypertension: impact on cardiovascular and renal disease In: Hypertension – a Companion to Brenner and Rector’s The Kidney. Eds. S. Oparil and M. Weber. Elsevier Science, Philadelphia. pp. 464-474, 2005 | 2005 |
Hall JE, Granger JP. Regulation of fluid and electrolyte balance in hypertension- role of hormones and peptides In: Hypertension- Principles and Practice. Eds. E.J. Battegay, G.Y.H.Lip, and G.L. Bakris. Taylor and Francis Group, LLC, Boca Raton. pp 121-142, 2005 | 2005 |
Hall JE, Jones DW, Henegar J, Dwyer TM, Kuo J. Obesity hypertension, and renal disease In: Obesity: Mechanisms and Clinical Management. Ed. R.H. Eckel, Lippincott, Williams & Wilkins, Philadelphia, pp. 273-300, 2003 | 2003 |
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Hypertension Primer, 3rd edition, American Heart Assoc. Eds. J. L. Izzo Jr. and H. C. Black. pp. 111-114, 2003 | 2003 |
Hall JE. Historical Perspective of the Renin-Angiotensin System In: Angiotensin Protocols- Methods in Molecular Medicine. Ed. D.H. Wang. Humana Press, Inc., p. 3-22, 2000 | 2000 |
Brands MW, Hall JE. Mechanisms for chronic antihypertensive effect of angiotensin II blockade In: Angiotensin II Receptor Antagonists. Ed. M. Epstein and H. R. Brunner, Hanley & Belfus, Inc., Philadelphia, p. 171-187, 2000 | 2000 |
Hall JE, Henegar JR, Shek EW, Brands MW. The renal circulation in obesity and insulin resistance In: Advances in Organ Biology: The Renal Circulation. Ed W.P. Anderson, JAI press, Greenwich, Connecticut, p. 383-397, 2000 | 2000 |
Hall JE, Brands MW. The renin-angiotensin-aldosterone system: renal mechanisms and circulatory homeostasis In: The Kidney: Physiology and Pathophysiology, 3rd Edition. Eds. D.W. Seldin and G. Giebisch. Raven Press, New York, p. 1009-1046, 2000 | 2000 |
Hall JE, Brands MW, Jones DW, Shek EW, Henegar JR. Mechanisms of obesity hypertension and relevance to essential hypertension In: Obesity: Impact on Cardiovascular Disease. Eds. G. Fletcher, S. Grundy, and L.Hayman. Futura Publishing Co., Inc., p133-153, 1999 | 1999 |
Hall JE. Cardiovascular and Renal Pathophysiology of Obesity In: ACE Inhibitors, Diabetes, and Obesity: Molecules, Metabolism, and Management | 1998 |
Hall JE, Brands MW, Shek EW, Henegar JR. Renal actions of angiotensin II and long-term blood pressure regulation In: Renin-Angiotensin, Ed. H. Ulfendahl and M. Aurell, Portland Press Ltd, London, p. 89-104, 1998 | 1998 |
Tyagi SC, Hayden MR, Hall JE. Role of angiotensin in angiogenesis and cardiac fibrosis in heart failure In: Angiotensin II Receptor Blockade: Physiological and Clinical Implications . Eds. N.S. Dhalla, P. Zahradka, I.M.C. Dixon, and R.E. Beamish. Progress in Experimental Cardiology 2:537-549, 1998 | 1998 |
Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation In: Primer on Hypertension, 2nd edition, American Heart Assoc.,Eds. J. L. Izzo Jr. and H. C. Black, p. 92-94, 1998 | 1998 |
Van Vliet BN, Hall JE, Lohmeier TE, Mizelle HL. Renal Circulation In: Nervous Control of Blood Vessels, Ed. T. Bennett and S. Gardiner. Harwood Academic Publishers, London, p. 371-433, 1996 | 1996 |
Hall JE, Guyton AC, Brands MW. Control of Sodium Excretion and Arterial Pressure by Intrarenal Mechanisms and the Renin-Angiotensin System. In: Hypertension: Pathophysiology, Diagnosis, and Management Eds. J.H. Laragh and B.M. Brenner. Raven Press, New York, 1995. p. 1451-1476 | 1995 |
Guyton AC, Hall JE, Coleman TG, Manning Jr. RD, Norman Jr. RA. The Dominant Role of the Kidneys in Long-term Arterial Pressure Regulation in Normal and Hypertensive States. In: Hypertension: Pathophysiology, Diagnosis and Management Eds. J.H. Laragh and B.M. Brenner. Raven Press, New York, 1995. p 1311-1326 | 1995 |
Hall JE, Granger JP. Role of Sodium and Fluid Excretion in Hypertension. In: Textbook of Hypertension Ed. J.D. Swales. Blackwell Scientific Pubs, Oxford, 1994. p 360-384 | 1994 |
Hall JE, Brands MW. Intrarenal Actions of Angiotensin II: Physiology and Pathophysiology. In: Current Advances in ACE Inhibtion Ed. G.A. McGregor and P. Sever. Churchill Livingstone, London, 1993. p 41-51 | 1993 |
Hall JE, Brands MW. Intrarenal and Circulating Angiotensin II and Renal Function. In: The Renin-Angiotensin System Eds. J.I.S. Robertson and M.G. Nicholls. Gower Medical Publishing, London, 1993. Vol I, Chapter 26, p 1-43 | 1993 |
Coleman TG, Hall JE. Regional Blood Flow Regulation. In: Primer on Hypertension, American Heart Associaton Eds. J.L. Izzo, Jr. and H.C. Black. 1993. p 79-82 | 1993 |
Coleman TG, Hall JE. A Mathematicl Model of Renal Hemdynamics and Excretory Function. In: Computer Modeling of Comples Biological Systems. Vol. 11, (Ed.) Ed. Sl. Iyengary. CRC Press, 1992, p. 89-124 | 1992 |
Hall JE, Guyton AC. The Kidney and Blood Pressure Regulation. In: Renovascular and Renal Parenchymatos Hypertension: Pathophysiology Diagnosis and Management Eds.: T.F. Luscher and N.M. Kaplan. Springer-Verlag Publishers, Berlin, 1992. p. 3-29 | 1992 |
Hall JE, Brands MW. The Renin-Angiotensin-Aldosterone System: Renal Mechanisms and Circulatory Homeostasis. In: The Kidney: Physiology and Pathophysiology, 2nd Edition Eds. D.W. Seldin and G. Giebisch. Raven Press, New York, 1992. p 1455-1504 | 1992 |
Hall JE, Guyton AC. Control of Sodium Excretion and Arterial Pressure by Intrarenal Mechanisms and the Renin-Angiotensin System. In: Hypertension: Pathophysiology, Diagnosis and Management Eds. J.H. Laragh, B.M. Brenner. Raven Press Ltd., New York, 1990. p 1105-1130 | 1990 |
Guyton AC, Hall JE, Coleman TG, Manning Jr. RD. The Dominant Role of the Kidneys in the Long-Term Regulation of Arterial Pressure in Normal and Hypertensive States. In: Hypertension: Pathophysiology. Diagnosis and Management. Eds. J.H. Laragh and B.M. Brenner. Raven Press Ltd., New York, 1990. p 1029-1052 | 1990 |
Hall JE. Angiotensin Converting Enzyme Inhibition: Renal Effects and Their Role in Reducing Arterial Pressure. In: Current Advances in ACE Inhibitions Eds. G.A. McGregor and P. Sever. Churchill Livingston, London, 1989. pp 9-24 | 1989 |
Hall JE, Montani JP, Woods LL, Mizelle HL. Role of vasopressin and pressure diuresis in regulation of arterial pressure and body fluid volumes. Vasopressin, cellular and integrative functions Eds. A.W. Cowley Jr, J.F. Liard, D.A. Ausiello. Raven Press, New York, 1988. pp. 193-200 | 1988 |
Hall JE, Guyton AC, Coleman TG, Woods LL, Mizelle HL. Renal excretory function and hypertension. In: Perspectives in hypertension, Vol 1, The kidney in hypertension. Eds. B.M. Brenner and J.H. Laragh. Raven Press, New York, 1987. pp. 1-20. | 1987 |
Petrini MF, Coleman TG, Hall JE. Basic Quantitative Concepts of Lung Function. The Lung. In: Mathematical Methods in Medicine, Part 2 Eds. D. Ingram and R. Bloch. John Wiley and Sons, New York, 1986. pp 295-336 | 1986 |
Coleman TG, Hall JE, Petrini MF. Basic Quantitative Concepts of the Circulating System. The Circulation. In: Mathematical Methods in Medicine, Part 2 Eds. D. Ingram, R. Bloch. John Wiley and Sons, New York, 1986. pp 175-195 | 1986 |
Hall JE. Role of Angiotensin and Aldosterone in Volume Homeostasis. In: Body Fluid Homeostasis. Contemporary Issues in Nephrology, Vol. 17 Eds. B.M. Brenner and J.H. Stein. Churchill Livingston, New York, 1986. p 69-100 | 1986 |
Hall JE, Coleman TG, Petrini MF. The Kidney. In: Mathematical Methods in Medicine, Part . Eds. D. Ingram and R. Bloch. Wiley Publishing Co., Ed. D. Ingram and R. Bloch. John Wiley and Sons, New York, 1986. pp. 427-471 | 1986 |
Hall JE, Montani JP. Role of the Kidney in Adrenocortical Induced Hypertension. In: The Adrenal Gland and Hypertension Eds. F. Mantero, E.G. Biglieri, J.W. Funder, B.A. Scoggins. Rave Press, New York, 1985, pp 185-208 | 1985 |
Guyton AC, Lohmeier TE, Hall JE, Smith MJ, Kastner PR. The Infinite Gain Principle for Arterial Pressure Control by the Kidney-Volume-Pressure System. In: Fundamental Fault in Hypertension Ed. M.P. Samishi. Martinus Nijhoff Publishers, Boston, 1984. p. 35-61 | 1984 |
Guyton AC, Manning RD, Lohmeier TE, Hall JE. The Kidney and Hypertension. In: Dopamine Receptor Agonists Ed. F.H. Messerli. Martinus Nijhoff Publishing, Boston, 1984. p. 87-103 | 1984 |
Guyton AC, Hall JE, Lohmeier TE, Manning Jr RD, Jackson TE, Kastner PR, Pan YJ. Role of the Kidney and Volume Control in the Pathogenesis of Hypertension. In: Handbook of Hypertension. Eds. W.H. Birkenhager and J.L. Reid. Vol. 1: Clinical Aspects of Essential Hypertension. Ed. J.I.S. Robertson. Elsevier, Amsterdam, 1983. pp. 216-238. | 1983 |
Young DB, Pan Y, Hall JE, Lohmeier TE. Importance of Antinatriuretic Eeffects of Angiotensin and Aldosterone in Hypertension. In: Salt and Cardiovascular Hypertension Eds. M.J. Fregley and M.R. Kare. Academic Press, Philadelphia, 1982. pp. 247-265 | 1982 |
Hall JE. Regulation of Renal Hemodynamics. In: International Review of Physiology. Cardiovascular Physiology IV, Volume 26 Ed. A.C. Guyton and J.E. Hall. University Park Press, Baltimore, 1982. pp. 243-321 | 1982 |
Coleman TG, Hall JE, Norman Jr. RA. Regulation of Arterial Blood Pressure. In: Hypertension. Contemporary Issues in Nephrology. Vol. 8 Eds. B.M. Brenner and J.H. Stein. Churchill Livingston, New York, 1981. pp. 1-20 | 1981 |
Guyton AC, Hall JE, Lohmeier TE, Manning Jr RD, Jackson TE. The Concept of Whole Body Autoregulation and the Dominant Role of the Kidneys for Long-Term Blood Pressure Regulation. In: Frontiers in Hypertension Research Eds. J.H. Laragh, F.R. Buhler, D.W. Seldin. Springer-Verlag, New York, 1981. p 125-134 | 1981 |
Coleman TG, Manning RD, Norman Jr. RA, Samar RE, Hall JE, Guyton AC. Experimental Renoprival Hypertension. In: Hemodynamics of Arterial Hypertension Eds. C.M. Ferrario, M.N. Levy, R.C. Tarazi, C.V. Mosby. 1980 | 1980 |
Hall JE, Jackson TE, Guyton AC. Feedback Control of Intrarenal Function by the Renin-Angiotensin System. In: Arterial Pressure and Hypertension Eds. A.C. Guyton. W.B. Saunders Co., 1980. p 192-204 | 1980 |
Guyton AC, Hall JE, Norman Jr RA, Smith JR MJ, Balfe JW, Kastner PR. Physiology of Blood Pressure Regulation. In: Childhood Prevention of Atherosclerosis and Hypertension Eds. R.M. Lauer, R.B. Shekelle. Raven Press, New York, 1980. pp. 251-262 | 1980 |
Guyton AC, Hall JE, Lohmeier TE, Jackson TE. Modern Concepts of Circulatory Function. In Cardiology (International Congress Series 470) Eds. S. Hayase, S. Murao. Excerpta Medica, Amsterdam, 1979. pp.60-68 | 1979 |
Guyton AC, Hall JE, Manning Jr RD, Norman Jr RA, DeClue JW. A Systems Analysis of Volume Regulation. In Alfred Benzon Symposium XI, Osmotic and Volume Regulation. Munksgaard, Copenhagen, 1978 pp 283-296 | 1978 |
Guyton AC, Cowley Jr. AW, Young DB, Coleman TG, Hall JE, DeClue JW. Integration and control of circulatory function In: International Review of Physiology. Cardiovascular Physiology II. Eds. A.C. Guyton and A.W. Cowley Jr. University Park Press, Baltimore, 1976. pp 341-385 | 1976 |
Guyton AC, Young DB, DeClue JW, Ferguson JD, McCaa RE, Cevese A, Trippodo NC, Hall JE. The Role of the Kidney in Hypertension In: Pathophysiology and Management of Arterial Hypertension. Eds. G. Berglund, L. Hansoon, and L. Werko. A. Lindgren and Soner A.B., Molndal, Sweden, 1975. pp 78-89 | 1975 |
Book | |
Hall, JE Guyton and Hall Textbook of Medical Physiology, 13th Edition Elsevier Saunders, Philadelphia, 2016 | 2016 |
Hall, JE Guyton and Hall Physiology Review, 3rd edition Elsevier Saunders, Philadelphia, 2016 | 2016 |
Hall, JE Pocket Companion for Guyton and Hall Textbook of Medical Physiology Elsevier Saunders, Philadelphia, 5th Edition, 2016 | 2016 |
Hall JE Guyton and Hall Physiology Review, 2nd edition Elsevier Saunders, Philadelphia, 2011 | 2011 |
Hall JE Pocket Companion for Guyton and Hall Textbook of Medical Physiology Elsevier Saunders, Philadelphia, 4th Edition, 2011 | 2011 |
Hall, JE Guyton and Hall Textbook of Medical Physiology, 12th Edition Elsevier Saunders, Philadelphia, 2011 | 2011 |
Lip GYP, Hall JE (eds.). Comprehensive Hypertension Elsevier, New York, 2007 | 2007 |
Hall JE. Guyton and Hall Physiology Review Elsevier Saunders, Philadelphia, 2006 | 2006 |
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall Elsevier Saunders, Philadelphia, 3rd Edition, 2006 | 2006 |
Guyton AC, Hall JE (ed.). Textbook of Medical Physiology, 11th Edition Elsevier Saunders, Philadelphia, 2006 | 2006 |
Hall JE, Adair TH. Rypins' Questions and Answers for Basic Sciences Review - Physiology, 4th Ed., ed. E.D. Frohlich J.B.Lippincott Co., Philadelphia, 2001 | 2001 |
Hall JE, Adair TH. Rypins’ Basic Sciences Review - Physiology, 18th Ed., ed. E.D. Frohlich J.B. Lippincott Co., Philadelphia, 2001 | 2001 |
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall, 2nd edition W.B. Saunders Co., Philadelphia, 2000 | 2000 |
Guyton AC, Hall JE. Textbook of Medical Physiology, 10th Edition W. B. Saunders Co., Philadelphia, 2000 | 2000 |
Guyton AC, Hall JE. Human Physiology and Mechanisms of Disease, 6th Edition W.B. Saunders Co., Philadelphia, 1997 | 1997 |
Hall JE, Adair TH. Physiology. Rypins’ Intensive Reviews Lippincott - Raven, Philadelphia, 1997 | 1997 |
Hall JE (ed.). Pocket Companion for Textbook of Medical Physiology, Guyton and Hall W.B. Saunders Co., Philadelphia, 1997 | 1997 |
Hall JE, Adair TH. Rypins’ Basic Sciences Review - Physiology, 17th Ed., ed. E.D. Frohlich J.B. Lippincott Co., Philadelphia, 1997 | 1997 |
Hall JE, Adair TH. Rypins’ Questions and Answers for Basic Sciences Review - Physiology, 3rd Ed., ed. E.D. Frohlich J.B.Lippincott Co., Philadelphia, 1997 | 1997 |
Guyton AC, Hall JE. Textbook of Medical Physiology, 9th Edition W.B. Saunders Co., Philadelphia, 1996 | 1996 |
Guyton AC, Hall JE. Cardiovascular Physiology IV, International Review of Physiology University Park Press, Baltimore, 1982 | 1982 |
Editorial Commentary | |
Jones DW, Hall JE. JNC-7 and evidence from new hypertension trials Hypertension. 2004; 43:1-3 | 2003 |
Hall JE. The renin-angiotensin system and control of renal function: historical perspective In: One Hundred Years of the Renin-Angiotensin System: Past Accomplishments and Future Prospects. Ed. M.G. Nichols., H.R. Brunner, H. Ikram, C.S. Sweet, and J.F. Walker. p.21-26, 1998 | 1998 |
Hall JE. Speculation on regulatory, integrative and comparative physiology (the Journal) Am J Physiol. 1996; 270:R1-R2 | 1996 |
Brands MW, Hall JE. Hyperinsulinemia and hypertension Nutr Metab Cardiovasc Dis. 1994; 3:155-157 | 1994 |
Letter to the Editor | |
Pickering TG. Hall JE, Appel L, Falkner B, Graves J, Hill M, Jones DW, Kurtz T, Sheps S, Roccella E. Response to recommendations for blood pressure measurement in human and experimental animals; Part 1: Blood pressure measurement in humans and miscuffing: A problem with new guidelines Hypertension. 2006; 48:e5-e6 | 2006 |
Skek EW, Hall JE, Brands MW. Leptin and the renin-angiotensin-aldosterone system Hypertension. 1998; 32:376 | 1998 |
Historical Article | |
Hall JE, The kidney, hypertension, and obesity. Hypertension (Dallas, Tex. : 1979), 2003 Mar;41(3 Pt 2):625-33 | 2003 |
Hall JE, Historical perspective of the renin-angiotensin system. Molecular biotechnology, 2003 May;24(1):27-39 | 2003 |
Comment | |
Kurtz TW, Griffin KA, Bidani AK, Davisson RL, Hall JE, AHA Council on High Blood Pressure Research, Professional and Public Education Subcommittee, Recommendations for blood pressure measurement in animals: summary of an AHA scientific statement from the Council on High Blood Pressure Research, Professional and Public Education Subcommittee. Arteriosclerosis, thrombosis, and vascular biology, 2005 Mar;25(3):478-9 | 2005 |
Jones DW, Hall JE, Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials. Hypertension (Dallas, Tex. : 1979), 2004 Jan;43(1):1-3 | 2004 |
Jones DW, Hall JE, The national high blood pressure education program: thirty years and counting. Hypertension (Dallas, Tex. : 1979), 2002 May;39(5):941-2 | 2002 |
Hall JE, Jones DW, What can we do about the "epidemic" of obesity. American journal of hypertension, 2002 Jul;15(7 Pt 1):657-9 | 2002 |
Hall JE, The promise of translational physiology. American journal of physiology. Cell physiology, 2001 Nov;281(5):C1411-2 | 2001 |
Editorial | |
Mancia G, Hall JE, Introduction to a Compendium on the Pathophysiology and Treatment of Hypertension. Circulation research, 2019 Mar 29;124(7):967-968 | 2019 |
Hall JE, Hall ME, Cardiometabolic Surgery for Treatment of Hypertension? Hypertension (Dallas, Tex. : 1979), 2019 Mar;73(3):543-546 | 2019 |
Hall JE, Thirtieth anniversary of Hypertension: evolution of a journal and a progress report. Hypertension (Dallas, Tex. : 1979), 2009 Oct;54(4):685-8 | 2009 |
Jones DW, Hall JE, Hypertension: pathways to success. Hypertension (Dallas, Tex. : 1979), 2008 May;51(5):1249-51 | 2008 |
Hall JE, Hypertension: update 2008. Hypertension (Dallas, Tex. : 1979), 2008 Sep;52(3):425-8 | 2008 |
Jones DW, Hall JE, World Hypertension Day 2007. Hypertension (Dallas, Tex. : 1979), 2007 May;49(5):939-40 | 2007 |
Jones DW, Hall JE, Racial and ethnic differences in blood pressure: biology and sociology. Circulation, 2006 Dec 19;114(25):2757-9 | 2006 |
Hall JE, The pioneering use of systems analysis to study cardiac output regulation. American journal of physiology. Regulatory, integrative and comparative physiology, 2004 Nov;287(5):R1009-11 | 2004 |
Hall JE, The promise of translational physiology. Journal of neurophysiology, 2003 Feb;89(2):646-7 | 2003 |
Presentations
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity and Metabolic Syndrome, First Caribbean Obesity Summit: Diabetes & Obesity; Second Scientific Meeting of the American Physiological Society, Puerto Rico Chapter, Ponce, Puerto Rico | 03/2012 |
Invited Symposia, Hypertension From Bench to Bedside: A Tale of Mice and Men, André Aisenstadt Memorial Clinical Day, Jewish General Hospital, Montreal, Canada | 10/2011 |
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Physiology of Cardiovascular Disease: Gender Disparities, American Physiological Society, Jackson, MS | 10/2011 |
National and International Invited Seminars/Lectures, Central Role of Obesity in Hypertension and Cardiometabolic Disease, American Heart Association Council for High Blood Pressure Research, Orlando, FL | 09/2011 |
Invited Symposia, 38th Annual Pharmacology Research Colloquium and the Department of Physiology and Pharmacology 2nd Students Research Forum, University of Toledo Health Sciences Campus, Toledo, OH | 06/2011 |
National and International Invited Seminars/Lectures, Role of Aldosterone and Mineralocorticoid Receptor Activation in Obesity Related Hypertension, American Society of Hypertension, New York, NY | 05/2011 |
National and International Invited Seminars/Lectures, Obesity-Related Hypertension: Basic Concepts and Clinical Implications, American Society of Hypertension, New York, NY | 05/2011 |
National and International Invited Seminars/Lectures, Hypertension in Obesity/Metabolic Syndrome: Basic Concepts and Clinical Implications, Yangtze River International Congress of Cardiology, Chongqing City, China | 04/2011 |
National and International Invited Seminars/Lectures, Mechanisms of Salt-Sensitive Hypertension and Target Organ Injury, Yantze River International Congress of Cardiology, Chongqing City, China | 04/2011 |
Visiting Professor, Visiting Professor, Third Medical University, Chongqing City, China | 04/2011 |
Invited Symposia, Leptin, obesity and hypertension: Understanding the key mechanisms, International Society of Nephrology, Vancouver, British Columbia, Canada | 04/2011 |
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Indiana Physiological Society Meeting, Indianapolis, Indiana | 02/2011 |
Scientific Presentations, Methodological Issues in Collecting Urinary Sodium in NHANES, National Heart, Lung and Blood Institute, Bethesda, MD | 01/2011 |
Invited Symposia, Obesity – A Growing Threat to our Health & Economy, Singing River Health System, Biloxi, MS | 11/2010 |
National and International Invited Seminars/Lectures, Obesity Hpertension and Renal Hemodynamics, FASEB Summer Research Conference on "Renal Hemodynamics: Mechanisms to Understand Disease, Saxton River, VT | 06/2010 |
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, University of Alberta Cardiovascular Centre, Edmonton, Canada | 06/2010 |
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, University of Missouri-Columbia, Columbia, Missouri | 05/2010 |
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Department of Physiology and Pharmacology, Department of Medicine Grands Rounds,University of Toledo College of Medicine, Toledo, Ohio | 05/2010 |
Invited Symposia, Renal Function and the Law of Starling, Symposium on “One Hundred Years of Starling: his Contributions to Physiology", Experimental Biology 2010, American Physiological Society, Anaheim, California | 04/2010 |
National and International Invited Seminars/Lectures, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Hypertension Symposium, Boston University School of Medicine, Boston, MA | 04/2010 |
Scientific Presentations, Pathophysiology of Obesity Hypertension, Merck & Co, Cardiovascular Diseases Division, Rahway, NJ | 10/2009 |
National and International Invited Seminars/Lectures, Pathophysiology of Obesity/Metabolic Syndrome, Michigan State University, Department of Toxicology, East Lansing, MI | 10/2009 |
Scientific Presentations, Session on “Meet the Expert”, XV Scientific Sessions of the Inter-American Society of Hytpertension, Inter-American Society of hypertension, Belo Horizonte, Brazil | 08/2009 |
National and International Invited Seminars/Lectures, Plenary lecture, XV Scientific Sessions of the Inter-American Society of Hytpertension-"Hypertension and Obesity", Inter-American Society of Hypertension, Belo Horizonte, Brazil | 08/2009 |
National and International Invited Seminars/Lectures, Meet the Expert Session on Obesity Hytension- What the Hypertension Specialist Know about Experimental Hypertension and Obesity, American Society of Hypertension, San Francisco, CA | 05/2009 |
National and International Invited Seminars/Lectures, Pathobiology of Obesity- What the Hypertension Specialist know about Experimental Hypertension and Obesity, American Society of Hypertension, San Francisco, CA | 05/2009 |
Invited Symposia, Pathophysiology of hypertension in obesity/metabolic syndrome, University of Arkansas Medical School, Department of Pharmacology and Toxicology, Little Rock, AR | 04/2009 |
National and International Invited Seminars/Lectures, Pathophysiology of hypertension in obesity/metabolic syndrome, University of Utah, Department of Medicine, Division of Nephrology, Salt Lake City, Utah | 04/2009 |
National and International Invited Seminars/Lectures, Hypothalamic melanocortins, sympathetic activation, and obesity hypertension, Palatin Technologies, Inc, Princeton, New Jersey | 02/2009 |
Invited Symposia, Invited Speaker, Medical Student Research Day, Medical Student Research Day, University of Alabama-Birmingham, Birmingham, Alabama | 11/2008 |
Regional Invited Seminars/Lectures, Pathophysiology of hypertension in obesity/metabolic syndrome: Role of adipokines, Department of Physiology & Biophysics, University of Alabama-Birmingham, Birmingham, AL | 11/2008 |
National and International Invited Seminars/Lectures, Obesity, Hypertension and Renal Hemodynamics, International Society of Nephrology Nexus Symposium, Diabetes and the Kidney, Dublin, Ireland | 06/2008 |
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Department of Medicine, University of Texas Health Science Center, San Antonio, TX | 05/2008 |
Invited Symposia, The Kidney: Aging, Apoptosis, Endocrine Sensitivity and the Kidney’s Role in Hypertension, Experimental Biology 2008, San Diego, CA | 04/2008 |
National and International Invited Seminars/Lectures, Hypertension and the Kidney, International Society of Nephrology Nexus Symposium, Hypertension and the Kidney, Vienna, Austria | 11/2007 |
National and International Invited Seminars/Lectures, Mechanisms of Hypertension in Obesity/Metabolic Syndrome, Canadian Hypertension Society 28th Annual Meeting, Quebec City, Canada | 10/2007 |
Invited Symposia, Pathophysiology of hypertension in obesity/metabolic syndrome, Department of Physiology, University of Maryland, Baltimore, MD | 05/2007 |
National and International Invited Seminars/Lectures, Obesity, Adipokines and Hypertension, 17th Meeting of Inter-American Society of Hypertension, Miami, FL | 05/2007 |
Invited Symposia, Invited Lecture, Clinical Nutrition Research Center, University of Alabama-Birmingham, Birmingham, AL | 03/2007 |
Invited Symposia, CVI Seminar, Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA | 02/2007 |
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Tulane University School of Medicine, New Orleans, LA | 11/2006 |
Meet the Professor, Cardiovascular Complications of Obesity, 3rd Endocrinology Canada International Symposium, Toronto, Canada | 11/2006 |
Invited Symposia, Pathology of Hypertension in Obesity/Metabolic Syndrome, 3rd Endocrinology Canada International Symposium, Toronto, Canada | 11/2006 |
Invited Symposia, Pathophysiology of Obesity Hypertension: Neurohumoral and Renal Mechanisms, Department of Medicine, Nephrology Grand Rounds, University of Virginia, Charlottesville, VA | 11/2006 |
Invited Symposia, Distinguished Lecturer, Department of Physiology, Anatomy and Genetics, Oxford University, Oxford, England, United Kingdom | 11/2006 |
National and International Invited Seminars/Lectures, Role of the Renin-Angiotensin Aldosterone System, Keynote Lecture at International Symposium, Sendai, Japan | 10/2006 |
National and International Invited Seminars/Lectures, Salt, Kidney and Hypertension, Keynote Lecture at International Symposium, Nagoya, Japan | 10/2006 |
National and International Invited Seminars/Lectures, Adipokines, Obesity and Hypertension, International Society of Hypertension, Fukuoka, Japan | 10/2006 |
Invited Symposia, Invited Professor-"Pathophysiology of Hypertension in Obesity/Metabolic Syndrome", Nephrology Division and Department of Physiology, University of Florida, Gainesville, FL | 08/2006 |
Invited Symposia, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Merck & Co., Cardiovascular Diseases Division, Rahway, NJ | 06/2006 |
National and International Invited Seminars/Lectures, Obesity and Hypertension: Role of the renin-angiotensin- aldosterone system, Novartis Institutes for Biomedical Research, East Hanover, NJ | 06/2006 |
Invited Symposia, Nephrology and Hypertension Grand Rounds-"Metabolic Syndrome, Hypertension, and Cardiovascular-Renal Disease", Mayo Clinic College of Medicine, Rochester, MN | 04/2006 |
Invited Symposia, Research Forum-Neurohumoral and Renal Mechanisms of Obesity Hypertension, Mayo Clinic College of Medicine, Rochester, MN | 04/2006 |
Scientific Presentations, Obesity and Renal Disease, Experimental Biology 2006, San Francisco, CA | 04/2006 |
Scientific Presentations, Melanocyte Stimulating Hormones and Their Receptors, Experimental Biology 2006, San Francisco, CA | 04/2006 |
Scientific Presentations, Pathophysiology of Hypertension in Obesity/Metabolic Syndrome, Eli Lilly Research Laboratories “Endocrine Think Tank”, Indianapolis, IN | 11/2005 |
Invited Symposia, Invited Lecture, Georgetown University Medical Center, Cardiovascular-Kidney Institute, Washington, DC | 10/2005 |
National and International Invited Seminars/Lectures, Obesity and metabolic syndrome, Inter-American Society of Hypertension Symposium, Cancun, Mexico | 04/2005 |
Invited Symposia, Vascular regulatory abnormalities in obesity, Microcirculatory Society's President's Symposium, San Diego, California | 04/2005 |
Invited Symposia, Hypertension and metabolic syndrome, Pfizer, St. Louis, Missouri | 01/2005 |
State/Local Invited Seminars/Lectures, A. Ross McIntyre Memorial Lecture, University of Nebraska Medical Center, Omaha, Nebraska | 2005 |
National and International Invited Seminars/Lectures, Hypertension Summer School, American Heart Association, Castine, Maine | 2005 |
Regional Invited Seminars/Lectures, Keynote Speaker at Regional Hypertension Workshop, Kellogg Biological Station, Michigan | 2005 |
National and International Invited Seminars/Lectures, Workshop on "Emerging Concepts on Neural Intractions in Hypertension", American Heart Association, Council for High Blood Pressure Research, Washington, D.C. | 2005 |
Invited Symposia, Renal mechanisms of salt sensitive hypertension, American Society of Hypertension, New York, NY | 05/2004 |
National and International Invited Seminars/Lectures, Mechanisms of obesity hypertension, 20th Scientific Meeting of the International Society of Hypertension, Sao Paulo, Brazil | 02/2004 |
Invited Symposia, Arthur C. Guyton: the Man and His Science, Experimental Biology, Washington, D.C. | 2004 |
Invited Symposia, Cardiovascular Injury and the Renin-Angiotensin System, Takeda Pharmaceuticals, New Orleans, Louisiana | 2004 |
Visiting Professor, Invited Lecture, Eastern Virginia Medical School, Department of Physiology | 2004 |
State/Local Invited Seminars/Lectures, Invited Lecture, Pfizer Global Research & Development, St. Louis, Missouri | 2004 |
State/Local Invited Seminars/Lectures, Invited Lecture, Louisiana State University, Department of Physiology, New Orleans, Louisiana | 2004 |
Visiting Professor, Invited Lecture, Medical College of Georgia, Deparment of Physiology, Augusta, Georgia | 2004 |
National and International Invited Seminars/Lectures, Keynote Lecture, The Society of Nephrology and Hypertension of Puerto Rico, San Juan, Puerto Rico | 2004 |
National and International Invited Seminars/Lectures, Keynote Lecture, The 4th Annual Meeting of The Safety Pharmacology Society, Cincinnati, Ohio | 2004 |
State/Local Invited Seminars/Lectures, Medicine Grand Rounds Lecture at "E. Eric Muirhead Hypertension Research Day", The University of Tennessee Health Sciences Center, Memphis, Tennessee | 2004 |
National and International Invited Seminars/Lectures, Renal Microcirculatory and Tubular Dynamics: Molecules to Man, FASEB Summer Conference, Pine Mountain, Georgia | 2004 |
State/Local Invited Seminars/Lectures, Invited Lecture, Merck, Sharpe & Dohme Obesity Research Group, Rahway, New Jersey | 2003 |
Visiting Professor, Invited Lecture, Wake Forest University, Bowman Gray School of Medicine, Hypertension and Vascular Disease Center, Winston Salem, North Carolina | 2003 |
National and International Invited Seminars/Lectures, Invited Lecture, 5th European Federation of Autonomic Societies Meeting, Toulouse, France | 2003 |
National and International Invited Seminars/Lectures, Invited Lecture, International Conference on Mediterranean Cardiovascular Risk, Murcia, Spain | 2003 |
State/Local Invited Seminars/Lectures, Invited Lecture, Medical College of Wisconsin, Department of Physiology | 2003 |
Invited Symposia, New Frontiers in Cardiovascular Disease Management, San Antonio, Texas | 2003 |
Regional Invited Seminars/Lectures, Plenary Session on "Syndrome X- Fact or Fiction", Southern Society for Clinical Investigation, New Orleans, Louisiana | 2003 |
National and International Invited Seminars/Lectures, Symposium in honor of Arthur C. Guyton, Biomedical Engineering Society, Nashville, Tennessee | 2003 |
State/Local Invited Seminars/Lectures, Symposium on "Obesity: Complications and Treatment", University of Houston, Heart and Kidney Institute | 2003 |
Invited Symposia, The Last 10 Years in Cardiovascular Disease Management, Wake Forest University School of Medicine, Winston Salem, North Carolina | 2003 |
National and International Invited Seminars/Lectures, Workshop on "The Insulin Resistance Syndrome and the Pathophysiology of Hypertension, Cardiovascular and Renal Disease", Council for High Blood Pressure Research Workshop, Washington, D.C. | 2003 |
National and International Invited Seminars/Lectures, Conference Magna Lecture on "Obesity, Hypertension and Kidney Disease- the Last Frontier of Prevention", Brazilian Society of Hypertension, Porto Alegre, Brazil | 2002 |
National and International Invited Seminars/Lectures, Hypertension and the Plurimetabolic Syndrome, Brazilian Society of Hypertension, Porto Alegre, Brazil | 2002 |
State/Local Invited Seminars/Lectures, Keynote Lecture, Hypertension and Related Disorders Meeting, Sydney, Australia | 2002 |
State/Local Invited Seminars/Lectures, Mechanisms of Hypertension and Renal Disease in the Metabolic Syndrome, GlaxoSmith Kline Pharmaceuticals Co., Philadelphia, Pennsylvania | 2002 |
State/Local Invited Seminars/Lectures, Medical Grand Rounds, University of Puerto Rico School of Medicine, San Juan, Puerto Rico | 2002 |
State/Local Invited Seminars/Lectures, Medical Grand Rounds, Veterans Administration Hospital, University of Puerto Rico School of Medicine, San Juan, Puerto Rico | 2002 |
Visiting Professor, Nephrology Grand Rounds, Thomas Jefferson Medical College, Philadelphia, Pennsylvania | 2002 |
National and International Invited Seminars/Lectures, Novartis Award Lecture, American Heart Association, Council for High Blood Pressure Research | 2002 |
National and International Invited Seminars/Lectures, Obesity, Hypertension and Kidney Disease, Kyushu University, Fukuoka, Japan | 2002 |
National and International Invited Seminars/Lectures, Physiological Approach to Hypertension Research: Role of the Kidney, 25th Meeting of Japanese Society of Hypertension, Tokyo, Japan | 2002 |
National and International Invited Seminars/Lectures, Symposium on "Blood Pressure Control in Cardiovascular Disease Prevention", Japanese Society of Hypertension, Tokyo, Japan | 2002 |
National and International Invited Seminars/Lectures, Symposium on "Hypertension and Diabetes: The Emerging Epidemic", American Heart Association, 75th Scientific Sessions, Chicago, Illinois | 2002 |
National and International Invited Seminars/Lectures, Symposium on "Obesity and Cardiovascular Disease", American Heart Association, 75th Scientific Sessions, Chicago, Illinois | 2002 |
National and International Invited Seminars/Lectures, The Metabolic Syndrome and Hypertension: The Next Frontier of Prevention and Treatment of Cardiovascular Disease, Tokyo Medical University, Tokyo, Japan | 2002 |
Invited Symposia, Vascular Biology and Hypertension Research Symposium, Destin, Florida | 2002 |
National and International Invited Seminars/Lectures, Experimental Models of Obesity and Hypertension, XIV Meeting of the Inter-American Society of Hypertension, Santiago, Chile | 2001 |
Visiting Professor, Invited Lecture, Indiana University School of Medicine, Indianapolis, Indiana | 2001 |
Burroughs Wellcome Visiting Professor, Invited Lecture, University of North Dakota School of Medicine, Vermillion, North Dakota | 2001 |
Visiting Professor, Invited Lecture, University of North Carolina, Department of Cell and Molecular Physiology, Chapel Hill, North Carolina | 2001 |
Visiting Professor, Invited Lecture, Department of Internal Medicine and Cardiovascular Research Institute, University of North Dakota, Sioux Falls, North Dakota | 2001 |
Visiting Professor, Invited Lecture, University of Kentucky, School of Pharmacy and School of Medicine | 2001 |
National and International Invited Seminars/Lectures, Invited Lecture, International Society of Obesity Hypertension, Berlin, Germany | 2001 |
National and International Invited Seminars/Lectures, Obesity , the Renin-Angiotensin System, and Renal Damage in the Hypertensive Patient, Spanish Hypertension Society, Malaga, Spain | 2001 |
National and International Invited Seminars/Lectures, Role of Leptin and Sympathetic Nervous System in Hypertension, International Pediatric Hypertension Association, San Francisco, California | 2001 |
Regional Invited Seminars/Lectures, Symposium on "Obesity-Associated Hypertension: Pathophysiology and Treatment", Consortium for Southeastern Hypertension Control, Charleston, South Carolina | 2001 |
National and International Invited Seminars/Lectures, Vertical Integration of Physiology in the Medical School Curriculum, Association of Charis of Departments of Physiology, Los Cabos, Mexico | 2001 |
National and International Invited Seminars/Lectures, Workshop on the "Pathophysiology of Obesity- Associated Cardiovascular Disease", National Heart, Lung and Blood Institute, Bethesda, Maryland | 2001 |
Regional Invited Seminars/Lectures, Hypertension and Cardiovascular Disease in ESRD, Southeastern Dialysis and Transplantation Association, Biloxi, Mississippi | 2000 |
National and International Invited Seminars/Lectures, Hypertension and the New Biology of Obesity, 1st John H. Laragh Conference on Advances in Hypertension Research, Boca Raton, Florida | 2000 |
Visiting Professor, Invited Lecture, Louisiana State University Medical Center, Shreveport, Louisiana | 2000 |
Visiting Professor, Invited Lecture, Georgetown University Medical Center, Washington, D.C. | 2000 |
Visiting Professor, Invited Lecture, University of Houston, Department of Physiology and Pharmaceutical Sciences, Houston, Texas | 2000 |
National and International Invited Seminars/Lectures, Mechanisms of Obesity Hypertension and Renal Disease, Cardiovascular Research Division, Searle Pharmaceuticals, St. Louis, Missouri | 2000 |
National and International Invited Seminars/Lectures, Obesity Hypertension, Spanish Society of Hypertension, Madrid, Spain | 2000 |
National and International Invited Seminars/Lectures, Richard Bright Award Lecture on "Obesity, Hypertension, and Kidney Disease", 15th Scientific Meeting of the American Society of Hypertension, New York, New York | 2000 |
National and International Invited Seminars/Lectures, State of the Art Lecture on "Mechanisms of Obesity Hypertension and Relevance to Essential Hypertension", International Society of Hypertension, Chicago, Illinois | 2000 |
National and International Invited Seminars/Lectures, Basic Science Review of Salt Intake and Cardiovascular Disease, American Society of Hypertension, New York, New York | 1999 |
State/Local Invited Seminars/Lectures, Distinguished Lecturer, Hypertension Research Center, University of Medicine and Dentistry of New Jersey, Newark, New Jersey | 1999 |
National and International Invited Seminars/Lectures, Integration and Regulation of Cardiovascular Function, The APS, Experimental Biology, Washington, D.C. | 1999 |
Visiting Professor, Invited Lecture, Colorado State University, Ft. Collins, Colorado | 1999 |
Visiting Professor, Invited Lecture, University of Alabama- Birmingham School of Medicine, Department of Physiology | 1999 |
National and International Invited Seminars/Lectures, Mechanisms of Obesity-Related Hypertension, Local vs. Circulating Angiotensin II: Are They Both Involved in Hypertension?, AHA, Third Hypertension Summer School, Boulder, Colorado | 1999 |
National and International Invited Seminars/Lectures, Obesity, Hypertension, and End-Stage Renal Disease, XIIIth Meeting of Inter-American Society of Hypertension, Buenos Aires, Argentina | 1999 |
National and International Invited Seminars/Lectures, Obesity: Impact on Cardiovascular Disease, American College of Cardiology, 48th Annual Sessions, New Orleans, Louisiana | 1999 |
National and International Invited Seminars/Lectures, Renal Mechanisms of Obesity Hypertension, International Symposium on Obesity and Hypertension, Berlin, Germany | 1999 |
National and International Invited Seminars/Lectures, Role of Neuropeptides and the Sympathetic Nervous System in Obesity Hypertension, III International Symposium on Vasoactive Peptides, Belo Horizonte, Brazil | 1999 |
National and International Invited Seminars/Lectures, Role of Obesity in Hypertension and End-Stage Renal Disease, Congresso da Sociedade Brasileira de Hipertensao, Rio de Janeiro, Brazil | 1999 |
National and International Invited Seminars/Lectures, The Metabolic Syndrome X: Convergence of Insulin Resistance, Hypertension, Obesity, and Dyslipidemias, New York Academy of Sciences, Jacksonville, Florida | 1999 |
Workshop, Workshop on Sodium and Blood Pressure, National Heart, Lung, and Blood Institute, Bethesda, Maryland | 1999 |
National and International Invited Seminars/Lectures, 100 Years of the Renin-Angiotensin System: Past Accomplishments and Future Prospects, International Symposium, Rome, Italy | 1998 |
National and International Invited Seminars/Lectures, Angiotensin Receptor Blockade and the Kidney, American Society of Nephrology, Philadelphia, Pennsylvania | 1998 |
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, VII Congress of Brazilian Society of Hypertension, Goiania, Brazil | 1998 |
National and International Invited Seminars/Lectures, Ernest G. Starling Distinguished Lecture, The American Physiological Society, Experimental Biology, San Francisco, California | 1998 |
Visiting Professor, Invited Lecture, Rush-Presbyterian- St. Luke's Medical Center, Rush University, Chicago, Illinois | 1998 |
Visiting Professor, Invited Lecture, Heart Institute, Universidade de Sao Paulo, Brazil | 1998 |
Visiting Professor, Invited Lecture, Physiology Department, Faculdade de Medicina de Ribeiro Preto, Da Universidade de Sao Paulo, Brazil | 1998 |
Visiting Scientist, Invited Lecture, Merck, Sharp and Dohme Research Laboratories, West Point, Pennsylvania | 1998 |
National and International Invited Seminars/Lectures, Is Obesity the Culprit in Causing Excess Hypertension and End-Stage Renal Disease in African-Americans?, Third Congress on Treatment of Cardiovascular Diseases in African-Americans, Dallas, Texas | 1998 |
State/Local Invited Seminars/Lectures, Keynote Lecture, 75th Anniversary of Physiology Department, Michigan State University, East Lansing, Michigan | 1998 |
National and International Invited Seminars/Lectures, Keynote Lecture, 4th Meeting on the Kidney and Hypertension, Tokyo, Japan | 1998 |
National and International Invited Seminars/Lectures, Mechanisms of Renal Dysfunction in Obesity and Role in Hypertension, American Society of Hypertension, New York, New York | 1998 |
State/Local Invited Seminars/Lectures, Obesity and Hypertension, Mississippi Academy of Sciences | 1998 |
National and International Invited Seminars/Lectures, Obesity: Impact on Cardiovascular Disease, American Heart Association, Amelia Island, Florida | 1998 |
State/Local Invited Seminars/Lectures, Pfizer Lecture, Clinical Research Institute of Montreal, Montreal, Canada | 1998 |
National and International Invited Seminars/Lectures, Salt, Hypertension and the Pathophysiology of Cardiovascular Disease, University of Tokyo, Tokyo, Japan | 1998 |
National and International Invited Seminars/Lectures, Sodium: To Restrict or Not to Restrict For the Hypertensive Patient, 7th Annual National Kidney Foundation Meeting, Nashville, Tennessee | 1998 |
State/Local Invited Seminars/Lectures, Why Is There So Much Cardiovascular Disease in Mississippi, Tougaloo College, Jackson, Mississippi | 1998 |
National and International Invited Seminars/Lectures, Abnormal Kidney Function as a Cause and Consequence of Obesity Hypertension, Experimental Biology, New Orleans, Louisiana | 1997 |
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, American Society of Hypertension, San Francisco, California | 1997 |
National and International Invited Seminars/Lectures, Cardiovascular and Renal Pathophysiology of Obesity, and Relevance to Essential Hypertension, Astra-Hassle, Gothenberg, Sweden | 1997 |
National and International Invited Seminars/Lectures, Insulin Resistance and Obesity, and Their Role in Cardiovascular and Renal Disease, American Society of Nephrology, Clinical Sciences Symposium, San Antonio, Texas | 1997 |
National and International Invited Seminars/Lectures, Intrarenal Actions of Angiotensin II and Long-Term Blood Pressure Regulation, International Centenary Symposium in Honor of Robert Tigerstedt, Stockholm, Sweden | 1997 |
Visiting Professor, Invited Lecture, Hypertension Center, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina | 1997 |
National and International Invited Seminars/Lectures, Obesity, Insulin Resistance and Cardiovascular Disease, International Symposium on Hypertension, Seville, Spain | 1997 |
National and International Invited Seminars/Lectures, Renal Mechanism of Obesity Hypertension and Relevance to Essential Hypertension, XXXIII International Congress of Physiological Sciences, St. Petersburg, Russia | 1997 |
National and International Invited Seminars/Lectures, Resistance to Metabolic Actions of Insulin and Cardiovascular Disease, Inter-American Society of Hypertension, Mexico City, Mexico | 1997 |
National and International Invited Seminars/Lectures, Salt-Sensitivie Hypertension and Vascular Disease, International Symposium on Hypertension, Seville, Spain | 1997 |
National and International Invited Seminars/Lectures, Advances in the Genetics and Therapy of Obesity: Cardiovascular Implications, American Heart Association Annual Meeting | 1996 |
National and International Invited Seminars/Lectures, Insulin Resistance and its Role in Cardiovascular Disease, Fourth Congress of Argentine Society of Hypertension, Buenos Aires, Argentina | 1996 |
National and International Invited Seminars/Lectures, Resistance to Metabolic Actions of Insulin and Hypertension, Hypertension Society of Mexico, Mexico City, Mexico | 1996 |
Regional Invited Seminars/Lectures, Salt, Vascular Injury, and Hypertension, Consortium of Southeastern Hypertension Centers, Raleigh, North Carolina | 1996 |
National and International Invited Seminars/Lectures, Salt-Sensitive Hypertension, Fourth Congress of Argentine Society of Hypertension, Buenos Aires, Argentina | 1996 |
National and International Invited Seminars/Lectures, Career Opportunities in the Medical School Basic Science Departments, Experimental Biology 1995, Atlanta, Georgia | 1995 |
National and International Invited Seminars/Lectures, Hypertension: Causes and Consequences of Renal Injury, Barcelona, Spain | 1995 |
Invited Symposia, Insulin Resistance and Hypertension, Philadelphia, Pennsylvania | 1995 |
National and International Invited Seminars/Lectures, Insulin Resistance and Hypertension in the Elderly, 3rd International Congress on Hypertension in the Elderly, Rome, Italy | 1995 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Tennessee, Memphis, Tennessee | 1995 |
National and International Invited Seminars/Lectures, Mechanisms of Obesity Associated Hypertension and Relevance to Essential Hypertension, International Congress of Nephrology, Madrid, Spain | 1995 |
National and International Invited Seminars/Lectures, Mechanisms of Obesity Hypertension and Their Relevance to Human Essential Hypertension, London Cardiovascular Society, London, Ontario, Canada | 1995 |
National and International Invited Seminars/Lectures, Obesity and Hypertension, Brookhaven National Laboratory, Montreal, Canada | 1995 |
National and International Invited Seminars/Lectures, Obesity, Insulin Resistance and Hypertension, North American Society for the Study of Obesity Annual Meeting, Baton Rouge, Louisiana | 1995 |
National and International Invited Seminars/Lectures, Pathophysiological Aspects of the Relationship Between Hypertension and Obesity, Spanish Society for Hypertension, Madrid, Spain | 1995 |
State/Local Invited Seminars/Lectures, Pathophysiology of Obesity Hypertension, Amylin Pharmaceuticals, Inc., San Diego, California | 1995 |
Regional Invited Seminars/Lectures, Physiological Mechanisms of Salt Sensitivity, Consortium of Southeastern Hypertension Centers, 2nd Annual Meeting, Charleston, South Carolina | 1995 |
National and International Invited Seminars/Lectures, Renal Mechanisms of Hypertension: Role of Obesity and Sodium, Brookhaven National Laboratory, New York, New York | 1995 |
State/Local Invited Seminars/Lectures, The Renin-Angiotensin System: Normal Physiology and Role in Hypertension, Symposium on "Angiotensin Receptor (ATI) Blockers", Jackson, MS | 1995 |
Invited Symposia, Insulin Resistance Syndrome: Role in a Panoply of Disorders, The Endocrine Society, 76th Annual Meeting, Anaheim, California | 1994 |
Invited Symposia, Insulin Resistance, Obesity, and Hypertension, Experimental Biology 1994, Anaheim, California | 1994 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Missouri School of Medicine, Columbia, Missouri | 1994 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Texas Health Sciences Center, San Antonio, Texas | 1994 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Louisville, Louisville, Kentucky | 1994 |
National and International Invited Seminars/Lectures, Neurohumoral and Renal Mechanisms of Obesity Hypertension, President's Symposium, American Society of Hypertension, New York, New York | 1994 |
National and International Invited Seminars/Lectures, Obesity Hypertension, the Renal Mdulla and the Renal Nerves, Hypertension Investigators Meeting, Amelia Island, Florida | 1994 |
Regional Invited Seminars/Lectures, The Kidney and Hypertension, Consortium of Southeastern Hypertension Centers Symposium, Asheville, North Carolina | 1994 |
Regional Invited Seminars/Lectures, Cellular and Molecular Mechanisms in Atherosclerosis and Hypertension, Fourteenth Annual Meeting of the Southeastern Pharmacology Society, Memphis, Tennessee | 1993 |
National and International Invited Seminars/Lectures, Insulin Resistance and Hypertension, Inter-American Society of Hypertension, San Diego, California | 1993 |
National and International Invited Seminars/Lectures, Insulin Resistance and Sympathetic Activity in Arterial Hypertension, Spanish Foundation for Cardiovascular Research, Madrid, Spain | 1993 |
Invited Symposia, International Symposium on ACE Inhibition, Amsterdam, the Netherlands | 1993 |
National and International Invited Seminars/Lectures, Interrelationships between Hyperinsulinemia, Hypertension and Diabetes, Including its Renal and Vascular Complications, American Society of Hypertension, New York, New York | 1993 |
State/Local Invited Seminars/Lectures, Invited Lecture, Parke-Davis Pharmaceutical Research, Cardiovascular Pharmacology Department, Ann Arbor, Michigan | 1993 |
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Nephrology, Utrecht University, Utrecht, the Netherlands | 1993 |
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Physiology, Tulane University, New Orleans, Louisiana | 1993 |
State/Local Invited Seminars/Lectures, Visiting Professor, Department of Physiology, University of Murcia School of Medicine, Murcia, Spain | 1993 |
State/Local Invited Seminars/Lectures, Hypertension in Theory and in Practice, Jackson, MS | 1992 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, University of Arkansas, Little Rock, Arkansas | 1992 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Medical Physiology, Texas A&M University, College Station, Texas | 1992 |
State/Local Invited Seminars/Lectures, John Whitney Memorial Medical Lecture, University of Arkansas Medical School, Little Rock, Arkansas | 1992 |
National and International Invited Seminars/Lectures, Kidney Function and Hypertension, 29th Meeting of Japanese Society of Applied Physiology, Gifu, Japan | 1992 |
National and International Invited Seminars/Lectures, Lewis K. Dahl Memorial Lecture, American Heart Association, New Orleans, Louisiana | 1992 |
Forum, Nephrology Forum, Kidney International, Boston, Massachusetts | 1992 |
National and International Invited Seminars/Lectures, Nephrology Research Conference, New England Medical Center, Tufts University, Boston, Massachusetts | 1992 |
National and International Invited Seminars/Lectures, Obesity, Hyperinsulinemia and Hypertension, Hypertension Society of Mexico, State of the Art Lecture, Mexico City, Mexico | 1992 |
Invited Symposia, Renal Excretory Function and Hypertension, Hypertension Investigators' Symposium, Amelia Island, Florida | 1992 |
National and International Invited Seminars/Lectures, The Kidney in Hypertension, Hypertension Society of Mexico, Mexico City, Mexico | 1992 |
National and International Invited Seminars/Lectures, Insulin and Hypertension, American Society of Hypertension, New York, New York | 1991 |
State/Local Invited Seminars/Lectures, Invited Lecture, Bristol-Meyers Squibb Pharmaceutical Group, Princeton, New Jersey | 1991 |
State/Local Invited Seminars/Lectures, Invited Lecture, The University of Iowa College of Medicine, Department of Internal Medicine, Iowa City, Iowa | 1991 |
Invited Symposia, Mechanisms of Endocrine Hypertension, American Physiological Society, San Antonio, Texas | 1991 |
Workshop, Nutrition and Hypertension, National Institutes of Health, Washington, DC | 1991 |
National and International Invited Seminars/Lectures, Obesity and Hypertension, American Society of Nephrology, Baltimore, Maryland | 1991 |
State/Local Invited Seminars/Lectures, The Kidney, Obesity and Essential Hypertension, Jackson, Mississippi | 1991 |
Invited Symposia, Treatment Considerations in the Mature and Elderly Hypertensive Patient, West Penn Hospital, Pennsylvania | 1991 |
Invited Symposia, ACE Inhibition in the 1990's, Napa, California | 1990 |
State/Local Invited Seminars/Lectures, Invited Lecture, Merck, Sharp & Dohme Research Laboratories, West Point, Pennsylvania | 1990 |
Invited Symposia, What is the Mechanism of One-Kidney, One-Clip Hypertension and its Relevance to Low-Renin Essential Hypertension?, American Society of Hypertension, New York, New York | 1990 |
Invited Symposia, ACE Inhibition in the 1990's and Clinical Trial Results with the New Agent Benazepril, West Palm Beach, Florida | 1989 |
National and International Invited Seminars/Lectures, Biological Responses to Prolonged Increase in Atrial Natriuretic Factor, Federation of American Societies of Experiemental Biology and Medicine, New Orleans, Louisiana | 1989 |
Invited Symposia, International Symposium on ACE Inhibition, London, England | 1989 |
State/Local Invited Seminars/Lectures, Invited Lecture, The Squibb Institute for Medical Research, Princeton, New Jersey | 1989 |
State/Local Invited Seminars/Lectures, Invited Lecture, University of South Carolina, Division of Nephrology, Charleston, South Carolina | 1989 |
State/Local Invited Seminars/Lectures, Invited Lecture, der Universitat Heidelberg, I. Physiologisches Institut, Heidelberg, Germany | 1989 |
National and International Invited Seminars/Lectures, Mechanisms of Sodium Homeostasis, Copenhagen, Denmark | 1989 |
National and International Invited Seminars/Lectures, Renal Hemodynamics: Integrative and Cellular Mechanisms, FASEB Summer Conference, Saxtons River, Vermont | 1989 |
National and International Invited Seminars/Lectures, The Renin-Angiotensin System in Volume and Pressure Homeostasis, International Congress of Physiological Sciences Symposium, Helsinki, Finland | 1989 |
Invited Symposia, Hypertension in the Aging Patient, American Geriatrics Society, Anaheim, California | 1988 |
National and International Invited Seminars/Lectures, Hypertension Research Symposium, University of Tennessee, Memphis, Tennessee | 1988 |
State/Local Invited Seminars/Lectures, Invited Lecture, Nephrology Research and Training Center, University of Alabama-Birmingham, Birmingham, Alabama | 1988 |
State/Local Invited Seminars/Lectures, Invited Lecture, Abbott Laboratories, Research Division, Abbott Park, Illinois | 1988 |
State/Local Invited Seminars/Lectures, Invited Lecture, Cardiovascular and Hypertension Center, The New York Hospital- Cornell Medical Center, New York, New York | 1988 |
State/Local Invited Seminars/Lectures, Invited Lecture, Mayo Clinic Fellows' Visiting Faculty, Rochester, Minnesota | 1988 |
National and International Invited Seminars/Lectures, The Intrarenal Circulation, American Society of Hypertension, New York, New York | 1988 |
State/Local Invited Seminars/Lectures, Invited Lecture, DuPont Experimental Station, Wilmington, Delaware | 1987 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, University of Cincinnati School of Medicine, Cincinnati, Ohio | 1987 |
State/Local Invited Seminars/Lectures, Invited Lecture, The University of Texas Health Science Center, School of Medicine, San Antonio, Texas | 1987 |
National and International Invited Seminars/Lectures, Vasopressin, Fluid- Electrolyte Regulation, Second International Vasopressin Conference, Smugglers Notch, Vermont | 1987 |
National and International Invited Seminars/Lectures, Hormones and Fluid Balance, International Union of Physiological Sciences, XXX International Congress, Vancouver, Canada | 1986 |
Regional Invited Seminars/Lectures, Invited Lecture, Toronto Society of Hypertension, Toronto, Canada | 1986 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin | 1986 |
State/Local Invited Seminars/Lectures, Invited Lecture, Louisiana State University School of Medicine, Shreveport, Louisiana | 1986 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, The University of Tennessee Health Science Center, Memphis, Tennessee | 1986 |
State/Local Invited Seminars/Lectures, Invited Lecture, DuPont Experimental Station, Wilmington, Delaware | 1986 |
National and International Invited Seminars/Lectures, Neurohormonal Regulation of Water and Electrolyte Balance: Neural and Hormonal Control of Kidney Functions, American Physiological Society, New Orleans, Louisiana | 1986 |
National and International Invited Seminars/Lectures, Physiological Role of the Intrarenal Renin-Angiotensin System, Federation of American Societies for Experimental Biology, Anaheim, California | 1985 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology and Biophysics, Mayo Medical School, Rochester, Minnesota | 1984 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Texas College of Osteopathic Medicine, Fort Worth, Texas | 1984 |
State/Local Invited Seminars/Lectures, Invited Lecture, Pfizer Central Research Group, Groton, Connecticut | 1984 |
National and International Invited Seminars/Lectures, New Concepts of Blood Pressure Regulation, Federation of American Societies for Experimental Biology, St. Louis, Missouri | 1984 |
Invited Symposia, The Adrenal Gland and Hypertension, Satellite Symposium of the International Society of Hypertension, Padova, Italy | 1984 |
National and International Invited Seminars/Lectures, The Renal Origin of Hypertension: Progress over 50 Years, Council of High Blood Pressure Research of the American Heart Association, Toledo, Ohio | 1984 |
State/Local Invited Seminars/Lectures, Invited Lecture, Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Melbourne, Australia | 1983 |
Invited Symposia, The Kidney in Essential Hypertension, Alton Oscher Medical Foundation, New Orleans, Louisiana | 1983 |
National and International Invited Seminars/Lectures, Intrinsic Regulation of Renal Hemodynamics, American Physiological Society, Cincinnati, Ohio | 1981 |
National and International Invited Seminars/Lectures, Renal Hemodynamics, Eighth International Congress of Nephrology, Athens, Greece | 1981 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Physiology, Michigan State University, East Lansing, Michigan | 1979 |
State/Local Invited Seminars/Lectures, Invited Lecture, Department of Hypertension, Cleveland Clinic, Cleveland, Ohio | 1976 |
Honors, Awards, and Recognition
Arthur C. Guyton Award and Lecture, Association of Chairs of Departments of Physiology | 2019 |
Carl G. Evers Basic Science Professor of the Year, UMMC Medical Students | 2017 |
The Clifford V. and Drusilla R. Harding Lecture, Oakland University | 2016 |
Basic and Clinical Sciences, for Guyton and Hall Textbook of Medical Physiology, 13th edition, British Medical Association | 2016 |
Thomas G. Muldoon Memorial Lectureship, Medical College of Georgia, Augusta University | 2016 |
Ray G. Daggs Award, American Physiological Society, “for distinguished service to the Society and to the science of physiology” | 2016 |
Scholar Award, Distinguished Lecture Series, Texas A&M University | 2016 |
2015 Distinguished Service Award, Association of Chairs of Departments of Physiology | 2015 |
American Heart Association Award of Meritorious Achievement, for “For significant, long-lasting scholarly contributions, leadership and mentorship in the field of hypertension, including ten years as a highly successful Editor-in-Chief of the AHA journal Hypertension and 30 years as a vital leader for the Council on Hypertension, American Heart Association | 2015 |
Visitante Ilustre de Facultad de Medicina, National University of Tucumán | 2015 |
John D. Bower M.D. Distinguished Lectureship, University of Virginia School of Medicine, Division of Nephrology | 2015 |
Joy Goodwin Distinguished Lectureship, Auburn University | 2015 |
Distinguished Membership Award, for “Outstanding service and unusually distinguished contributions to experimental and clinical research in hypertension”, International Society of Hypertension | 2014 |
2014 Professor of the Year Award (selected for outstanding contributions to research, education and service from over 50,000 faculty members in SEC schools), Southeastern Conference | 2014 |
2014 Faculty Achievement Award, Southeastern Conference, University of Mississippi | 2014 |
Distinguished Alumni Award and Inductee into Hall of Fame, Kent State University, College of Education, Health and Human Services | 2013 |
Sir George Pickering Distinguished Lecture, British Hypertension Society | 2013 |
Doctor Honoris Causa, Grigore T. Popa Universitatea De Medicina Si Farmacie, Iasi, Romania | 2013 |
Excellence Award and Inductee into Mississippi Innovators Hall of Fame, Mississippi Technology Alliance | 2012 |
Franz Volhard Award and Lecture for Outstanding Research, International Society of Hypertension | 2012 |
Dr. Joseph Dvorkin Memorial Lecture, University of Alberta Cardiovascular Research Centre | 2010 |
J.O. Davis Graduate Student Distinguished Lecturer, University of Missouri at Columbia, College of Medicine | 2010 |
Lifetime Achievement Award, Inter-American Society of Hypertension | 2009 |
Executive Council, International Society of Hypertension | 2008 |
Presidential Lecture, Canadian Society of Hypertension | 2007 |
Norman C. Nelson Order for Teaching Excellence, University of Mississippi Medical Center | 2007 |
Mayerson/DiLuzio Memorial Lecture, Tulane School of Medicine | 2006 |
British Medical Association Book Competition Award, for Textbook of Medical Physiology, 11th edition, British Medical Association, Basic and Clinical Sciences | 2006 |
2005 Distinguished Achievement Award, American Heart Association, Council for High Blood Pressure Research | 2005 |
Carl G. Evers "All Star" Professor, University of Mississippi Medical Center Student Body | 2005 |
A. Ross McIntyre Award and Lecture, University of Nebraska Medical Center | 2005 |
Executive Council and Treasurer, International Union of Physiological Science | 2005 |
Lifetime Achievement Award, Consortium of Southeastern Hypertension Centers | 2003 |
Carl G. Evers "All Star" Professor, University of Mississippi Medical Center Student body | 2003 |
Michael J. Hack Memorial Lecture, Medical College of Wisconsin | 2003 |
Editor-in-Chief, Hypertension Journal, American Heart Association | 2002 |
Executive Scientific Council, International Society of Hypertension | 2002 |
Novartis Award for Hypertension Research, Council for High Blood Pressure Research, American Heart Association | 2002 |
President, Inter-American Society of Hypertension | 2001 |
President, The American Physiological Society | 2001 |
Visiting Professor in Basic Medical Sciences, Burroughs Wellcome Fund | 2000 |
Richard Bright Award, American Society of Hypertension | 2000 |
Chair, Council for High Blood Pressure Research, American Heart Association | 1998 |
Ernest H. Starling Award and Distinguished Lecturer, The American Physiological Society | 1998 |
Robert Tigerstedt Lifetime Achievement Award, Merck, Sharp & Dohme, International Society of Hypertension | 1998 |
Pfizer Distinguished Lectureship, Clinical Research Institute of Montreal, Canada | 1998 |
Billy S. Guyton Distinguished Professor, University of Mississippi Medical Center | 1996 |
Editor-in-Chief, American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, The American Physiological Society | 1996 |
Chair, Section Advisory Committee, The American Physiological Society | 1996 |
Special Research Achievement Award, American Heart Association, Mississippi Affiliate | 1996 |
Executive Council, American Society of Hypertension | 1995 |
Frederick A. P. Barnard Distinguished Professor, University of Mississippi | 1993 |
Treasurer and Executive Council, Inter-American Society of Hypertension | 1993 |
John E. Whitney Memorial Award and Lecture, University of Arkansas | 1992 |
Lewis K. Dahl Award and Lectureship, American Heart Association | 1992 |
Chairman, Water & Electrolyte Homeostasis Section, The American Physiological Society | 1991 |
Elected to Executive Council, The American Physiological Society | 1991 |
Marion Young Scholar Award, The American Society of Hypertension | 1988 |
Harry Goldblatt Award in Cardiovascular Research, Council for High Blood Pressure Research, American Heart Association | 1984 |
Travel Grant Award, American Society of Nephrology, 9th International Congress of Nephrology, Los Angeles, California | 1984 |
Travel Grant Award, American Physiological Society, 9th Congress of International Union of Physiological Sciences, Sidney, Australia | 1983 |
Travel Grant Award, American Society of Nephrology, 8th International Congress of Nephrology, Athens, Greece | 1981 |
Elected Fellow, Circulation Group, American Physiological Society | 1980 |
Elected Fellow, Council for High Blood Pressure Research, American Heart Association | 1980 |
Research Career Development Award, National Institutes of Health | 1979 |
Ernest G. Spivey Research Award, American Heart Association, Mississippi Affiliate | 1979 |
Research Service Award, National Institutes of Health | 1975 |
Title IV Predoctoral Fellow Award, NDEA | 1970 |
Award for scholastic achievement, Phi Delta Kappa | 1968 |
Magna Cum Laude Graduate, Kent State University | 1968 |
Deans List for academic achievement, Kent State University | 1964 |
Committee Service
Vice Chancellor's Research Advisory Committee, Member | 2013 - Present |
MEDICAL CENTER-MARKETING, Member | 2012 - 2014 |
MEDICAL CENTER-DIVERSITY, Member | 2012 - 2014 |
Biomedical Research Grants Committee, Member | 2012 - 2013 |
Search Committee for Obesity Center Director, Chair | 2012 - 2013 |
MEDICAL CENTER-CANCER INSTITUTE INTERNAL ADVISORY, Vice Chair | 2012 - 2013 |
Chief Development Officer Search Committee, Member | 2011 - 2012 |
School of Pharmacy Research Awards Committee, Member | 2011 - Present |
UMMC/VA Affiliation Partnership Council, Member | 2011 - 2014 |
Institutional Advisory Board, Mississippi Institute for the Improvement of Geographic Minority Health, Member | 2010 - 2013 |
MEDICAL CENTER-MASTER PLANNING, Member | 2009 - 2014 |
MEDICAL CENTER-MASTER PLANNING, Member | 2009 - 2014 |
Pediatrics Chair Search Committee, Member | 2009 - 2011 |
UMMC Vice Chancellor for Health Affairs Search Committee, Member | 2009 - 2010 |
Committee for Selection of Billy S. Guyton Professors, Member | 2009 - 2009 |
MEDICAL CENTER-SACS LEADERSHIP, Member | 2008 - 2014 |
Institutional Enhancement Committee, Member | 2007 - 2013 |
Conflict of Interest Committee, Member | 2006 - 2013 |
MEDICAL CENTER-SPACE, Member | 2006 - 2014 |
Search Committee for UMMC Cancer Insititute Director, Vice Chair | 2006 - 2009 |
Facilities Strategic Planning Committee, Member | 2006 - 2008 |
Human Resources Strategic Planning Committee, Member | 2006 - 2008 |
Advisory Committee, Development Director | 2006 - 2007 |
Science and Medicine Advisory Committee, Delta Health Alliance, Chair | 2006 - 2007 |
MEDICAL CENTER-ANIMAL CARE AND USE, Ex-Officio Member | 2005 - 2013 |
Biomedical Research Grants Committee, Chair | 2005 - 2012 |
Cancer Institute Steering Committee, Vice Chair | 2005 - 2013 |
Compliance Subcommittee for Research, Chair | 2005 - 2013 |
MEDICAL CENTER-INSTITUTIONAL COMPLIANCE, Member | 2005 - 2013 |
MEDICAL CENTER-LIBRARY FACULTY ADVISORY, Member | 2005 - 2011 |
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Chair | 2004 - 2004 |
MEDICAL CENTER-RESEARCH ADVISORY, Chair | 2003 - 2013 |
Internal Advisory Board, Center of Excellence in Women's Health, Member | 2003 - 2008 |
Search Committee for UMMC Development Director, Member | 2003 - 2004 |
Internal Advisory Board, Center of Psychiatric Neurosciences, Member | 2002 - Present |
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member | 2000 - 2003 |
Dean's Graduate Research Award Selection Committee, Member | 1998 - 2009 |
Dean's Graduate Scholarship Selection Committee, Member | 1998 - 2009 |
Jackson Heart Study Scientific Directions Committee, Chair | 1998 - 2003 |
Jackson Heart Study Protocol Development Committee, Chair | 1998 - 1999 |
Steering Committee, Sesquicentennial Campaign, Member | 1998 - 1998 |
Long Range Planning Committee, Member | 1996 - 2013 |
Research Advisory/Development Committee, Member | 1996 - 2013 |
Biomedical Research Grants Committee, Member | 1996 - 2005 |
American Cancer Society Institutional Research Grants Committee, Member | 1996 - 1996 |
Howard Hughes Institutional Research Grants Committee, Member | 1996 - 1996 |
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Chair | 1994 - 1994 |
SCHOOL OF DENTISTRY-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member | 1994 - 1998 |
Transfusion Medical Education Advisory Committee, Member | 1990 - 2000 |
Anesthesiology Chair Search Advisory Search Committee, Member | 1990 - 1990 |
School of Dentistry, Executive Faculty, Member | 1989 - Present |
SCHOOL OF MEDICINE-EXECUTIVE FACULTY, Member | 1989 - Present |
Basic Science Promotions Committee, Member | 1989 - 2008 |
SCHOOL OF MEDICINE-FACULTY APPOINTMENTS, PROMOTIONS AND TENURE, Member | 1989 - 1993 |
Neurology Chair Search Advisory Committee, Member | 1989 - 1989 |
Surgery Chair Search Advisory Committee, Member | 1989 - 1989 |
SCHOOL OF GRADUATE STUDIES IN THE HEALTH SCIENCES-GRADUATE COUNCIL, Member | 1980 - Present |
Other Service
Institutional Cost Reduction Task Force, Member | 2009 - 2009 |
Pediatrics Chair Search Advisory Committee, Member | 2009 - Present |
Search committee for Obesity Center Director, Chair | 2009 - Present |
UMMC Vice Chancellor for Health Affairs Search Committee, Member | 2009 - 2010 |
Committee for Selection of Billy S. Guyton Professors, Member | 2009 - 2009 |
Institutional Quality Board, Member | 2008 - 2009 |
Institutional Enhancement Committee, Member | 2007 - Present |
University of Mississipi Medical Center Research Foundation, Vice President | 2006 - 2013 |
Search Committee for UMMC Cancer Institute Directo, Co-Chair | 2006 - 2009 |
Facilities Strategic Planning Committee, Member | 2006 - 2008 |
Human Resources Strategic Planning Committee, Member | 2006 - 2008 |
Development Director Advisory Search Committee, Member | 2006 - 2007 |
Science and Medicine Advisory Committee, Delta Health Alliance, Chair | 2006 - 2007 |
Biomedical Research Grants Committee, Chair | 2005 - Present |
Compliance Subcommittee for Research, Chair | 2005 - Present |
Institutional Animal Care and Use Committee, Ex-Officio member | 2005 - Present |
Internal Advisory Board, Center of Excellence in Women’s Health, Member | 2003 - 2008 |
Research Strategic Task Force, Chair | 2003 - 2004 |
Search Committee for UMMC Development Director, Member | 2003 - 2004 |
Research Council, Department of Medicine, Member | 2001 - 2009 |
Dean's Graduate Research Award Selection Committee, Member | 1998 - Present |
Dean's Graduate Scholarship Selection Committee, Member | 1998 - Present |
Jackson Heart Study Scientific Directions Committee, Chair | 1998 - 2003 |
Jackson Heart Study Protocol Development Committee, Chair | 1998 - 1999 |
Steering Committee, Sesquicentennial Campaign, Member | 1998 - 1998 |
Biomedical Research Grants Committee, Member | 1996 - Present |
Research Development Committee, Member | 1996 - Present |
American Cancer Society Institutional Research Grants Committee, Member | 1996 - 1996 |
Howard Hughes Institutional Research Grants Committee, Member | 1996 - 1996 |
Transfusion Medical Education Advisory Committee, Member | 1990 - 2000 |
Anesthesiology Chair Search Advisory Search Committe, Member | 1990 - 1990 |
Surgery Chair Search Advisory Committee, Member | 1990 - 1990 |
Neurology Chair Search Advisory Committee, Member | 1989 - 1989 |
AHA, Council for High Blood Pressure Research, Fellow | 1980 - Present |
Graduate Program in Physiology and Biophysics, Director | 1980 - 1990 |
Participant, American Heart Association Research Summit | 2012 |
Teaching Experience
611, Medicine, Course, Course Director, PHYS | 2012 |
611, Medicine, Course, Course Director, PHYS | 2011 |
611, Medicine, Course, Course Director, PHYS | 2010 |
611, Medicine, Course, Course Director, PHYS | 2009 |
611, Medicine, Course, Course Director, PHYS | 2008 |
611, Medicine, Course, Course Director, PHYS | 2007 |
Directed Student Learning
Supervised Research, Advised: Benjamin Pace | 2011 - Present |
Supervised Research, Advised: Corey Parish | 2011 - 2011 |
Summer Research Volunteer, Advised: Ahmad Adi | 2010 - 2010 |
Supervised Research, Advised: Ahmad Adi | 2010 - 2011 |
Supervised Research, Advised: John Rushing | 2010 - 2011 |
Supervised Research, Advised: Mark Davis | 2009 - Present |
Supervised Research, Advised: Benjamin Pace | 2009 - 2010 |
Supervised Research, Advised: Mark Davis | 2009 - 2010 |
Supervised Undergraduate Research, Advised: Jarrett Morgan | 2009 - 2009 |
Advisor, Advised: Mark Davis | 2008 - 2008 |
Advisor, Advised: Gray Wallace | 2007 - 2007 |
Supervised Research, Advised: Nathan Freeman | 2006 - 2011 |
Summer Research Program, Advised: John (Barr) Biglane | 2006 - 2006 |
Summer Research Program, Advised: Lauren Cantwell | 2006 - 2006 |
Thesis Advisor, Advised: Wendy Case | 2006 - 2006 |
Supervised Research, Advised: John (Barr) Biglane | 2006 - 2006 |
Supervised Research, Advised: Lauren Cantwell | 2006 - 2006 |
Supervised Undergraduate Research, Advised: Joshua Lasseigne | 2005 - 2005 |
Supervised Undergraduate Research, Advised: Tracie Perkins | 2005 - 2005 |
Supervised Research, Advised: Brittany Penland | 2005 - 2005 |
Supervised Research, Advised: John V. Roberts | 2005 - 2005 |
Supervised Research, Advised: Lila Hudson | 2004 - 2005 |
Supervised Undergraduate Research, Advised: Elizabeth Fowler | 2004 - 2004 |
Supervised Undergraduate Research, Advised: Paul Brown | 2004 - 2004 |
Supervised Research, Advised: Mary Alissa Willis | 2004 - 2004 |
Supervised Undergraduate Research, Advised: Amel Mohamed | 2003 - 2003 |
Supervised Undergraduate Research, Advised: Chiatne McFarland | 2003 - 2003 |
Supervised Undergraduate Research, Advised: James Arthur Burwell II | 2003 - 2003 |
Major Advsior, The Role of NA+-K+2CI- Cotransporter 1 in Cerebral Artery Contraction and in Neonatal Hypoxia-Ischemia Advised: Yun Dai | 2003 - 2003 |
Dissertation Committee Member, Involvement of Mitogen- Activated Protein Kinase in the Pathogenesis of Cerebral Vasospasm Advised: Alexander Zubkov | 2001 - 2001 |
Supervised Undergraduate Research, Advised: Allison Hailman | 2000 - 2002 |
Supervised Undergraduate Research, Advised: Leigh Ammons | 2000 - 2002 |
Supervised Undergraduate Research, Advised: Melanie Hand | 2000 - 2000 |
Supervised Undergraduate Research, Advised: Megan Carlyle | 1999 - 2000 |
Supervised Research, Advised: O. Barrett Jones | 1999 - 2000 |
Dissertation Committee Chair, Role of Potassium in Protecting Against Arteriosclerosis and Neointimal Lesion Formation Advised: Ge Ma | 1999 - 1999 |
Dissertation Committee Member, Advised: Jan ter Maaten | 1999 - 1999 |
Supervised Undergraduate Research, Advised: Joel Paul Martin | 1999 - 1999 |
Supervised Undergraduate Research, Advised: LeShawn McNair | 1999 - 1999 |
Supervised Undergraduate Research, Advised: Monica Davis | 1999 - 1999 |
Supervised Research, Advised: Matthew Verucchi | 1999 - 1999 |
Supervised Undergraduate Research, Advised: Kim Anderson | 1998 - 1999 |
Supervised Research, Advised: Glenn (Andy) Brien | 1998 - 1999 |
Supervised Undergraduate Research, Advised: Lafarra Young | 1998 - 1998 |
Supervised Research, Advised: Omar Logue | 1998 - 1998 |
Supervised Research, Advised: Paul Kim | 1998 - 1998 |
Dissertation Committee Member, Mechanisms of Insulin Hypertension in Rats Advised: Henry Keen | 1997 - 1997 |
Supervised Research, Advised: William Hewitt | 1997 - 1997 |
Supervised Undergraduate Research, Advised: Clifton R. Barker | 1996 - 1997 |
Dissertation Committee Member, Interaction Between Intrarenal Nitric Oxide and the Renin-Angiotensin System in the Control of Kidney Function and Blood Pressure Advised: Christine Schnackenber | 1996 - 1996 |
Dissertation Committee Member, Adaptation of Blood Vascular System to Maximum Metabolic Demand Advised: Jian Hang | 1995 - 1995 |
Dissertation Committee Member, Renal and Cardiovascular Mechanisms of Obesity Hypertension Advised: Magdalena Alonso-Galicia | 1995 - 1995 |
Supervised Research, Advised: Timothy Hopkins | 1995 - 1995 |
Supervised Undergraduate Research, Advised: John Bradley Madden | 1994 - 1996 |
Dissertation Committee Member, Endothelium-derived Nitric Oxide and Arterial Pressure Regulation Advised: Lufei Hu | 1994 - 1994 |
Supervised Research, Advised: William Lee | 1994 - 1994 |
Supervised Research, Advised: Angela Gardner | 1993 - 1993 |
Supervised Research, Advised: David Harrison | 1993 - 1993 |
Supervised Research, Advised: Michael Holman | 1992 - 1992 |
Dissertation Committee Member, Role of Total Peripheral Resistance in the Long-Term Control of Arterial Blood Pressure and the Pathogenesis of Hypertension Advised: Min Huang | 1991 - 1991 |
Dissertation Committee Member, Effects of Acute Hyperkalemia on Renal Hemodynamics and Renal Secretion in Intact Animals Advised: Huabao Lin | 1990 - 1990 |
Dissertation Committee Member, Investigation of Canine Forelimb Arterial Vascular Pressure Gradients with Reference to the Ability of Peripheral Measurement Sites to Estimate the Parameters of the Central Aortic Pressure Advised: A. William Paulsen | 1989 - 1989 |
Dissertation Committee Member, Adrenergic Regulation of Renin Release and the Role of Angiotensin II in Mediating the Renal Actions of Norepinephrine Advised: Hun Mo Yang | 1989 - 1989 |
Dissertation Committee Member, Role of the Transvascular Fluid Flux and Lymph Flow in Extracellular Fluid Volume Regulation During Vasoconstrictor and Volume-loading Hypertension Advised: Jorge Valenzuela-Williams | 1989 - 1989 |
Dissertation Committee Member, Effects of Selective B2-Agonist on Circulatory Control Mechanisms in Dogs Advised: Bahij Nuwayhid | 1987 - 1987 |
Major Advisor, Role of the Renal Nerves in the Long Term Control of Renal Hemodynamics and Electrolyte Excretion Advised: H. Leland Mizelle | 1987 - 1987 |
Dissertation Committee Member, Analysis of the Cardiovascular Effects of Arginine Vasopressin in Dogs Advised: Udom Tipayomontri | 1984 - 1984 |
Dissertation Committee Member, Baroreceptor Gain, Arterial Pressure and Heart Rate in Arterial Baroreceptor Denervated and Spontaneously Hypertensive Rats Advised: Ann Dent | 1983 - 1983 |
Major Advisor, Control of Renal Hemodynamics, Electrolyte Excretion and Arterial Pressure: Role of the Kallikrein-Kinin System Advised: Joey Granger | 1983 - 1983 |
Dissertation Committee Chair, Reactive and Exercise Hyperemic During High Levels of Adenosine Infusion Advised: Robert Hester | 1982 - 1982 |
Dissertation Committee Member, Oxygen Consumption, Heart Rate, and Subjective Rating Under Conditions of Relaxation and Active Coping Advised: James Hollandsworth | 1982 - 1982 |
Dissertation Committee Member, Evaluation of Reflex Control of Arterial Pressure by Sinusoidal Blood Volume Changes in Baroreceptor Denervated and Baroreceptor Innervated Dogs Advised: David Brown | 1981 - 1981 |
Dissertation Committee Member, The Interaction of Volume and Osmoreceptors in the Control of Plasma Vasopressin, Body Fluid Volumes, and Electrolytes Advised: Edmund Quillen | 1981 - 1981 |
Dissertation Committee Member, Experimental Aldosterone Hypertension Advised: Yi-Jen Pan | 1979 - 1979 |
Dissertation Committee Member, The Pulmonary Circulation: Studies on Alveolar Hypoxia and Vascular Smooth Muscle Metabolism Advised: Richard Parker | 1978 - 1978 |
Supervised Research, Advised: Beth Mitcheltree-Miller | |
Supervised Research, Advised: Robert Meacham III | |
Supervised Research, Advised: William N. Dixon | |
Supervised Research, Advised: John E. Ammons | |
Supervised Research, Advised: Robert Stewart | |
Supervised Research, Advised: Andrew C. Brown | |
Supervised Research, Advised: Lee E. Herring | |
Supervised Research, Advised: Melynda Cummins | |
Supervised Research, Advised: Jennifer DeCrane | |
Supervised Research, Advised: S. Keith Rushing | |
Supervised Research, Advised: Ava H. Bell | |
Supervised Research, Advised: George M. Thurber | |
Supervised Research, Advised: Anthony E. Daniels | |
Supervised Research, Advised: Aubrey L. Scott | |
Supervised Research, Advised: Celia Lauren Morse | |
Supervised Research, Advised: Douglas N. Packer |
Fellows supervised
University of Mississippi Medical Center Department of Physiology, Training Faculty, 34 fellows supervised, Hall Lab | 01/1976 - Present |